[
  {
    "id": 146500,
    "drug": {
      "current_status": "MARKETED",
      "id": 27344,
      "drug_code": 89593,
      "updated_date": "2025-12-03T00:32:21-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259891,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259890,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02411326",
      "brand_name": "APO-AMLODIPINE-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251555006"
    },
    "created_date": "2021-10-01T13:05:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02411326",
    "company_name": "APOTEX INC",
    "atc_number": "C10BX",
    "atc_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
    "estimated_end_date": "2021-11-19T00:00:00-05:00",
    "actual_start_date": "2021-09-27T00:00:00-04:00",
    "actual_end_date": "2021-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-15T19:26:13-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMLODIPINE-ATORVASTATIN",
    "en_drug_common_name": "AMLODIPINE-ATORVASTATIN",
    "fr_drug_brand_name": "APO-AMLODIPINE-ATORVASTATIN",
    "fr_drug_common_name": "AMLODIPINE-ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN\r\nAMLODIPINE",
    "fr_ingredients": "AMLODIPINE-ATORVASTATIN",
    "drug_strength": "20MG\r\n10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146503,
    "drug": {
      "current_status": "MARKETED",
      "id": 98810,
      "drug_code": 93890,
      "updated_date": "2020-04-03T06:53:05-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261809,
          "ingredient": {
            "id": 3258,
            "ingredient_code": 17051,
            "en_name": "DARIFENACIN",
            "fr_name": "Darifénacine (Bromhydrate de darifénacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452510",
      "brand_name": "APO-DARIFENACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151554001"
    },
    "created_date": "2021-10-01T13:10:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452510",
    "company_name": "APOTEX INC",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2021-09-27T00:00:00-04:00",
    "actual_end_date": "2022-01-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-24T13:27:11-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DARIFENACIN",
    "en_drug_common_name": "DARIFENACIN",
    "fr_drug_brand_name": "APO-DARFENACIN",
    "fr_drug_common_name": "DARFENACIN",
    "en_ingredients": "DARIFENACIN",
    "fr_ingredients": "DARFENACIN",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146508,
    "drug": {
      "current_status": "MARKETED",
      "id": 11642,
      "drug_code": 68716,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254331,
          "ingredient": {
            "id": 806,
            "ingredient_code": 7538,
            "en_name": "MEDROXYPROGESTERONE ACETATE",
            "fr_name": "Acétate de médroxyprogestérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244727",
      "brand_name": "AA-MEDROXY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106339005"
    },
    "created_date": "2021-10-01T13:14:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244727",
    "company_name": "APOTEX INC",
    "atc_number": "G03DA",
    "atc_description": "PROGESTOGENS",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2021-09-27T00:00:00-04:00",
    "actual_end_date": "2022-01-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2022-01-31T13:22:26-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MEDROXY TABLETS",
    "en_drug_common_name": "MEDROXY",
    "fr_drug_brand_name": "APO-MEDROXY",
    "fr_drug_common_name": "MEDROXY",
    "en_ingredients": "MEDROXYPROGESTERONE ACETATE",
    "fr_ingredients": "Acétate de médroxyprogestérone",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146511,
    "drug": {
      "current_status": "MARKETED",
      "id": 12398,
      "drug_code": 70894,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254565,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246699",
      "brand_name": "APO-NAPROXEN EC TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109634001"
    },
    "created_date": "2021-10-01T13:17:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246699",
    "company_name": "APOTEX INC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2021-09-29T00:00:00-04:00",
    "actual_start_date": "2021-09-27T00:00:00-04:00",
    "actual_end_date": "2021-09-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-01T13:36:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-NAPROXEN EC TABLETS",
    "en_drug_common_name": "NAPROXEN",
    "fr_drug_brand_name": "APO-NAPROXEN ECT",
    "fr_drug_common_name": "NAPROXEN",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146514,
    "drug": {
      "current_status": "MARKETED",
      "id": 9048,
      "drug_code": 61676,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253562,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02238280",
      "brand_name": "APO-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417003"
    },
    "created_date": "2021-10-01T13:22:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238280",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2021-09-27T00:00:00-04:00",
    "actual_end_date": "2021-12-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-06T15:52:28-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "APO-SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146519,
    "drug": {
      "current_status": "MARKETED",
      "id": 12536,
      "drug_code": 71248,
      "updated_date": "2025-05-15T02:31:24-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254606,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247014",
      "brand_name": "APO-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415002"
    },
    "created_date": "2021-10-01T13:26:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247014",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2021-10-18T00:00:00-04:00",
    "actual_start_date": "2021-09-27T00:00:00-04:00",
    "actual_end_date": "2021-10-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-20T13:24:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN",
    "fr_drug_brand_name": "APO-SIMVASTATIN",
    "fr_drug_common_name": "SIMVASTATIN",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146522,
    "drug": {
      "current_status": "MARKETED",
      "id": 12536,
      "drug_code": 71248,
      "updated_date": "2025-05-15T02:31:24-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254606,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247014",
      "brand_name": "APO-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415002"
    },
    "created_date": "2021-10-01T13:28:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247014",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2021-10-25T00:00:00-04:00",
    "actual_start_date": "2021-09-27T00:00:00-04:00",
    "actual_end_date": "2021-10-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-25T12:13:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN",
    "fr_drug_brand_name": "APO-SIMVASTATIN",
    "fr_drug_common_name": "SIMVASTATIN",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146579,
    "drug": {
      "current_status": "MARKETED",
      "id": 10198,
      "drug_code": 6511,
      "updated_date": "2025-05-15T02:30:37-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8250909,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00644331",
      "brand_name": "PRO-AMOX-250",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63297",
      "number_of_ais": "1",
      "ai_group_no": "0131314003"
    },
    "created_date": "2021-10-01T16:02:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00644331",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "J01CA",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2021-11-02T00:00:00-04:00",
    "actual_start_date": "2021-10-01T00:00:00-04:00",
    "actual_end_date": "2021-11-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-11-03T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PRO-AMOX-250",
    "en_drug_common_name": "AMOX 250",
    "fr_drug_brand_name": "PRO AMOX 250",
    "fr_drug_common_name": "AMOX 250",
    "en_ingredients": "AMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "250MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146596,
    "drug": {
      "current_status": "MARKETED",
      "id": 3868,
      "drug_code": 19442,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252489,
          "ingredient": {
            "id": 158,
            "ingredient_code": 5319,
            "en_name": "POTASSIUM PHOSPHATE DIBASIC",
            "fr_name": "Phosphate de potassium dibasique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "236",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252488,
          "ingredient": {
            "id": 160,
            "ingredient_code": 6337,
            "en_name": "POTASSIUM PHOSPHATE MONOBASIC",
            "fr_name": "Phosphate de potassium monobasique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "224",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139545",
      "brand_name": "POTASSIUM PHOSPHATES INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81739",
      "number_of_ais": "2",
      "ai_group_no": "0207483001"
    },
    "created_date": "2021-10-01T20:08:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139545",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2021-10-01T00:00:00-04:00",
    "estimated_end_date": "2021-10-12T00:00:00-04:00",
    "actual_start_date": "2021-10-01T00:00:00-04:00",
    "actual_end_date": "2021-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-22T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "POTASSIUM PHOSPHATES INJECTION, USP",
    "en_drug_common_name": "Potassium Phosphates Injection, USP PBP Vial 3 mmol / mL 50 mL",
    "fr_drug_brand_name": "Phosphates de potassium injectables USP, fiole GFP",
    "fr_drug_common_name": "Phosphates de potassium injectables USP, fiole GFP à 3 mmol / mL de 50 mL",
    "en_ingredients": "POTASSIUM PHOSPHATE DIBASIC\r\nPOTASSIUM PHOSPHATE MONOBASIC",
    "fr_ingredients": "Phosphate de potassium dibasique\r\nPhosphate de potassium monobasique",
    "drug_strength": "236MG\r\n224MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146621,
    "drug": {
      "current_status": "MARKETED",
      "id": 14304,
      "drug_code": 74388,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255153,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8255152,
          "ingredient": {
            "id": 1624,
            "ingredient_code": 11213,
            "en_name": "DORZOLAMIDE",
            "fr_name": "Dorzolamide (Chlorhydrate de dorzolamide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02258692",
      "brand_name": "COSOPT PRESERVATIVE-FREE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0237301001"
    },
    "created_date": "2021-10-04T18:04:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02258692",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2021-10-04T00:00:00-04:00",
    "estimated_end_date": "2021-10-18T00:00:00-04:00",
    "actual_start_date": "2021-10-04T00:00:00-04:00",
    "actual_end_date": "2021-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-15T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "COSOPT",
    "en_drug_common_name": "Dorzolamide and timolol ophthalmic solution",
    "fr_drug_brand_name": "COSOPT",
    "fr_drug_common_name": "collyre de dorzolamide et timolol",
    "en_ingredients": "TIMOLOL\r\nDORZOLAMIDE",
    "fr_ingredients": "dorzolamide hydrochloride' timolol maleate",
    "drug_strength": "5MG\r\n20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146626,
    "drug": {
      "current_status": "MARKETED",
      "id": 101487,
      "drug_code": 100038,
      "updated_date": "2021-02-08T05:57:12-05:00",
      "company": {
        "id": 1760,
        "created_date": "2017-03-09T13:25:38-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 15083,
        "mfr_code": "",
        "name": "DR REDDY'S LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "SURVEY NOS. 42, 45, 46 & 54, INNOVATION PLAZA, BACHUPALLY",
        "province": "TELANGANA",
        "country": "INDIA",
        "city": "MEDCHAL-MALKAJGIRI",
        "postal_code": "500090",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266020,
          "ingredient": {
            "id": 3042,
            "ingredient_code": 13153,
            "en_name": "ERTAPENEM",
            "fr_name": "Ertapénem (Ertapénem sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02511150",
      "brand_name": "ERTAPENEM FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149104002"
    },
    "created_date": "2021-10-04T18:43:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02511150",
    "company_name": "DR REDDY'S LABORATORIES LTD",
    "atc_number": "J01DH",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2021-11-03T00:00:00-04:00",
    "actual_start_date": "2021-10-04T00:00:00-04:00",
    "actual_end_date": "2021-11-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-11-04T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ERTAPENEM FOR INJECTION",
    "en_drug_common_name": "ERTAPENEM FOR INJECTION",
    "fr_drug_brand_name": "Ertapénem pour injection",
    "fr_drug_common_name": "Ertapénem pour injection",
    "en_ingredients": "ERTAPENEM",
    "fr_ingredients": "Ertapénem",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 VIALS / CARTON",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146634,
    "drug": {
      "current_status": "MARKETED",
      "id": 6730,
      "drug_code": 44188,
      "updated_date": "2025-12-03T00:30:37-05:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8253162,
          "ingredient": {
            "id": 2236,
            "ingredient_code": 420,
            "en_name": "GADODIAMIDE",
            "fr_name": "Gadodiamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "287",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02172771",
      "brand_name": "OMNISCAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9823",
      "number_of_ais": "1",
      "ai_group_no": "0126095001"
    },
    "created_date": "2021-10-04T19:37:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172771",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08CA",
    "atc_description": "MAGNETIC RESONANCE IMAGING CONTRAST MEDIA",
    "estimated_end_date": "2021-10-19T00:00:00-04:00",
    "actual_start_date": "2021-10-04T00:00:00-04:00",
    "actual_end_date": "2021-10-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-19T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OMNISCAN",
    "en_drug_common_name": "Gadodiamide injection USP",
    "fr_drug_brand_name": "OMNISCAN",
    "fr_drug_common_name": "gadodiamide pour injection USP",
    "en_ingredients": "GADODIAMIDE",
    "fr_ingredients": "Gadodiamide",
    "drug_strength": "287MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 mL vials",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146649,
    "drug": {
      "current_status": "MARKETED",
      "id": 13618,
      "drug_code": 73439,
      "updated_date": "2025-05-15T02:31:34-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254922,
          "ingredient": {
            "id": 3116,
            "ingredient_code": 1227,
            "en_name": "FLUMAZENIL",
            "fr_name": "Flumazénil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02249561",
      "brand_name": "FLUMAZENIL INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122202001"
    },
    "created_date": "2021-10-05T02:52:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02249561",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "V03AB",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2021-12-10T00:00:00-05:00",
    "actual_start_date": "2021-10-04T00:00:00-04:00",
    "actual_end_date": "2021-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-12-07T01:37:21-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FLUMAZENIL INJECTION",
    "en_drug_common_name": "FLUMAZENIL",
    "fr_drug_brand_name": "FLUMAZENIL INJECTION",
    "fr_drug_common_name": "FLUMAZENIL INJECTION",
    "en_ingredients": "FLUMAZENIL",
    "fr_ingredients": "Flumazénil",
    "drug_strength": "0.1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5ML10LIVI",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146652,
    "drug": {
      "current_status": "MARKETED",
      "id": 13882,
      "drug_code": 73813,
      "updated_date": "2025-05-15T02:31:36-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254990,
          "ingredient": {
            "id": 590,
            "ingredient_code": 4922,
            "en_name": "VITAMIN D3",
            "fr_name": "Vitamine D3"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02253178",
      "brand_name": "SANDOZ D 10 000",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108524005"
    },
    "created_date": "2021-10-05T02:54:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02253178",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A11CC",
    "atc_description": "VIT A AND D, INCL COMBINATIONS OF THE TWO",
    "estimated_end_date": "2021-10-08T00:00:00-04:00",
    "actual_start_date": "2021-10-04T00:00:00-04:00",
    "actual_end_date": "2021-10-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-16T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ D 10 000",
    "en_drug_common_name": "SANDOZ D 10 000",
    "fr_drug_brand_name": "SANDOZ D 10 000",
    "fr_drug_common_name": "SANDOZ D 10 000",
    "en_ingredients": "VITAMIN D3",
    "fr_ingredients": "Vitamine D3",
    "drug_strength": "10000UNIT",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60SGC BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146655,
    "drug": {
      "current_status": "MARKETED",
      "id": 20782,
      "drug_code": 82577,
      "updated_date": "2025-05-15T02:32:34-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257352,
          "ingredient": {
            "id": 3240,
            "ingredient_code": 11780,
            "en_name": "TAMSULOSIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tamsulosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02340208",
      "brand_name": "SANDOZ TAMSULOSIN CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133680001"
    },
    "created_date": "2021-10-05T02:56:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02340208",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2021-10-15T00:00:00-04:00",
    "actual_start_date": "2021-10-04T00:00:00-04:00",
    "actual_end_date": "2021-10-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-20T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TAMSULOSIN CR",
    "en_drug_common_name": "TAMSULOSIN CR",
    "fr_drug_brand_name": "SANDOZ TAMSULOSIN CR",
    "fr_drug_common_name": "TAMSULOSIN CR",
    "en_ingredients": "TAMSULOSIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tamsulosine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100PRT BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146679,
    "drug": {
      "current_status": "MARKETED",
      "id": 3562,
      "drug_code": 18937,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252402,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "234",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139510",
      "brand_name": "SODIUM CHLORIDE INJECTION, USP",
      "brand_name_fr": "CHLORURE DE SODIUM INJECTABLE, USP",
      "descriptor": "SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "81223",
      "number_of_ais": "1",
      "ai_group_no": "0100053008"
    },
    "created_date": "2021-10-05T13:09:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139510",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2021-10-08T00:00:00-04:00",
    "estimated_end_date": "2021-11-10T00:00:00-05:00",
    "actual_end_date": "2021-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-11T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SODIUM CHLORIDE INJECTION, USP",
    "en_drug_common_name": "Sodium Chloride Injection, USP 4 mEq/mL SD Vial 30 mL",
    "fr_drug_brand_name": "Chlorure de sodium injectable, USP",
    "fr_drug_common_name": "Chlorure de sodium injectable, USP, 4 mEq/mL, fioles DU, 30 mL",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "234MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "30 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146691,
    "drug": {
      "current_status": "MARKETED",
      "id": 10446,
      "drug_code": 65701,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253942,
          "ingredient": {
            "id": 1492,
            "ingredient_code": 7567,
            "en_name": "BECLOMETHASONE DIPROPIONATE",
            "fr_name": "Dipropionate de béclométhasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02242030",
      "brand_name": "QVAR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106320003"
    },
    "created_date": "2021-10-05T14:20:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242030",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2021-12-13T00:00:00-05:00",
    "actual_start_date": "2021-12-06T00:00:00-05:00",
    "actual_end_date": "2021-12-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-12-15T21:11:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "QVAR",
    "en_drug_common_name": "QVAR",
    "fr_drug_brand_name": "QVAR",
    "fr_drug_common_name": "QVAR",
    "en_ingredients": "BECLOMETHASONE DIPROPIONATE",
    "fr_ingredients": "Dipropionate de béclométhasone",
    "drug_strength": "100MCG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "200 dose",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146694,
    "drug": {
      "current_status": "MARKETED",
      "id": 7384,
      "drug_code": 49818,
      "updated_date": "2025-12-03T00:30:39-05:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253294,
          "ingredient": {
            "id": 2196,
            "ingredient_code": 7559,
            "en_name": "PREDNICARBATE",
            "fr_name": "Prednicarbate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02230642",
      "brand_name": "DERMATOP EMOLLIENT CREAM",
      "brand_name_fr": "DERMATOP CRÈME ÉMOLLIENTE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0120996001"
    },
    "created_date": "2021-10-05T14:23:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230642",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2022-09-30T00:00:00-04:00",
    "actual_start_date": "2021-09-03T00:00:00-04:00",
    "actual_end_date": "2021-09-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-04-28T13:41:13-04:00",
    "status": "resolved",
    "en_comments": "Delay in production related to excipient",
    "fr_comments": "delai en production",
    "en_drug_brand_name": "DERMATOP EMOLLIENT CREAM",
    "en_drug_common_name": "DERMATOP EMOLLIENT CREAM",
    "fr_drug_brand_name": "DERMATOP EMOLLIENT CREAM",
    "fr_drug_common_name": "DERMATOP EMOLLIENT CREAM",
    "en_ingredients": "PREDNICARBATE",
    "fr_ingredients": "Prednicarbate",
    "drug_strength": "0.1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "60 g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146697,
    "drug": {
      "current_status": "MARKETED",
      "id": 25210,
      "drug_code": 87699,
      "updated_date": "2025-05-15T02:33:39-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259123,
          "ingredient": {
            "id": 3728,
            "ingredient_code": 933,
            "en_name": "ZOLPIDEM TARTRATE",
            "fr_name": "Tartrate de zolpidem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02391678",
      "brand_name": "SUBLINOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122857001"
    },
    "created_date": "2021-10-05T14:28:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02391678",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "N05CF",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "estimated_end_date": "2021-12-07T00:00:00-05:00",
    "actual_start_date": "2021-09-08T00:00:00-04:00",
    "actual_end_date": "2021-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-12-09T14:27:21-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SUBLINOX",
    "en_drug_common_name": "SUBLINOX",
    "fr_drug_brand_name": "SUBLINOX",
    "fr_drug_common_name": "SUBLINOX",
    "en_ingredients": "ZOLPIDEM TARTRATE",
    "fr_ingredients": "Tartrate de zolpidem",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "SUBLINGUAL\r\nSUBLINGUAL",
    "drug_route_fr": "Sublinguale\r\nSublinguale",
    "drug_package_quantity": "30 tabs",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146703,
    "drug": {
      "current_status": "MARKETED",
      "id": 9014,
      "drug_code": 61553,
      "updated_date": "2025-12-03T00:30:41-05:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253555,
          "ingredient": {
            "id": 810,
            "ingredient_code": 9418,
            "en_name": "DIAZEPAM",
            "fr_name": "Diazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02238162",
      "brand_name": "DIASTAT",
      "brand_name_fr": "",
      "descriptor": "PREFILLED RECTAL DELIVERY SYSTEM",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103614001"
    },
    "created_date": "2021-10-05T14:42:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238162",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2021-10-08T00:00:00-04:00",
    "actual_start_date": "2021-09-07T00:00:00-04:00",
    "actual_end_date": "2021-10-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-12-09T14:36:19-05:00",
    "status": "resolved",
    "en_comments": "awaiting QA release",
    "fr_comments": "en attente relâche QA",
    "en_drug_brand_name": "DIASTAT",
    "en_drug_common_name": "DIASTAT",
    "fr_drug_brand_name": "DIASTAT",
    "fr_drug_common_name": "DIASTAT",
    "en_ingredients": "DIAZEPAM",
    "fr_ingredients": "Diazépam",
    "drug_strength": "5MG",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "RECTAL\r\nRECTAL",
    "drug_route_fr": "Rectale\r\nRectale",
    "drug_package_quantity": "10 mg 2pk",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146717,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20392,
      "drug_code": 81923,
      "updated_date": "2025-05-15T04:15:18-04:00",
      "company": {
        "id": 334,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4763,
        "mfr_code": "NNA08",
        "name": "NOVO NORDISK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "101-2476 ARGENTIA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 6M1",
        "post_office_box": "",
        "contact_information": "1 800 465 4334"
      },
      "drug_ingredients": [
        {
          "id": 8347654,
          "ingredient": {
            "id": 2868,
            "ingredient_code": 12072,
            "en_name": "GLUCAGON",
            "fr_name": "Glucagon (source: ADN recombiné)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02333619",
      "brand_name": "GLUCAGEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142861001"
    },
    "created_date": "2021-10-06T13:50:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02333619",
    "company_name": "NOVO NORDISK CANADA INC",
    "atc_number": "H04AA",
    "atc_description": "GLYCOGENOLYTIC HORMONES",
    "anticipated_start_date": "2021-10-06T00:00:00-04:00",
    "estimated_end_date": "2021-10-13T00:00:00-04:00",
    "actual_start_date": "2021-10-06T00:00:00-04:00",
    "actual_end_date": "2021-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-10-14T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Resolved, product is available",
    "fr_comments": "Resout, produit disponible",
    "en_drug_brand_name": "GLUCAGEN",
    "en_drug_common_name": "GLUCAGEN 1 MG",
    "fr_drug_brand_name": "GLUCAGEN",
    "fr_drug_common_name": "GLUCAGEN 1MG",
    "en_ingredients": "GLUCAGON",
    "fr_ingredients": "GLUCAGON",
    "drug_strength": "1MG",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "1 x 1MG",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146719,
    "drug": {
      "current_status": "MARKETED",
      "id": 57721,
      "drug_code": 95102,
      "updated_date": "2025-05-15T02:35:49-04:00",
      "company": {
        "id": 876,
        "created_date": "2017-03-09T13:23:25-05:00",
        "updated_date": "2025-05-15T02:30:24-04:00",
        "company_code": 10225,
        "mfr_code": "",
        "name": "DR. REDDY'S LABORATORIES INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "SUITE 4000 4TH FLOOR",
        "street_name": "600 COLLEGE ROAD EAST",
        "province": "NEW JERSEY",
        "country": "UNITED STATES",
        "city": "PRINCETON",
        "postal_code": "08540",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262455,
          "ingredient": {
            "id": 848,
            "ingredient_code": 7554,
            "en_name": "PROGESTERONE",
            "fr_name": "Progestérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02463113",
      "brand_name": "REDDY-PROGESTERONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106327002"
    },
    "created_date": "2021-10-06T14:14:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02463113",
    "company_name": "DR REDDY'S LABORATORIES INC",
    "atc_number": "G03DA",
    "atc_description": "PROGESTOGENS",
    "anticipated_start_date": "2022-01-01T00:00:00-05:00",
    "estimated_end_date": "2022-02-04T00:00:00-05:00",
    "actual_start_date": "2022-01-01T00:00:00-05:00",
    "actual_end_date": "2022-02-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-02-07T12:05:52-05:00",
    "status": "resolved",
    "fr_comments": "Le produit est actuellement soumis à un processus d’affectation des quantités.",
    "en_drug_brand_name": "REDDY-PROGESTERONE",
    "en_drug_common_name": "PROGESTERONE CAPSULES",
    "fr_drug_brand_name": "REDDY-PROGESTERONE",
    "fr_drug_common_name": "Progestérone en capsules",
    "en_ingredients": "PROGESTERONE",
    "fr_ingredients": "Progestérone",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Blister packages with 30 capsules and bottles of 100 capsules.",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146725,
    "drug": {
      "current_status": "MARKETED",
      "id": 52167,
      "drug_code": 91749,
      "updated_date": "2025-05-15T02:34:33-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260773,
          "ingredient": {
            "id": 2840,
            "ingredient_code": 12034,
            "en_name": "MOXIFLOXACIN",
            "fr_name": "Moxifloxacine (Chlorhydrate de moxifloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "250",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02433087",
      "brand_name": "MOXIFLOXACIN INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142242002"
    },
    "created_date": "2021-10-06T14:25:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02433087",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "anticipated_start_date": "2021-10-05T00:00:00-04:00",
    "estimated_end_date": "2022-01-17T00:00:00-05:00",
    "actual_start_date": "2021-10-05T00:00:00-04:00",
    "actual_end_date": "2022-01-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-06T21:28:24-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MOXIFLOXACIN INJECTION",
    "en_drug_common_name": "Moxifloxacin Injection 1.6 mg/mL freeflex® Bag 250 mL",
    "fr_drug_brand_name": "Moxifloxacine injectable",
    "fr_drug_common_name": "Moxifloxacine injectable à 1,6 mg/mL en sacs freeflexMD de 250 mL",
    "en_ingredients": "MOXIFLOXACIN",
    "fr_ingredients": "Moxifloxacine",
    "drug_strength": "400MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "250 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146732,
    "drug": {
      "current_status": "MARKETED",
      "id": 694,
      "drug_code": 115,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250114,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037818",
      "brand_name": "BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP",
      "brand_name_fr": "CHLORURE DE SODIUM AVEC BACTÉRIOSTATIQUE INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "03696",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2021-10-06T15:05:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037818",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "B05CB",
    "atc_description": "IRRIGATING SOLUTIONS",
    "actual_start_date": "2021-10-20T00:00:00-04:00",
    "actual_end_date": "2023-11-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-11-09T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "10mL format remains available.",
    "fr_comments": "Le format 10mL demeure disponible.",
    "en_drug_brand_name": "BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP",
    "fr_drug_brand_name": "BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP",
    "fr_drug_common_name": "BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "25 x 30mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146735,
    "drug": {
      "current_status": "MARKETED",
      "id": 99241,
      "drug_code": 95694,
      "updated_date": "2020-04-03T06:53:31-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8262760,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02468514",
      "brand_name": "DEXTROSE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102181001"
    },
    "created_date": "2021-10-06T15:08:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02468514",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "actual_start_date": "2021-10-20T00:00:00-04:00",
    "actual_end_date": "2022-05-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-19T13:23:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DEXTROSE INJECTION USP",
    "en_drug_common_name": "DEXTROSE INJECTION USP",
    "fr_drug_brand_name": "DEXTROSE INJECTION USP",
    "fr_drug_common_name": "DEXTROSE INJECTION USP",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "500MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 x 50mL ANSYR II syringes",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146739,
    "drug": {
      "current_status": "MARKETED",
      "id": 5258,
      "drug_code": 3383,
      "updated_date": "2025-05-15T02:30:29-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8250506,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00402257",
      "brand_name": "STERILE WATER FOR INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54123",
      "number_of_ais": "1",
      "ai_group_no": "0105143002"
    },
    "created_date": "2021-10-06T15:52:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00402257",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2021-12-03T00:00:00-05:00",
    "actual_start_date": "2021-10-06T00:00:00-04:00",
    "actual_end_date": "2021-12-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-04T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Water for Injection format 10 x 50mL vials is available for purchase (product code: L0010028) (DIN: 00402257).",
    "fr_comments": "Water for Injection format 10 x 50mL vials is available for purchase (product code: L0010028) (DIN: 00402257).",
    "en_drug_brand_name": "STERILE WATER FOR INJECTION USP",
    "en_drug_common_name": "Water for Injection USP",
    "fr_drug_brand_name": "Eau stérile pour injection USP",
    "fr_drug_common_name": "Eau stérile pour injection USP",
    "en_ingredients": "WATER",
    "fr_ingredients": "Eau",
    "drug_strength": "100%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 10mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146759,
    "drug": {
      "current_status": "MARKETED",
      "id": 6618,
      "drug_code": 43846,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253115,
          "ingredient": {
            "id": 1348,
            "ingredient_code": 1755,
            "en_name": "CARBOPLATIN",
            "fr_name": "Carboplatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02126680",
      "brand_name": "CARBOPLATIN INJECTION BP",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "S9916",
      "number_of_ais": "1",
      "ai_group_no": "0117892002"
    },
    "created_date": "2021-10-06T19:27:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02126680",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "L01XA",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "actual_start_date": "2021-10-06T00:00:00-04:00",
    "actual_end_date": "2021-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-11-02T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CARBOPLATIN INJECTION BP",
    "en_drug_common_name": "CARBOPLATIN INJECTION BP",
    "fr_drug_brand_name": "Carboplatine Injectable BP",
    "fr_drug_common_name": "Carboplatine Injectable BP",
    "en_ingredients": "CARBOPLATIN",
    "fr_ingredients": "Carboplatine",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146795,
    "drug": {
      "current_status": "MARKETED",
      "id": 53455,
      "drug_code": 94808,
      "updated_date": "2025-05-15T02:35:43-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262286,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02460653",
      "brand_name": "APO-METFORMIN ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773003"
    },
    "created_date": "2021-10-07T14:14:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02460653",
    "company_name": "APOTEX INC",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2021-12-17T00:00:00-05:00",
    "actual_start_date": "2021-10-04T00:00:00-04:00",
    "actual_end_date": "2021-12-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-06T15:44:15-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METFORMIN ER",
    "en_drug_common_name": "METFORMIN ER",
    "fr_drug_brand_name": "APO-METFORMIN ER",
    "fr_drug_common_name": "METFORMIN ER",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "1000MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146798,
    "drug": {
      "current_status": "MARKETED",
      "id": 13266,
      "drug_code": 72841,
      "updated_date": "2025-05-15T02:31:30-04:00",
      "company": {
        "id": 1080,
        "created_date": "2017-03-09T13:23:42-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 3652,
        "mfr_code": "",
        "name": "DENTSPLY CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1",
        "street_name": "525 ROWNTREE DAIRY ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 7K6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254816,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.005",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8254815,
          "ingredient": {
            "id": 1256,
            "ingredient_code": 308,
            "en_name": "ARTICAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'articaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02248489",
      "brand_name": "4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000 (0.005MG/ML)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0226661002"
    },
    "created_date": "2021-10-07T14:49:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248489",
    "company_name": "DENTSPLY CANADA LIMITED",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2021-10-07T00:00:00-04:00",
    "estimated_end_date": "2021-11-30T00:00:00-05:00",
    "actual_start_date": "2021-10-07T00:00:00-04:00",
    "actual_end_date": "2021-12-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-13T19:14:00-05:00",
    "status": "resolved",
    "en_drug_brand_name": "4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000 (0.005MG/ML)",
    "en_drug_common_name": "Articaine Hydrochloride 40 mg/mL and Epinephrine Injection 1:200,000",
    "fr_drug_brand_name": "4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000 (0.005MG/ML)",
    "fr_drug_common_name": "Articaine Hydrochloride 40 mg/mL and Epinephrine Injection 1:200,000",
    "en_ingredients": "EPINEPHRINE\r\nARTICAINE HYDROCHLORIDE",
    "fr_ingredients": "Épinéphrine\r\nChlorhydrate d'articaïne",
    "drug_strength": "0.005MG\r\n40MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration\r\nBloc/Infiltration",
    "drug_package_quantity": "100 1.8 mL cartridges/box",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146801,
    "drug": {
      "current_status": "MARKETED",
      "id": 20210,
      "drug_code": 81649,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 1080,
        "created_date": "2017-03-09T13:23:42-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 3652,
        "mfr_code": "",
        "name": "DENTSPLY CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1",
        "street_name": "525 ROWNTREE DAIRY ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 7K6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257166,
          "ingredient": {
            "id": 718,
            "ingredient_code": 10271,
            "en_name": "MEPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de mépivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02330733",
      "brand_name": "3% POLOCAINE DENTAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100583001"
    },
    "created_date": "2021-10-07T14:55:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330733",
    "company_name": "DENTSPLY CANADA LIMITED",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2021-10-07T00:00:00-04:00",
    "estimated_end_date": "2021-12-20T00:00:00-05:00",
    "actual_start_date": "2021-10-07T00:00:00-04:00",
    "actual_end_date": "2021-12-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-01-13T19:13:30-05:00",
    "status": "resolved",
    "en_drug_brand_name": "3% POLOCAINE DENTAL",
    "en_drug_common_name": "MEPIVACAINE HYDROCHLORIDE",
    "fr_drug_brand_name": "3% POLOCAINE DENTAL",
    "fr_drug_common_name": "MEPIVACAINE HYDROCHLORIDE",
    "en_ingredients": "MEPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de mépivacaïne",
    "drug_strength": "30MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "BLOCK/INFILTRATION\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration\r\nBloc/Infiltration",
    "drug_package_quantity": "50 x 1.8 mL Cartridges",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146847,
    "drug": {
      "current_status": "MARKETED",
      "id": 18380,
      "drug_code": 79651,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256439,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310899",
      "brand_name": "TEVA-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055001"
    },
    "created_date": "2021-10-07T16:46:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310899",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2021-11-30T00:00:00-05:00",
    "actual_start_date": "2021-10-06T00:00:00-04:00",
    "actual_end_date": "2021-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-11T19:27:21-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN 10 MG FC TABS",
    "fr_drug_brand_name": "TEVA-ATORVASTATIN 10 MG FC TABS",
    "fr_drug_common_name": "ATORVASTATIN 10 MG FC TABS",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146850,
    "drug": {
      "current_status": "MARKETED",
      "id": 7720,
      "drug_code": 5072,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250704,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00342092",
      "brand_name": "TEVA-CEPHALEXIN 250",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59603",
      "number_of_ais": "1",
      "ai_group_no": "0105911002"
    },
    "created_date": "2021-10-07T16:52:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00342092",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2021-11-30T00:00:00-05:00",
    "actual_start_date": "2021-10-06T00:00:00-04:00",
    "actual_end_date": "2021-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-08T21:09:35-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CEPHALEXIN 250",
    "en_drug_common_name": "CEPHALEXIN SUSP 250MG/5ML",
    "fr_drug_brand_name": "TEVA-CEPHALEXIN SUSP 250MG/5ML",
    "fr_drug_common_name": "CEPHALEXIN SUSP 250MG/5ML",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "250MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146853,
    "drug": {
      "current_status": "MARKETED",
      "id": 13000,
      "drug_code": 72255,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254749,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247945",
      "brand_name": "TEVA-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858004"
    },
    "created_date": "2021-10-07T16:54:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247945",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2021-11-30T00:00:00-05:00",
    "actual_start_date": "2021-10-06T00:00:00-04:00",
    "actual_end_date": "2021-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-11T19:27:39-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL 2.5MG CAPS",
    "fr_drug_brand_name": "TEVA-RAMIPRIL 2.5MG CAPS",
    "fr_drug_common_name": "RAMIPRIL 2.5MG CAPS",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146856,
    "drug": {
      "current_status": "MARKETED",
      "id": 2124,
      "drug_code": 14504,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251972,
          "ingredient": {
            "id": 1080,
            "ingredient_code": 2023,
            "en_name": "SUCRALFATE",
            "fr_name": "Sucralfate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02045702",
      "brand_name": "TEVA-SUCRALFATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76137",
      "number_of_ais": "1",
      "ai_group_no": "0114237002"
    },
    "created_date": "2021-10-07T16:55:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02045702",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BX",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2021-10-31T00:00:00-04:00",
    "actual_start_date": "2021-10-06T00:00:00-04:00",
    "actual_end_date": "2021-11-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-11-05T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SUCRALFATE",
    "en_drug_common_name": "SUCRALFATE 1GM TABLETS",
    "fr_drug_brand_name": "TEVA-SUCRALFATE 1GM TABLETS",
    "fr_drug_common_name": "SUCRALFATE 1GM TABLETS",
    "en_ingredients": "SUCRALFATE",
    "fr_ingredients": "Sucralfate",
    "drug_strength": "1G",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146867,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 550,
      "drug_code": 1118,
      "updated_date": "2025-05-15T03:24:09-04:00",
      "company": {
        "id": 58,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8481,
        "mfr_code": "PIA08",
        "name": "PALADIN PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 BLVD ALEXIS-NIHON, SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": "",
        "contact_information": "1-866-340-1112\r\npaladincs@endo.com"
      },
      "drug_ingredients": [
        {
          "id": 8271377,
          "ingredient": {
            "id": 244,
            "ingredient_code": 9062,
            "en_name": "ACENOCOUMAROL",
            "fr_name": "Acénocoumarol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00010383",
      "brand_name": "SINTROM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "36032",
      "number_of_ais": "1",
      "ai_group_no": "0104595001"
    },
    "created_date": "2021-10-07T17:23:45-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00010383",
    "company_name": "PALADIN LABS INC.",
    "atc_number": "B01AA",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "discontinuation_date": "2019-08-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2021-10-07T17:25:51-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "SINTROM",
    "en_drug_common_name": "ACENOCOUMAROL TABLETS",
    "fr_drug_brand_name": "SIMTROM",
    "fr_drug_common_name": "COMPRIME D'ACENOCOUMAROL",
    "en_ingredients": "ACENOCOUMAROL",
    "fr_ingredients": "Acénocoumarol",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100s",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146870,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 320,
      "drug_code": 1084,
      "updated_date": "2025-05-15T03:24:06-04:00",
      "company": {
        "id": 58,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8481,
        "mfr_code": "PIA08",
        "name": "PALADIN PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 BLVD ALEXIS-NIHON, SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": "",
        "contact_information": "1-866-340-1112\r\npaladincs@endo.com"
      },
      "drug_ingredients": [
        {
          "id": 8271294,
          "ingredient": {
            "id": 244,
            "ingredient_code": 9062,
            "en_name": "ACENOCOUMAROL",
            "fr_name": "Acénocoumarol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00010391",
      "brand_name": "SINTROM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "35493",
      "number_of_ais": "1",
      "ai_group_no": "0104595002"
    },
    "created_date": "2021-10-07T17:27:56-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00010391",
    "company_name": "PALADIN LABS INC.",
    "atc_number": "B01AA",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "discontinuation_date": "2020-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2021-10-07T17:29:57-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "SINTROM",
    "en_drug_common_name": "ACENOCOUMAROL TABLETS",
    "fr_drug_brand_name": "SIMTROM",
    "fr_drug_common_name": "Comprime d'Acénocoumarol",
    "en_ingredients": "ACENOCOUMAROL",
    "fr_ingredients": "Acénocoumarol",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100s",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146880,
    "drug": {
      "current_status": "MARKETED",
      "id": 63995,
      "drug_code": 81328,
      "updated_date": "2025-05-15T02:32:26-04:00",
      "company": {
        "id": 12493,
        "created_date": "2019-06-14T02:15:03-04:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 17542,
        "mfr_code": "",
        "name": "CURIUM CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "217 & 220",
        "street_name": "2572 BOUL. DANIEL-JOHNSON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2R3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257038,
          "ingredient": {
            "id": 14565,
            "ingredient_code": 8044,
            "en_name": "GALLIUM CITRATE GA 67",
            "fr_name": "Citrate de gallium 67 GA"
          },
          "ingredient_supplied_ind": "I",
          "strength": "74",
          "strength_unit": "MBq",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02327813",
      "brand_name": "GALLIUM (GA67) CITRATE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152589005"
    },
    "created_date": "2021-10-07T19:27:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327813",
    "company_name": "CURIUM CANADA INC",
    "atc_number": "V09HX",
    "anticipated_start_date": "2021-10-08T00:00:00-04:00",
    "estimated_end_date": "2021-10-15T00:00:00-04:00",
    "actual_start_date": "2021-10-08T00:00:00-04:00",
    "actual_end_date": "2021-10-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-19T13:32:12-04:00",
    "status": "resolved",
    "en_comments": "The most recent lot of Gallium Citrate Ga 67 Injection is outside our specifications for release.\r\n\r\nAs a result, product will not be available for shipment Oct 8-14, 2021.\r\nThe next lot is scheduled to release on Friday, Oct. 15.\r\n\r\nWe apologize for an inconvenience caused by this issue.",
    "fr_comments": "Le dernier lot de citrate de gallium est à l'extérieur de notre spécification de relâche, conséquemment, le produit ne sera pas disponible entre le 8et le 14 octobre. Le prochain lot devrait être relaché le 15Octobre.\r\n\r\nNous nous excusons des inconvénients.",
    "en_drug_brand_name": "GALLIUM (GA67) CITRATE INJECTION",
    "en_drug_common_name": "Gallium (Ga 67) Citrate injection",
    "fr_drug_brand_name": "Solution injectable de citrate de gallium Ga 67",
    "fr_drug_common_name": "Solution injectable de citrate de gallium Ga 67",
    "en_ingredients": "GALLIUM CITRATE GA 67",
    "fr_ingredients": "gallium",
    "drug_strength": "74MBq",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "6 & 12 mCi",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146883,
    "drug": {
      "current_status": "DORMANT",
      "id": 64878,
      "drug_code": 81520,
      "updated_date": "2025-05-15T06:55:39-04:00",
      "company": {
        "id": 12493,
        "created_date": "2019-06-14T02:15:03-04:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 17542,
        "mfr_code": "",
        "name": "CURIUM CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "217 & 220",
        "street_name": "2572 BOUL. DANIEL-JOHNSON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2R3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368329,
          "ingredient": {
            "id": 28205,
            "ingredient_code": 20491,
            "en_name": "INDIUM IN 111 CHLORIDE",
            "fr_name": "Chlorure d'indium IN 111"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MCI",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "Not Applicable/non applicable",
      "brand_name": "HIGH PURITY INDIUM CHLORIDE IN 111 STERILE SOLUTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152615003"
    },
    "created_date": "2021-10-07T19:33:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02329468",
    "company_name": "CURIUM CANADA INC",
    "atc_number": "UNASS",
    "anticipated_start_date": "2021-10-08T00:00:00-04:00",
    "estimated_end_date": "2021-10-15T00:00:00-04:00",
    "actual_start_date": "2021-10-08T00:00:00-04:00",
    "actual_end_date": "2021-10-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-19T13:32:33-04:00",
    "status": "resolved",
    "en_comments": "Due to a mechanical issue encountered during production of Indium In 111 Chloride Sterile Solution, we will be unable to support orders between Oct 8-14, 2021.\r\nThe next lot is scheduled to release Friday, Oct 15, 2021.\r\nWe apologize for any inconvenience caused by this issue.",
    "fr_comments": "Nous avons rencontré un problème mécanique durant la production et nous serons incapable de supporter les commandes entre le 8 et le 14 octobre 2021. le prochain lot devrait être relaché le 15OCT.\r\n\r\nNous nous excusons des inconvénients.",
    "en_drug_brand_name": "HIGH PURITY INDIUM CHLORIDE IN 111 STERILE SOLUTION",
    "en_drug_common_name": "Solution injectable de chlorure d'indium 111 de pureté élevée",
    "fr_drug_brand_name": "Solution injectable de chlorure d'indium de pureté élevée",
    "fr_drug_common_name": "Solution injectable de chlorure d'indium de pureté élevée",
    "en_ingredients": "INDIUM IN 111 CHLORIDE",
    "fr_ingredients": "In 111",
    "drug_strength": "10MCI",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 mCi/ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146890,
    "drug": {
      "current_status": "MARKETED",
      "id": 26858,
      "drug_code": 89145,
      "updated_date": "2025-05-15T02:33:56-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259679,
          "ingredient": {
            "id": 1580,
            "ingredient_code": 2953,
            "en_name": "CYTARABINE",
            "fr_name": "Cytarabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02406772",
      "brand_name": "PMS-CYTARABINE",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108854005"
    },
    "created_date": "2021-10-07T21:30:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02406772",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2022-01-04T00:00:00-05:00",
    "estimated_end_date": "2022-02-25T00:00:00-05:00",
    "actual_end_date": "2022-02-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-16T15:41:15-05:00",
    "status": "resolved",
    "en_comments": "Limited supply. Anticipated BO from January 4, 2022 to February 25, 2022",
    "fr_comments": "Limited supply. Anticipated BO from January 4, 2022 to February 25, 2022",
    "en_drug_brand_name": "PMS-CYTARABINE",
    "en_drug_common_name": "CYTARABINE",
    "fr_drug_brand_name": "pms-CYTARABINE",
    "fr_drug_common_name": "CYTARABINE",
    "en_ingredients": "CYTARABINE",
    "fr_ingredients": "Cytarabine",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRATHECAL\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRATHECAL",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntrathécale\r\nSous-cutanée\r\nIntraveineuse\r\nIntrathécale",
    "drug_package_quantity": "2000mg/20mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146898,
    "drug": {
      "current_status": "MARKETED",
      "id": 24794,
      "drug_code": 87346,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258956,
          "ingredient": {
            "id": 1472,
            "ingredient_code": 7490,
            "en_name": "LEVONORGESTREL",
            "fr_name": "Lévonorgestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258955,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387883",
      "brand_name": "ALYSENA 28",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0220415005"
    },
    "created_date": "2021-10-08T15:02:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387883",
    "company_name": "APOTEX INC",
    "atc_number": "G03AA",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "estimated_end_date": "2021-12-12T00:00:00-05:00",
    "actual_start_date": "2021-10-04T00:00:00-04:00",
    "actual_end_date": "2021-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-13T13:27:17-05:00",
    "status": "resolved",
    "en_comments": "single pack of 28 BLS is available",
    "fr_comments": "single pack of 28 BLS is available",
    "en_drug_brand_name": "ALYSENA 28",
    "en_drug_common_name": "ALYSENA",
    "fr_drug_brand_name": "ALYSENA",
    "fr_drug_common_name": "ALYSENA",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nLEVONORGESTREL",
    "fr_ingredients": "Éthinylestradiol\r\nLévonorgestrel",
    "drug_strength": "20MCG\r\n100MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Triple pack of 28 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146901,
    "drug": {
      "current_status": "MARKETED",
      "id": 26480,
      "drug_code": 88798,
      "updated_date": "2025-05-15T02:33:51-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259548,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02403153",
      "brand_name": "APO-AMITRIPTYLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101524003"
    },
    "created_date": "2021-10-08T15:08:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403153",
    "company_name": "APOTEX INC",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2021-10-04T00:00:00-04:00",
    "actual_end_date": "2022-05-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-13T21:08:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMITRIPTYLINE",
    "en_drug_common_name": "AMITRIPTYLINE",
    "fr_drug_brand_name": "APO AMITRIPTYLINE",
    "fr_drug_common_name": "AMITRIPTYLINE",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146904,
    "drug": {
      "current_status": "MARKETED",
      "id": 11514,
      "drug_code": 68273,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254283,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244305",
      "brand_name": "APO-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929003"
    },
    "created_date": "2021-10-08T15:12:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244305",
    "company_name": "APOTEX INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2021-10-29T00:00:00-04:00",
    "actual_start_date": "2021-10-04T00:00:00-04:00",
    "actual_end_date": "2021-10-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-29T13:33:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "APO GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146907,
    "drug": {
      "current_status": "MARKETED",
      "id": 16536,
      "drug_code": 77363,
      "updated_date": "2025-05-15T02:31:51-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255879,
          "ingredient": {
            "id": 2138,
            "ingredient_code": 11104,
            "en_name": "ONDANSETRON",
            "fr_name": "Ondansétron"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02288192",
      "brand_name": "APO-ONDANSETRON",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131120001"
    },
    "created_date": "2021-10-08T15:16:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02288192",
    "company_name": "APOTEX INC",
    "atc_number": "A04AA",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "estimated_end_date": "2022-03-04T00:00:00-05:00",
    "actual_start_date": "2021-10-04T00:00:00-04:00",
    "actual_end_date": "2022-02-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-28T13:30:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ONDANSETRON",
    "en_drug_common_name": "ONDANSETRON",
    "fr_drug_brand_name": "APO ONDANSETRON",
    "fr_drug_common_name": "ONDANSETRON",
    "en_ingredients": "ONDANSETRON",
    "fr_ingredients": "Ondansétron",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146910,
    "drug": {
      "current_status": "MARKETED",
      "id": 63374,
      "drug_code": 95701,
      "updated_date": "2025-05-15T02:36:07-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262767,
          "ingredient": {
            "id": 4138,
            "ingredient_code": 16100,
            "en_name": "PERINDOPRIL ARGININE",
            "fr_name": "Périndopril arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "14",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8262766,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02468581",
      "brand_name": "APO-PERINDOPRIL/AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0257790003"
    },
    "created_date": "2021-10-08T15:21:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02468581",
    "company_name": "APOTEX INC",
    "atc_number": "C09BB",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2021-11-05T00:00:00-04:00",
    "actual_start_date": "2021-10-04T00:00:00-04:00",
    "actual_end_date": "2021-10-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-25T12:07:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PERINDOPRIL/AMLODIPINE",
    "en_drug_common_name": "PERINDOPRIL/AMLODIPINE",
    "fr_drug_brand_name": "APO PERINDOPRIL/AMLODIPINE",
    "fr_drug_common_name": "PERINDOPRIL/AMLODIPINE",
    "en_ingredients": "AMLODIPINE\r\nPERINDOPRIL ARGININE",
    "fr_ingredients": "PERINDOPRIL/AMLODIPINE",
    "drug_strength": "10MG\r\n14MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146913,
    "drug": {
      "current_status": "MARKETED",
      "id": 14950,
      "drug_code": 75378,
      "updated_date": "2025-05-15T02:31:40-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255349,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02268396",
      "brand_name": "APO-SUMATRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238001"
    },
    "created_date": "2021-10-08T15:24:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02268396",
    "company_name": "APOTEX INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2021-12-24T00:00:00-05:00",
    "actual_start_date": "2021-10-04T00:00:00-04:00",
    "actual_end_date": "2021-12-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-22T18:28:17-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SUMATRIPTAN",
    "en_drug_common_name": "SUMATRIPTAN",
    "fr_drug_brand_name": "APO-SUMATRIPTAN",
    "fr_drug_common_name": "SUMATRIPTAN",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "SUMATRIPTAN",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146927,
    "drug": {
      "current_status": "DORMANT",
      "id": 21440,
      "drug_code": 83828,
      "updated_date": "2025-05-15T06:55:41-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368460,
          "ingredient": {
            "id": 2442,
            "ingredient_code": 11516,
            "en_name": "ROPINIROLE",
            "fr_name": "Ropinirole (Chlorhydrate de ropinirole)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353059",
      "brand_name": "ROPINIROLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132618003"
    },
    "created_date": "2021-10-08T20:45:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353059",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2021-09-13T00:00:00-04:00",
    "estimated_end_date": "2022-03-31T00:00:00-04:00",
    "actual_start_date": "2021-09-13T00:00:00-04:00",
    "actual_end_date": "2022-04-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-06T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "closed due to duplicate report 146199",
    "en_drug_brand_name": "ROPINIROLE",
    "en_drug_common_name": "ROPINIROLE",
    "fr_drug_brand_name": "ROPINIROLE",
    "fr_drug_common_name": "ROPINIROLE",
    "en_ingredients": "ROPINIROLE",
    "fr_ingredients": "ROPINIROLE (ROPINIROLE HYDROCHLORIDE)",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146944,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7400,
      "drug_code": 49957,
      "updated_date": "2025-05-15T03:51:08-04:00",
      "company": {
        "id": 654,
        "created_date": "2017-03-09T13:23:00-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 15139,
        "mfr_code": "",
        "name": "GRIFOLS THERAPEUTICS LLC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "8368 CLAYTON BLVD",
        "province": "NORTH CAROLINA",
        "country": "UNITED STATES",
        "city": "CLAYTON",
        "postal_code": "27520",
        "post_office_box": "",
        "contact_information": "GrifolsCanadaMedInfo@grifols.com"
      },
      "drug_ingredients": [
        {
          "id": 8315440,
          "ingredient": {
            "id": 12464,
            "ingredient_code": 22956,
            "en_name": "TETANUS IMMUNOGLOBULIN",
            "fr_name": "Immunoglobuline antitétanique (humaine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "DOSE",
          "base": false
        }
      ],
      "din": "02230697",
      "brand_name": "HYPERTET S/D",
      "brand_name_fr": "",
      "descriptor": "ALSO KNOWN AS TETANUS IMMUNE GLOBULINE HUMAN. SINGLE DOSE PREFILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133051001"
    },
    "created_date": "2021-10-08T20:56:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230697",
    "company_name": "GRIFOLS THERAPEUTICS LLC",
    "atc_number": "J06BB",
    "atc_description": "IMMUNOGLOBULINS",
    "anticipated_start_date": "2021-10-08T00:00:00-04:00",
    "estimated_end_date": "2021-12-10T00:00:00-05:00",
    "actual_end_date": "2021-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-12-11T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Resolved. Grifols was in process of transitioning to HyperTET® produced using an updated manufacturing process that has been approved by Health Canada. Grifols was managing a tight supply to bridge the gap until the new batch was available in Canada early December. Because of limited stock at Grifols Canada, during the transition Grifols was focusing on filling orders that were specific to an immediate patient need, rather than stock replacement.",
    "fr_comments": "Résolu. Grifols était en train de déployer une mise à jour du processus de fabrication pour HyperTET, approuvé par Santé Canada. Grifols gérait  une pénurie de l’approvisionnement de cette drogue jusqu’à ce que le nouveau lot soit disponible au Canada au début de décembre. Afin de gérer le stock limité de Grifols Canada, pendant la transition, Grifols se concentrait sur l'exécution des commandes spécifiques aux besoins immédiats des patients plutôt que sur le remplacement des stocks.",
    "en_drug_brand_name": "HYPERTET S/D",
    "en_drug_common_name": "TETANUS IMMUNOGLOBULIN (HUMAN), SOLVENT DETERGENT TREATED",
    "fr_drug_brand_name": "HYPERTET S/D",
    "fr_drug_common_name": "IMMUNOGLOBULINE ANTITÉTANIQUE (HUMAINE), TRAITE PAR SOLVANT/DETERGENT",
    "en_ingredients": "TETANUS IMMUNOGLOBULIN",
    "fr_ingredients": "IMMUNOGLOBULINE ANTITÉTANIQUE",
    "drug_strength": "250UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "250 AU PRE-FILLED SYRINGE",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146947,
    "drug": {
      "current_status": "DORMANT",
      "id": 21438,
      "drug_code": 83827,
      "updated_date": "2025-05-15T06:55:41-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368459,
          "ingredient": {
            "id": 2442,
            "ingredient_code": 11516,
            "en_name": "ROPINIROLE",
            "fr_name": "Ropinirole (Chlorhydrate de ropinirole)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353040",
      "brand_name": "ROPINIROLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132618001"
    },
    "created_date": "2021-10-08T21:17:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353040",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "hc_updated_date": "2024-02-15T13:26:58-05:00",
    "anticipated_start_date": "2021-09-21T00:00:00-04:00",
    "estimated_end_date": "2022-12-21T00:00:00-05:00",
    "actual_start_date": "2021-09-22T00:00:00-04:00",
    "actual_end_date": "2021-10-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-15T13:27:00-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ROPINIROLE",
    "en_drug_common_name": "ROPINIROLE",
    "fr_drug_brand_name": "ROPINIROLE",
    "fr_drug_common_name": "ROPINIROLE",
    "en_ingredients": "ROPINIROLE",
    "fr_ingredients": "ROPINIROLE (ROPINIROLE HYDROCHLORIDE)",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146987,
    "drug": {
      "current_status": "MARKETED",
      "id": 25060,
      "drug_code": 87574,
      "updated_date": "2025-05-15T02:33:37-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259082,
          "ingredient": {
            "id": 2826,
            "ingredient_code": 12026,
            "en_name": "RILUZOLE",
            "fr_name": "Riluzole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02390299",
      "brand_name": "MYLAN-RILUZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141861001"
    },
    "created_date": "2021-10-13T13:29:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390299",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N07XX",
    "atc_description": "OTHER NERVOUS SYSTEM DRUGS",
    "estimated_end_date": "2021-10-19T00:00:00-04:00",
    "actual_start_date": "2021-10-06T00:00:00-04:00",
    "actual_end_date": "2021-10-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-26T19:17:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-RILUZOLE",
    "en_drug_common_name": "RILUZOLE",
    "fr_drug_brand_name": "MYLAN-RILUZOLE",
    "fr_drug_common_name": "RILUZOLE",
    "en_ingredients": "RILUZOLE",
    "fr_ingredients": "Riluzole",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146990,
    "drug": {
      "current_status": "MARKETED",
      "id": 14102,
      "drug_code": 74134,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8255092,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02256118",
      "brand_name": "MYLAN-MIRTAZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928002"
    },
    "created_date": "2021-10-13T13:31:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02256118",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2021-12-08T00:00:00-05:00",
    "estimated_end_date": "2021-12-14T00:00:00-05:00",
    "actual_end_date": "2021-10-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-26T19:18:17-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MYLAN-MIRTAZAPINE",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "MYLAN-MIRTAZAPINE",
    "fr_drug_common_name": "MIRTAZAPINE",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 146993,
    "drug": {
      "current_status": "MARKETED",
      "id": 1522,
      "drug_code": 13302,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251750,
          "ingredient": {
            "id": 572,
            "ingredient_code": 649,
            "en_name": "LIPASE",
            "fr_name": "Lipase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251749,
          "ingredient": {
            "id": 570,
            "ingredient_code": 648,
            "en_name": "PROTEASE",
            "fr_name": "Protéase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1600",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251748,
          "ingredient": {
            "id": 568,
            "ingredient_code": 253,
            "en_name": "AMYLASE",
            "fr_name": "Amylase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25500",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01985205",
      "brand_name": "CREON MINIMICROSPHERES 25",
      "brand_name_fr": "CREON MINIMICROSPHERES 25",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74650",
      "number_of_ais": "3",
      "ai_group_no": "0302964041"
    },
    "created_date": "2021-10-13T13:40:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01985205",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "A09AA",
    "atc_description": "DIGESTIVES, INCL ENZYMES",
    "anticipated_start_date": "2021-10-18T00:00:00-04:00",
    "estimated_end_date": "2021-10-25T00:00:00-04:00",
    "actual_start_date": "2021-10-18T00:00:00-04:00",
    "actual_end_date": "2021-10-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-10-27T00:16:23-04:00",
    "status": "resolved",
    "en_comments": "Globally allocated SKU",
    "fr_comments": "Globally allocated SKU",
    "en_drug_brand_name": "CREON MINIMICROSPHERES 25",
    "en_drug_common_name": "CREON MINIMICROSPHERES 25",
    "fr_drug_brand_name": "CREON MINIMICROSPHERES 25",
    "fr_drug_common_name": "CREON MINIMICROSPHERES 25",
    "en_ingredients": "PROTEASE\r\nAMYLASE\r\nLIPASE",
    "fr_ingredients": "Protéase\r\nAmylase\r\nLipase",
    "drug_strength": "1600UNIT\r\n25500UNIT\r\n25000UNIT",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "25",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147032,
    "drug": {
      "current_status": "MARKETED",
      "id": 3696,
      "drug_code": 19143,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252453,
          "ingredient": {
            "id": 1016,
            "ingredient_code": 751,
            "en_name": "L-LEUCINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de l-leucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "310",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252452,
          "ingredient": {
            "id": 378,
            "ingredient_code": 10237,
            "en_name": "HISTIDINE",
            "fr_name": "Histidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "220",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252451,
          "ingredient": {
            "id": 224,
            "ingredient_code": 8865,
            "en_name": "GLYCINE",
            "fr_name": "Glycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1040",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252450,
          "ingredient": {
            "id": 1020,
            "ingredient_code": 935,
            "en_name": "L-PROLINE",
            "fr_name": "L-proline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "210",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252449,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "90",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252448,
          "ingredient": {
            "id": 1022,
            "ingredient_code": 938,
            "en_name": "L-ARGININE",
            "fr_name": "L-arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "520",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252447,
          "ingredient": {
            "id": 388,
            "ingredient_code": 193,
            "en_name": "L-LYSINE",
            "fr_name": "L-lysine (Acétate de L-lysine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "290",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252446,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16.6",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252445,
          "ingredient": {
            "id": 1026,
            "ingredient_code": 941,
            "en_name": "L-THREONINE",
            "fr_name": "L-thréonine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "210",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252444,
          "ingredient": {
            "id": 1024,
            "ingredient_code": 939,
            "en_name": "L-VALINE",
            "fr_name": "L-valine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "230",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252443,
          "ingredient": {
            "id": 390,
            "ingredient_code": 2959,
            "en_name": "L-ALANINE",
            "fr_name": "L-ALANINE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1040",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252442,
          "ingredient": {
            "id": 1018,
            "ingredient_code": 897,
            "en_name": "L-TYROSINE",
            "fr_name": "L-tyrosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252441,
          "ingredient": {
            "id": 1028,
            "ingredient_code": 944,
            "en_name": "L-ISOLEUCINE",
            "fr_name": "L-isoleucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252440,
          "ingredient": {
            "id": 392,
            "ingredient_code": 7217,
            "en_name": "METHIONINE",
            "fr_name": "Méhionine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "290",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252439,
          "ingredient": {
            "id": 1014,
            "ingredient_code": 750,
            "en_name": "L-PHENYLALANINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de l-phénylalanine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "310",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02046709",
      "brand_name": "CLINIMIX",
      "brand_name_fr": "",
      "descriptor": "5% AMINO ACIDS (BLEND B) WITHOUT ELECTROLYTES IN 16.6% DEXTROSE INJECTION",
      "pediatric_flag": false,
      "accession_number": "81434",
      "number_of_ais": "15",
      "ai_group_no": "1550858002"
    },
    "created_date": "2021-10-13T15:48:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02046709",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2021-10-13T00:00:00-04:00",
    "estimated_end_date": "2021-10-21T00:00:00-04:00",
    "actual_start_date": "2021-10-13T00:00:00-04:00",
    "actual_end_date": "2021-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-10-25T13:28:46-04:00",
    "status": "resolved",
    "en_comments": "Baxter is experiencing a delay in raw materials which has resulted in a supply disruption on certain CLINIMIX and TRAVASOL products. Impacted products have been placed on allocation. The supply issue is expected to be resolved in early October. Contact your Baxter sales rep or Baxter customer service for list of available CLINIMIX products which remain available to order.",
    "fr_comments": "Baxter connaît un retard dans son approvisionnement en matières premières, ce qui a entraîné une perturbation de l’approvisionnement de certains produits CLINIMIX et TRAVASOL. Les produits touchés ont été mis sous allocation. Le problème d’approvisionnement devrait être résolu au début d’octobre. Veuillez communiquer avec votre représentant Baxter ou avec le Service à la clientèle de Baxter pour obtenir la liste des produits CILINIMIX disponibles qui peuvent encore être commandés.",
    "en_drug_brand_name": "CLINIMIX",
    "en_drug_common_name": "CLINIMIX 5% Amino Acids (Blend B) in 16.6% Dextrose Injection",
    "fr_drug_brand_name": "CLINIMIX",
    "fr_drug_common_name": "CLINIMIX 5% Amino Acids (Blend B) in 16.6% Dextrose Injection",
    "en_ingredients": "L-ISOLEUCINE\r\nL-LYSINE\r\nMETHIONINE\r\nL-PHENYLALANINE HYDROCHLORIDE\r\nL-LEUCINE HYDROCHLORIDE\r\nDEXTROSE\r\nL-TYROSINE\r\nL-PROLINE\r\nL-ARGININE\r\nGLYCINE\r\nL-ALANINE\r\nTRYPTOPHAN\r\nL-THREONINE\r\nHISTIDINE\r\nL-VALINE",
    "fr_ingredients": "L-isoleucine\r\nL-lysine\r\nMéhionine\r\nChlorhydrate de l-phénylalanine\r\nChlorhydrate de l-leucine\r\nDextrose\r\nL-tyrosine\r\nL-proline\r\nL-arginine\r\nGlycine\r\nTryptophane\r\nL-thréonine\r\nHistidine\r\nL-valine",
    "drug_strength": "240MG\r\n290MG\r\n290MG\r\n310MG\r\n310MG\r\n16.6G\r\n20MG\r\n210MG\r\n520MG\r\n1040MG\r\n1040MG\r\n90MG\r\n210MG\r\n220MG\r\n230MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1000mL (JB6770P)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147067,
    "drug": {
      "current_status": "MARKETED",
      "id": 100267,
      "drug_code": 98629,
      "updated_date": "2020-04-03T06:54:34-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264832,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8264831,
          "ingredient": {
            "id": 210,
            "ingredient_code": 2375,
            "en_name": "CLOTRIMAZOLE",
            "fr_name": "Clotrimazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02496410",
      "brand_name": "TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0216399001"
    },
    "created_date": "2021-10-13T18:46:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02496410",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D01AC",
    "atc_description": "ANTIFUNGALS FOR TOPICAL USE",
    "estimated_end_date": "2021-10-22T00:00:00-04:00",
    "actual_start_date": "2021-10-07T00:00:00-04:00",
    "actual_end_date": "2021-10-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-21T21:20:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE",
    "en_drug_common_name": "bupropion",
    "fr_drug_brand_name": "TARO CLOT 1% BETADIP 0.05% CREAM 50 G",
    "fr_drug_common_name": "CLOTRIMAZOLE/BETAMETHASONE",
    "en_ingredients": "CLOTRIMAZOLE\r\nBETAMETHASONE",
    "fr_ingredients": "Clotrimazole\r\nBétaméthasone",
    "drug_strength": "1%\r\n0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147070,
    "drug": {
      "current_status": "MARKETED",
      "id": 65756,
      "drug_code": 95841,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262840,
          "ingredient": {
            "id": 3710,
            "ingredient_code": 20671,
            "en_name": "FINGOLIMOD",
            "fr_name": "Fingolimod (Chlorhydrate de Fingolimod)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02469618",
      "brand_name": "TARO-FINGOLIMOD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152886001"
    },
    "created_date": "2021-10-13T18:50:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02469618",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2022-04-15T00:00:00-04:00",
    "actual_start_date": "2021-09-01T00:00:00-04:00",
    "actual_end_date": "2022-04-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-25T14:20:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-FINGOLIMOD",
    "en_drug_common_name": "TARO FINGOLIMOD 0.5MG 2X14's BLISTER",
    "fr_drug_brand_name": "TARO FINGOLIMOD 0.5MG 2X14's BLISTER",
    "fr_drug_common_name": "FINGOLIMOD",
    "en_ingredients": "FINGOLIMOD",
    "fr_ingredients": "Fingolimod",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "2 x 14",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147089,
    "drug": {
      "current_status": "MARKETED",
      "id": 62785,
      "drug_code": 96647,
      "updated_date": "2025-12-03T00:33:49-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263257,
          "ingredient": {
            "id": 2566,
            "ingredient_code": 11772,
            "en_name": "BUPROPION HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupropion"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02475804",
      "brand_name": "TARO-BUPROPION XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131140003"
    },
    "created_date": "2021-10-13T19:10:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02475804",
    "company_name": "SUN PHARMA CANADA INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2023-02-03T00:00:00-05:00",
    "actual_start_date": "2021-09-23T00:00:00-04:00",
    "actual_end_date": "2023-02-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-02-10T15:04:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-BUPROPION XL",
    "en_drug_common_name": "TARO BUPROPION XL 150mg 500 Tablet / Comprimé",
    "fr_drug_brand_name": "TARO BUPROPION XL 150mg 500 Tablet / Comprimé",
    "fr_drug_common_name": "BUPROPION",
    "en_ingredients": "BUPROPION HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupropion",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147092,
    "drug": {
      "current_status": "MARKETED",
      "id": 21342,
      "drug_code": 83747,
      "updated_date": "2025-05-15T02:32:43-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257561,
          "ingredient": {
            "id": 272,
            "ingredient_code": 20170,
            "en_name": "ENALAPRIL SODIUM",
            "fr_name": "Énalapril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02352230",
      "brand_name": "TARO-ENALAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152325001"
    },
    "created_date": "2021-10-13T19:57:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02352230",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2022-08-26T00:00:00-04:00",
    "actual_start_date": "2022-03-27T00:00:00-04:00",
    "actual_end_date": "2022-05-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-19T15:36:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-ENALAPRIL",
    "en_drug_common_name": "RAN ENALAPRIL 2.5mg 100 Tablet / Comprimé",
    "fr_drug_brand_name": "RAN\tENALAPRIL 2.5mg 100 Tablet / Comprimé",
    "fr_drug_common_name": "ENALAPRIL",
    "en_ingredients": "ENALAPRIL SODIUM",
    "fr_ingredients": "Énalapril sodique",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147095,
    "drug": {
      "current_status": "DORMANT",
      "id": 20032,
      "drug_code": 81384,
      "updated_date": "2025-12-03T02:32:25-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368322,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02328313",
      "brand_name": "TARO-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332007"
    },
    "created_date": "2021-10-13T20:01:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02328313",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-01-28T00:00:00-05:00",
    "actual_start_date": "2021-10-01T00:00:00-04:00",
    "actual_end_date": "2022-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-19T15:43:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-RISPERIDONE",
    "en_drug_common_name": "RAN RISPERIDONE 0.5mg 100 Tablet / Comprimé",
    "fr_drug_brand_name": "RAN RISPERIDONE 0.5mg 100 Tablet / Comprimé",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147098,
    "drug": {
      "current_status": "MARKETED",
      "id": 53021,
      "drug_code": 94454,
      "updated_date": "2025-05-15T02:35:34-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262117,
          "ingredient": {
            "id": 2586,
            "ingredient_code": 11787,
            "en_name": "CAPECITABINE",
            "fr_name": "Capécitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457490",
      "brand_name": "TARO-CAPECITABINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134120001"
    },
    "created_date": "2021-10-13T20:07:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457490",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "estimated_end_date": "2022-11-11T00:00:00-05:00",
    "actual_start_date": "2021-10-01T00:00:00-04:00",
    "actual_end_date": "2022-11-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2022-11-04T01:02:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CAPECITABINE",
    "en_drug_common_name": "TARO CAPECITABINE TAB 150MG 10X6 BLISTER",
    "fr_drug_brand_name": "TARO CAPECITABINE TAB 150MG 10X6 BLISTER",
    "fr_drug_common_name": "CAPECITABINE",
    "en_ingredients": "CAPECITABINE",
    "fr_ingredients": "Capécitabine",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "10 X 6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147101,
    "drug": {
      "current_status": "MARKETED",
      "id": 53023,
      "drug_code": 94455,
      "updated_date": "2025-05-15T02:35:34-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262118,
          "ingredient": {
            "id": 2586,
            "ingredient_code": 11787,
            "en_name": "CAPECITABINE",
            "fr_name": "Capécitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457504",
      "brand_name": "TARO-CAPECITABINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134120002"
    },
    "created_date": "2021-10-13T20:10:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457504",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "estimated_end_date": "2022-10-14T00:00:00-04:00",
    "actual_start_date": "2021-08-26T00:00:00-04:00",
    "actual_end_date": "2022-10-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2022-11-04T01:06:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CAPECITABINE",
    "en_drug_common_name": "TARO CAPECITABINE TAB 500MG 10X12BLISTER",
    "fr_drug_brand_name": "TARO CAPECITABINE TAB 500MG 10X12BLISTER",
    "fr_drug_common_name": "CAPECITABINE",
    "en_ingredients": "CAPECITABINE",
    "fr_ingredients": "Capécitabine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "10 X 12",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147104,
    "drug": {
      "current_status": "MARKETED",
      "id": 64726,
      "drug_code": 97970,
      "updated_date": "2025-05-15T02:38:00-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264204,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02489619",
      "brand_name": "TARO-CLOBETASOL SPRAY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2021-10-13T20:13:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02489619",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2021-10-29T00:00:00-04:00",
    "actual_start_date": "2021-09-15T00:00:00-04:00",
    "actual_end_date": "2021-10-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-26T18:47:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLOBETASOL SPRAY",
    "en_drug_common_name": "TARO CLOBETASOL SPRAY 0.05% 59ml",
    "fr_drug_brand_name": "TARO CLOBETASOL SPRAY 0.05% 59ml",
    "fr_drug_common_name": "CLOBETASOL",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "SPRAY",
    "drug_dosage_form_fr": "Pulvérisation",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "59",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147107,
    "drug": {
      "current_status": "MARKETED",
      "id": 28436,
      "drug_code": 90557,
      "updated_date": "2025-05-15T02:34:15-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260306,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02420988",
      "brand_name": "TARO-DICLOFENAC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114417007"
    },
    "created_date": "2021-10-13T20:15:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420988",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "M02AA",
    "atc_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
    "estimated_end_date": "2021-10-29T00:00:00-04:00",
    "actual_start_date": "2021-09-24T00:00:00-04:00",
    "actual_end_date": "2021-10-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-26T18:49:20-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-DICLOFENAC",
    "en_drug_common_name": "TARO DICLOFENAC SOLUTION 1.5% 60ML",
    "fr_drug_brand_name": "TARO\tDICLOFENAC SOLUTION 1.5% 60ML",
    "fr_drug_common_name": "DICLOFENAC",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "1.5%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147110,
    "drug": {
      "current_status": "MARKETED",
      "id": 30760,
      "drug_code": 92820,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261327,
          "ingredient": {
            "id": 2740,
            "ingredient_code": 11923,
            "en_name": "TEMOZOLOMIDE",
            "fr_name": "Témozolomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443511",
      "brand_name": "TARO-TEMOZOLOMIDE",
      "brand_name_fr": "TARO-TÉMOZOLOMIDE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138781003"
    },
    "created_date": "2021-10-13T20:18:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443511",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "L01AX",
    "atc_description": "ALKYLATINGAGENTS",
    "estimated_end_date": "2021-10-29T00:00:00-04:00",
    "actual_start_date": "2021-09-23T00:00:00-04:00",
    "actual_end_date": "2021-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-26T18:50:55-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-TEMOZOLOMIDE",
    "en_drug_common_name": "TARO TEMOZOLOMIDE CAP 100MG 1x5 BLISTER",
    "fr_drug_brand_name": "TARO TEMOZOLOMIDE CAP 100MG 1x5 BLISTER",
    "fr_drug_common_name": "TEMOZOLOMIDE",
    "en_ingredients": "TEMOZOLOMIDE",
    "fr_ingredients": "Témozolomide",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1 X 5",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147113,
    "drug": {
      "current_status": "MARKETED",
      "id": 602,
      "drug_code": 11329,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251507,
          "ingredient": {
            "id": 400,
            "ingredient_code": 9928,
            "en_name": "VALINE",
            "fr_name": "Valine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "580",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251506,
          "ingredient": {
            "id": 376,
            "ingredient_code": 10223,
            "en_name": "PHENYLALANINE",
            "fr_name": "Phénylalanine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "560",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251505,
          "ingredient": {
            "id": 394,
            "ingredient_code": 9396,
            "en_name": "PROLINE",
            "fr_name": "Proline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "680",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251504,
          "ingredient": {
            "id": 386,
            "ingredient_code": 10243,
            "en_name": "THREONINE",
            "fr_name": "Thréonine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "420",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251503,
          "ingredient": {
            "id": 382,
            "ingredient_code": 10239,
            "en_name": "LEUCINE",
            "fr_name": "Leucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "730",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251502,
          "ingredient": {
            "id": 384,
            "ingredient_code": 10242,
            "en_name": "ARGININE",
            "fr_name": "Arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.15",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251501,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "180",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251500,
          "ingredient": {
            "id": 392,
            "ingredient_code": 7217,
            "en_name": "METHIONINE",
            "fr_name": "Méhionine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251499,
          "ingredient": {
            "id": 388,
            "ingredient_code": 193,
            "en_name": "L-LYSINE",
            "fr_name": "L-lysine (Acétate de L-lysine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "580",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8251498,
          "ingredient": {
            "id": 398,
            "ingredient_code": 9927,
            "en_name": "SERINE",
            "fr_name": "Sérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251497,
          "ingredient": {
            "id": 396,
            "ingredient_code": 9750,
            "en_name": "TYROSINE",
            "fr_name": "Tyrosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251496,
          "ingredient": {
            "id": 378,
            "ingredient_code": 10237,
            "en_name": "HISTIDINE",
            "fr_name": "Histidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "480",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251495,
          "ingredient": {
            "id": 390,
            "ingredient_code": 2959,
            "en_name": "L-ALANINE",
            "fr_name": "L-ALANINE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.07",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251494,
          "ingredient": {
            "id": 224,
            "ingredient_code": 8865,
            "en_name": "GLYCINE",
            "fr_name": "Glycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.03",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251493,
          "ingredient": {
            "id": 402,
            "ingredient_code": 9929,
            "en_name": "ISOLEUCINE",
            "fr_name": "Isoleucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00872296",
      "brand_name": "TRAVASOL",
      "brand_name_fr": "",
      "descriptor": "BLEND C",
      "pediatric_flag": false,
      "accession_number": "71962",
      "number_of_ais": "15",
      "ai_group_no": "1517080002"
    },
    "created_date": "2021-10-13T21:30:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00872296",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2021-10-13T00:00:00-04:00",
    "estimated_end_date": "2021-11-04T00:00:00-04:00",
    "actual_start_date": "2021-10-13T00:00:00-04:00",
    "actual_end_date": "2021-11-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-05T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Baxter is experiencing supply constraints on Travasol 3L (Baxter Code JB6583) due to manufacturing delays.  Get well is expected early November 2021.  Please contact your Baxter Nutrition Sales Specialist if you  have  any  questions  or  require  additional  information.",
    "fr_comments": "Baxter connaît des contraintes d'approvisionnement concernant Travasol 3 L (code de produit Baxter JB6583) en raison de retards de fabrication.  Le retour à la normale est prévu en début novembre 2021.  Si vous avez  des  questionsou  avez besoin de renseignements supplémentaires, veuillez communiquer avec votre spécialiste commercial en nutrition de Baxter.",
    "en_drug_brand_name": "TRAVASOL",
    "en_drug_common_name": "10% Amino acids (Blend C) injection",
    "fr_drug_brand_name": "TRAVASOL",
    "fr_drug_common_name": "10% Amino acids (Blend C) injection",
    "en_ingredients": "LEUCINE\r\nSERINE\r\nTYROSINE\r\nPROLINE\r\nARGININE\r\nGLYCINE\r\nL-ALANINE\r\nTRYPTOPHAN\r\nTHREONINE\r\nHISTIDINE\r\nVALINE\r\nISOLEUCINE\r\nL-LYSINE\r\nMETHIONINE\r\nPHENYLALANINE",
    "fr_ingredients": "Leucine\r\nSérine\r\nTyrosine\r\nProline\r\nArginine\r\nGlycine\r\nTryptophane\r\nThréonine\r\nHistidine\r\nValine\r\nIsoleucine\r\nL-lysine\r\nMéhionine\r\nPhénylalanine",
    "drug_strength": "730MG\r\n500MG\r\n40MG\r\n680MG\r\n1.15G\r\n1.03G\r\n2.07G\r\n180MG\r\n420MG\r\n480MG\r\n580MG\r\n600MG\r\n580MG\r\n400MG\r\n560MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "3000mL (JB6583)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147116,
    "drug": {
      "current_status": "MARKETED",
      "id": 3424,
      "drug_code": 18686,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252350,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02014874",
      "brand_name": "70% DEXTROSE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80957",
      "number_of_ais": "1",
      "ai_group_no": "0102181015"
    },
    "created_date": "2021-10-13T21:31:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02014874",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2021-10-16T00:00:00-04:00",
    "estimated_end_date": "2021-11-04T00:00:00-04:00",
    "actual_start_date": "2021-10-16T00:00:00-04:00",
    "actual_end_date": "2021-11-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-05T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Baxter is experiencing a supply disruption on 70% Dextrose 3L format (Baxter code JB0297) which will continue until the first week of November.  Limited supply of the 2L format (Baxter code 2B0296H) is available.  Please contact your Baxter Nutrition Sales Specialist if you  have  any  questions  or  require  additional  information.",
    "fr_comments": "Baxter connaît une perturbation de l'approvisionnement en dextrose injectable à 70 %, format de 3L (code de produit Baxter JB0297) qui se poursuivra jusqu'à la première semaine de novembre. Un approvisionnement limité du format de 2L (code de produit Baxter 2B0296H) est disponible.  Si vous avez  des  questionsou  avez besoin de renseignements supplémentaires, veuillez communiquer avec votre spécialiste commercial en nutrition de Baxter.",
    "en_drug_brand_name": "70% DEXTROSE INJECTION USP",
    "en_drug_common_name": "70% Dextrose Injection, USP",
    "fr_drug_brand_name": "70% Dextrose Injection, USP",
    "fr_drug_common_name": "70% Dextrose Injection, USP",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "70G",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "3000mL Bag",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147137,
    "drug": {
      "current_status": "DORMANT",
      "id": 26856,
      "drug_code": 89144,
      "updated_date": "2025-05-15T06:55:49-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368976,
          "ingredient": {
            "id": 1580,
            "ingredient_code": 2953,
            "en_name": "CYTARABINE",
            "fr_name": "Cytarabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02406764",
      "brand_name": "PMS-CYTARABINE",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108854001"
    },
    "created_date": "2021-10-14T13:03:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02406764",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2021-10-06T00:00:00-04:00",
    "estimated_end_date": "2021-12-14T00:00:00-05:00",
    "actual_start_date": "2021-10-14T00:00:00-04:00",
    "actual_end_date": "2021-12-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-14T21:44:50-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-CYTARABINE",
    "en_drug_common_name": "CYTARABINE",
    "fr_drug_brand_name": "PMS-CYTARABINE",
    "fr_drug_common_name": "CYTARABINE",
    "en_ingredients": "CYTARABINE",
    "fr_ingredients": "Cytarabine",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRATHECAL\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRATHECAL",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntrathécale\r\nSous-cutanée\r\nIntraveineuse\r\nIntrathécale",
    "drug_package_quantity": "100mg/5mL VIAL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147140,
    "drug": {
      "current_status": "MARKETED",
      "id": 26858,
      "drug_code": 89145,
      "updated_date": "2025-05-15T02:33:56-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259679,
          "ingredient": {
            "id": 1580,
            "ingredient_code": 2953,
            "en_name": "CYTARABINE",
            "fr_name": "Cytarabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02406772",
      "brand_name": "PMS-CYTARABINE",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108854005"
    },
    "created_date": "2021-10-14T13:05:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02406772",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2021-10-06T00:00:00-04:00",
    "estimated_end_date": "2021-11-15T00:00:00-05:00",
    "actual_start_date": "2021-10-14T00:00:00-04:00",
    "actual_end_date": "2021-11-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-20T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-CYTARABINE",
    "en_drug_common_name": "CYTARABINE",
    "fr_drug_brand_name": "PMS-CYTARABINE",
    "fr_drug_common_name": "CYTARABINE",
    "en_ingredients": "CYTARABINE",
    "fr_ingredients": "Cytarabine",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRATHECAL\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRATHECAL",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntrathécale\r\nSous-cutanée\r\nIntraveineuse\r\nIntrathécale",
    "drug_package_quantity": "1000mg/10mL VIAL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147153,
    "drug": {
      "current_status": "MARKETED",
      "id": 7908,
      "drug_code": 51386,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253418,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02231934",
      "brand_name": "OXY.IR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107552003"
    },
    "created_date": "2021-10-14T13:27:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231934",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2021-10-14T00:00:00-04:00",
    "estimated_end_date": "2021-10-22T00:00:00-04:00",
    "actual_start_date": "2021-10-14T00:00:00-04:00",
    "actual_end_date": "2021-10-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-19T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OXY.IR",
    "en_drug_common_name": "Oxycodone Hydrochloride Immediate Release Tablets",
    "fr_drug_brand_name": "Oxy•IR",
    "fr_drug_common_name": "Comprimés de chlorhydrate d’oxycodone à libération immédiate",
    "en_ingredients": "OXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'oxycodone",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147158,
    "drug": {
      "current_status": "MARKETED",
      "id": 25254,
      "drug_code": 87742,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259152,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392135",
      "brand_name": "BIO-AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131437002"
    },
    "created_date": "2021-10-14T13:52:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392135",
    "company_name": "BIOMED PHARMA",
    "atc_number": "C08CA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "actual_start_date": "2021-10-13T00:00:00-04:00",
    "actual_end_date": "2021-10-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-10-26T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Nous gardons le format de 500",
    "fr_comments": "Nous gardons le format de 500",
    "en_drug_brand_name": "BIO-AMLODIPINE",
    "en_drug_common_name": "AMLODIPINE",
    "fr_drug_brand_name": "BIO",
    "fr_drug_common_name": "AMLODIPINE",
    "en_ingredients": "AMLODIPINE",
    "fr_ingredients": "AMLODIPINE",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147161,
    "drug": {
      "current_status": "MARKETED",
      "id": 64936,
      "drug_code": 97578,
      "updated_date": "2025-12-03T00:34:13-05:00",
      "company": {
        "id": 1952,
        "created_date": "2017-03-09T13:26:33-05:00",
        "updated_date": "2025-05-15T02:30:24-04:00",
        "company_code": 15890,
        "mfr_code": "",
        "name": "STERINOVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3005 AVENUE JOSE-MARIA ROSELL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HYACINTHE",
        "postal_code": "J2S 0J9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263895,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02485540",
      "brand_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "0.4 MG/ML",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698020"
    },
    "created_date": "2021-10-14T13:58:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02485540",
    "company_name": "STERINOVA INC.",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2021-10-15T00:00:00-04:00",
    "estimated_end_date": "2021-11-05T00:00:00-04:00",
    "actual_start_date": "2021-10-15T00:00:00-04:00",
    "actual_end_date": "2021-11-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-11-05T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "Hydromorphone Hydrochloride Injection USP",
    "fr_drug_brand_name": "Chlorhydrate d'Hydromorphone Injectable USP",
    "fr_drug_common_name": "Chlorhydrate d'Hydromorphone Injectable USP",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "40MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "30 x 100 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147165,
    "drug": {
      "current_status": "MARKETED",
      "id": 25298,
      "drug_code": 87775,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259169,
          "ingredient": {
            "id": 2182,
            "ingredient_code": 27,
            "en_name": "ANASTROZOLE",
            "fr_name": "Anastrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392488",
      "brand_name": "BIO-ANASTROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128681001"
    },
    "created_date": "2021-10-14T14:03:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392488",
    "company_name": "BIOMED PHARMA",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "actual_start_date": "2021-10-13T00:00:00-04:00",
    "actual_end_date": "2021-10-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-10-26T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Nous gardons le format 3x10",
    "fr_comments": "Nous gardons le format 3x10",
    "en_drug_brand_name": "BIO-ANASTROZOLE",
    "en_drug_common_name": "ANASTROZOLE",
    "fr_drug_brand_name": "BIO",
    "fr_drug_common_name": "ANASTROZOLE",
    "en_ingredients": "ANASTROZOLE",
    "fr_ingredients": "Anastrozole",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147216,
    "drug": {
      "current_status": "MARKETED",
      "id": 18384,
      "drug_code": 79653,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256441,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310910",
      "brand_name": "TEVA-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055003"
    },
    "created_date": "2021-10-14T15:34:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310910",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2021-12-31T00:00:00-05:00",
    "actual_start_date": "2021-10-12T00:00:00-04:00",
    "actual_end_date": "2021-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-17T13:51:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN 40MG FC TABS",
    "fr_drug_brand_name": "TEVA-ATORVASTATIN 40MG FC TABS",
    "fr_drug_common_name": "ATORVASTATIN 40MG FC TABS",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147219,
    "drug": {
      "current_status": "MARKETED",
      "id": 11068,
      "drug_code": 67217,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254158,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243314",
      "brand_name": "TEVA-NAPROXEN EC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109634003"
    },
    "created_date": "2021-10-14T15:36:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243314",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2022-02-28T00:00:00-05:00",
    "actual_start_date": "2021-10-13T00:00:00-04:00",
    "actual_end_date": "2022-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-17T15:23:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-NAPROXEN EC",
    "en_drug_common_name": "NAPROXEN-EC 500MG TAB",
    "fr_drug_brand_name": "TEVA-NAPROXEN-EC 500MG TAB",
    "fr_drug_common_name": "NAPROXEN-EC 500MG TAB",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147231,
    "drug": {
      "current_status": "MARKETED",
      "id": 24996,
      "drug_code": 87512,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259038,
          "ingredient": {
            "id": 292,
            "ingredient_code": 8565,
            "en_name": "TOBRAMYCIN",
            "fr_name": "Tobramycine (Sulfate de tobramycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02389622",
      "brand_name": "TEVA-TOBRAMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110230004"
    },
    "created_date": "2021-10-14T16:01:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389622",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01GB",
    "atc_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
    "estimated_end_date": "2021-12-31T00:00:00-05:00",
    "actual_start_date": "2021-10-13T00:00:00-04:00",
    "actual_end_date": "2021-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-12-17T13:51:30-05:00",
    "status": "resolved",
    "en_comments": "Will cover 100% of market through allocation to Est end Date.",
    "en_drug_brand_name": "TEVA-TOBRAMYCIN",
    "en_drug_common_name": "TOBRAMYCIN INH SLN 60MG/ML 5ML",
    "fr_drug_brand_name": "TEVA-TOBRAMYCIN INH SLN 60MG/ML 5ML",
    "fr_drug_common_name": "TOBRAMYCIN INH SLN 60MG/ML 5ML",
    "en_ingredients": "TOBRAMYCIN",
    "fr_ingredients": "Tobramycine",
    "drug_strength": "60MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "56",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147236,
    "drug": {
      "current_status": "MARKETED",
      "id": 2822,
      "drug_code": 16804,
      "updated_date": "2025-05-15T02:30:56-04:00",
      "company": {
        "id": 16877,
        "created_date": "2020-06-16T21:30:06-04:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 17770,
        "mfr_code": "",
        "name": "JUNO PHARMACEUTICALS CORP.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "402",
        "street_name": "2233 ARGENTIA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 2X7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252159,
          "ingredient": {
            "id": 1284,
            "ingredient_code": 1298,
            "en_name": "ISOSORBIDE-5-MONONITRATE",
            "fr_name": "5-mononitrate d'isosorbide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02126559",
      "brand_name": "IMDUR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78738",
      "number_of_ais": "1",
      "ai_group_no": "0120456002"
    },
    "created_date": "2021-10-14T18:49:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02126559",
    "company_name": "JUNO PHARMACEUTICALS CORP.",
    "atc_number": "C01DA",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "anticipated_start_date": "2021-10-14T00:00:00-04:00",
    "estimated_end_date": "2022-12-21T00:00:00-05:00",
    "actual_start_date": "2021-10-14T00:00:00-04:00",
    "actual_end_date": "2022-12-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-22T03:27:37-05:00",
    "status": "resolved",
    "en_drug_brand_name": "IMDUR",
    "en_drug_common_name": "isosorbide-5-mononitrate extended release tablets",
    "fr_drug_brand_name": "IMDUR  EXTENDED RELEASE TABLETS 60MG",
    "fr_drug_common_name": "ISOSORBIDE-5-MONONITRATE",
    "en_ingredients": "ISOSORBIDE-5-MONONITRATE",
    "fr_ingredients": "5-mononitrate d'isosorbide",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147264,
    "drug": {
      "current_status": "MARKETED",
      "id": 2566,
      "drug_code": 16162,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252090,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8252089,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01976184",
      "brand_name": "SENSORCAINE WITH EPINEPHRINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77948",
      "number_of_ais": "2",
      "ai_group_no": "0204884001"
    },
    "created_date": "2021-10-14T22:46:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01976184",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2021-11-15T00:00:00-05:00",
    "estimated_end_date": "2021-11-30T00:00:00-05:00",
    "actual_end_date": "2021-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-11-12T19:13:32-05:00",
    "status": "avoided_shortage",
    "en_comments": "VR44563CA1",
    "en_drug_brand_name": "SENSORCAINE WITH EPINEPHRINE",
    "en_drug_common_name": "bupivacaine HCI 0.25% w/epin. 1:200M 10x20mL SU Vial",
    "fr_drug_brand_name": "Sensorcaine®",
    "fr_drug_common_name": "bupivacaine HCI 0.25% w/epin. 1:200M 10x20mL SU Vial",
    "en_ingredients": "EPINEPHRINE\r\nBUPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Épinéphrine\r\nChlorhydrate de bupivacaïne",
    "drug_strength": "5MCG\r\n2.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nBLOCK/INFILTRATION\r\nEPIDURAL\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Épidurale\r\nBloc/Infiltration\r\nÉpidurale\r\nBloc/Infiltration",
    "drug_package_quantity": "10 vials",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147269,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12078,
      "drug_code": 70039,
      "updated_date": "2025-05-15T04:04:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8336482,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "180",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245919",
      "brand_name": "SANDOZ DILTIAZEM T",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863007"
    },
    "created_date": "2021-10-15T02:01:32-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02245919",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "discontinuation_date": "2021-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-15T02:02:18-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ DILTIAZEM T",
    "en_drug_common_name": "DILTIAZEM T",
    "fr_drug_brand_name": "SANDOZ DILTIAZEM T",
    "fr_drug_common_name": "DILTIAZEM T",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "180MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100/Btl",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147289,
    "drug": {
      "current_status": "MARKETED",
      "id": 23374,
      "drug_code": 85968,
      "updated_date": "2025-12-03T00:31:50-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258439,
          "ingredient": {
            "id": 2182,
            "ingredient_code": 27,
            "en_name": "ANASTROZOLE",
            "fr_name": "Anastrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02374420",
      "brand_name": "APO-ANASTROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128681001"
    },
    "created_date": "2021-10-15T12:20:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02374420",
    "company_name": "APOTEX INC",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2022-03-04T00:00:00-05:00",
    "actual_start_date": "2021-10-12T00:00:00-04:00",
    "actual_end_date": "2022-02-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-19T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ANASTROZOLE",
    "en_drug_common_name": "ANASTROZOLE",
    "fr_drug_brand_name": "APO ANASTROZOLE",
    "fr_drug_common_name": "ANASTROZOLE",
    "en_ingredients": "ANASTROZOLE",
    "fr_ingredients": "Anastrozole",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147292,
    "drug": {
      "current_status": "MARKETED",
      "id": 7692,
      "drug_code": 50637,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253380,
          "ingredient": {
            "id": 490,
            "ingredient_code": 1212,
            "en_name": "FLUVOXAMINE MALEATE",
            "fr_name": "Maléate de fluvoxamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02231329",
      "brand_name": "APO-FLUVOXAMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122450002"
    },
    "created_date": "2021-10-15T12:23:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231329",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2021-12-09T00:00:00-05:00",
    "actual_start_date": "2021-10-12T00:00:00-04:00",
    "actual_end_date": "2021-11-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-11-29T13:14:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FLUVOXAMINE TABLETS",
    "en_drug_common_name": "FLUVOXAMINE",
    "fr_drug_brand_name": "APO FLUVOXAMINE",
    "fr_drug_common_name": "FLUVOXAMINE",
    "en_ingredients": "FLUVOXAMINE MALEATE",
    "fr_ingredients": "Maléate de fluvoxamine",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147299,
    "drug": {
      "current_status": "MARKETED",
      "id": 11640,
      "drug_code": 68715,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254330,
          "ingredient": {
            "id": 806,
            "ingredient_code": 7538,
            "en_name": "MEDROXYPROGESTERONE ACETATE",
            "fr_name": "Acétate de médroxyprogestérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244726",
      "brand_name": "AA-MEDROXY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106339004"
    },
    "created_date": "2021-10-15T12:29:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244726",
    "company_name": "APOTEX INC",
    "atc_number": "G03DA",
    "atc_description": "PROGESTOGENS",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2021-10-12T00:00:00-04:00",
    "actual_end_date": "2022-01-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2022-01-31T13:19:09-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MEDROXY TABLETS",
    "en_drug_common_name": "MEDROXY",
    "fr_drug_brand_name": "APO-MEDROXY",
    "fr_drug_common_name": "MEDROXY",
    "en_ingredients": "MEDROXYPROGESTERONE ACETATE",
    "fr_ingredients": "Acétate de médroxyprogestérone",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147302,
    "drug": {
      "current_status": "MARKETED",
      "id": 15610,
      "drug_code": 76294,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255598,
          "ingredient": {
            "id": 806,
            "ingredient_code": 7538,
            "en_name": "MEDROXYPROGESTERONE ACETATE",
            "fr_name": "Acétate de médroxyprogestérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02277298",
      "brand_name": "AA-MEDROXY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106339006"
    },
    "created_date": "2021-10-15T12:33:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02277298",
    "company_name": "APOTEX INC",
    "atc_number": "G03DA",
    "atc_description": "PROGESTOGENS",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2021-10-12T00:00:00-04:00",
    "actual_end_date": "2022-01-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2022-01-31T13:24:16-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MEDROXY",
    "en_drug_common_name": "MEDROXY",
    "fr_drug_brand_name": "APO-MEDROXY",
    "fr_drug_common_name": "MEDROXY",
    "en_ingredients": "MEDROXYPROGESTERONE ACETATE",
    "fr_ingredients": "Acétate de médroxyprogestérone",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147305,
    "drug": {
      "current_status": "MARKETED",
      "id": 11872,
      "drug_code": 69618,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254400,
          "ingredient": {
            "id": 2956,
            "ingredient_code": 12253,
            "en_name": "FONDAPARINUX SODIUM",
            "fr_name": "Fondaparinux sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02245531",
      "brand_name": "ARIXTRA",
      "brand_name_fr": "ARIXTRA",
      "descriptor": "0.5ML SINGLE USE PRE-FILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0146781001"
    },
    "created_date": "2021-10-15T12:49:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245531",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "B01AX",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2022-01-01T00:00:00-05:00",
    "estimated_end_date": "2022-01-15T00:00:00-05:00",
    "actual_end_date": "2021-12-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-12-22T15:21:49-05:00",
    "status": "avoided_shortage",
    "en_comments": "GR90683CA1",
    "en_drug_brand_name": "ARIXTRA",
    "en_drug_common_name": "fondaparinux sodium injection (0.5 mL)",
    "fr_drug_brand_name": "Arixtra®",
    "fr_drug_common_name": "fondaparinux sodium injection (0.5 mL)",
    "en_ingredients": "FONDAPARINUX SODIUM",
    "fr_ingredients": "Fondaparinux sodique",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "10 PF Syringe",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147308,
    "drug": {
      "current_status": "DORMANT",
      "id": 31384,
      "drug_code": 93678,
      "updated_date": "2025-05-15T06:55:56-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369354,
          "ingredient": {
            "id": 2536,
            "ingredient_code": 11714,
            "en_name": "NADROPARIN CALCIUM",
            "fr_name": "Nadroparine calcique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9500",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02450623",
      "brand_name": "FRAXIPARINE",
      "brand_name_fr": "",
      "descriptor": "0.4 ML (3800 IU) PREFILLED SYRINGE - ORANGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131662001"
    },
    "created_date": "2021-10-15T12:51:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02450623",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2022-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-03-02T06:00:02-05:00",
    "status": "active_confirmed",
    "en_comments": "GR96459CA1",
    "en_drug_brand_name": "FRAXIPARINE",
    "en_drug_common_name": "nadroparin calcium injection (0.4 mL)",
    "fr_drug_brand_name": "Arixtra®",
    "fr_drug_common_name": "nadroparin calcium injection (0.4 mL)",
    "en_ingredients": "NADROPARIN CALCIUM",
    "fr_ingredients": "Nadroparine calcique",
    "drug_strength": "9500UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "10 PF Syringe",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147319,
    "drug": {
      "current_status": "DORMANT",
      "id": 31386,
      "drug_code": 93679,
      "updated_date": "2025-05-15T06:55:56-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369355,
          "ingredient": {
            "id": 2536,
            "ingredient_code": 11714,
            "en_name": "NADROPARIN CALCIUM",
            "fr_name": "Nadroparine calcique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9500",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02450631",
      "brand_name": "FRAXIPARINE",
      "brand_name_fr": "",
      "descriptor": "0.6 ML (5700 IU) PREFILLED SYRINGE - BROWN",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131662001"
    },
    "created_date": "2021-10-15T12:57:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02450631",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2022-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-08-16T05:00:02-04:00",
    "status": "active_confirmed",
    "en_comments": "GR96536CA1",
    "en_drug_brand_name": "FRAXIPARINE",
    "en_drug_common_name": "nadroparin calcium injection (0.6 mL)",
    "fr_drug_brand_name": "Fraxiparine®",
    "fr_drug_common_name": "nadroparin calcium injection (0.6 mL)",
    "en_ingredients": "NADROPARIN CALCIUM",
    "fr_ingredients": "Nadroparine calcique",
    "drug_strength": "9500UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "10 PF Syringe",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147322,
    "drug": {
      "current_status": "DORMANT",
      "id": 31388,
      "drug_code": 93680,
      "updated_date": "2025-05-15T06:55:56-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369356,
          "ingredient": {
            "id": 2536,
            "ingredient_code": 11714,
            "en_name": "NADROPARIN CALCIUM",
            "fr_name": "Nadroparine calcique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9500",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02450658",
      "brand_name": "FRAXIPARINE",
      "brand_name_fr": "",
      "descriptor": "1 ML (9500 IU) PREFILLED SYRINGE - VIOLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131662001"
    },
    "created_date": "2021-10-15T13:00:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02450658",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2022-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-02T06:00:02-05:00",
    "status": "active_confirmed",
    "en_comments": "GR96678CA1",
    "en_drug_brand_name": "FRAXIPARINE",
    "en_drug_common_name": "nadroparin calcium injection (1.0 mL)",
    "fr_drug_brand_name": "Fraxiparine®",
    "fr_drug_common_name": "nadroparin calcium injection (1.0 mL)",
    "en_ingredients": "NADROPARIN CALCIUM",
    "fr_ingredients": "Nadroparine calcique",
    "drug_strength": "9500UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "10 PF Syringe",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147326,
    "drug": {
      "current_status": "MARKETED",
      "id": 8416,
      "drug_code": 585,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250158,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00001732",
      "brand_name": "XYLOCAINE 1%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "23886",
      "number_of_ais": "1",
      "ai_group_no": "0101280004"
    },
    "created_date": "2021-10-15T13:07:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00001732",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2022-04-15T00:00:00-04:00",
    "estimated_end_date": "2022-04-30T00:00:00-04:00",
    "actual_end_date": "2022-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-16T15:24:08-05:00",
    "status": "avoided_shortage",
    "en_comments": "VR89896CA1",
    "en_drug_brand_name": "XYLOCAINE 1%",
    "en_drug_common_name": "lidocaine HCI 1% Plain 50x10mL SU Polyamp® Duofit®",
    "fr_drug_brand_name": "Xylocaine®",
    "fr_drug_common_name": "lidocaine HCI 1% Plain 50x10mL SU Polyamp® Duofit®",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lidocaïne",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration\r\nBloc/Infiltration",
    "drug_package_quantity": "50 PE Polyamp",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147329,
    "drug": {
      "current_status": "MARKETED",
      "id": 28808,
      "drug_code": 90922,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260456,
          "ingredient": {
            "id": 2680,
            "ingredient_code": 11865,
            "en_name": "CELECOXIB",
            "fr_name": "Célécoxib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02424533",
      "brand_name": "JAMP-CELECOXIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137043001"
    },
    "created_date": "2021-10-15T13:11:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02424533",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "M01AH",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2021-10-15T00:00:00-04:00",
    "actual_start_date": "2021-09-15T00:00:00-04:00",
    "actual_end_date": "2021-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-24T16:02:24-05:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-CELECOXIB",
    "en_drug_common_name": "Celecoxib Capsules",
    "fr_drug_brand_name": "JAMP-Celecoxib",
    "fr_drug_common_name": "Capsules de célécoxib",
    "en_ingredients": "CELECOXIB",
    "fr_ingredients": "Célécoxib",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147331,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25948,
      "drug_code": 88332,
      "updated_date": "2025-12-03T01:30:52-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352498,
          "ingredient": {
            "id": 3218,
            "ingredient_code": 12329,
            "en_name": "GALANTAMINE",
            "fr_name": "Galantamine (Bromhydrate de galantamine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02398370",
      "brand_name": "PMS-GALANTAMINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144660002"
    },
    "created_date": "2021-10-15T13:11:42-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02398370",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2021-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-15T13:12:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-GALANTAMINE ER",
    "en_drug_common_name": "GALANTAMINE",
    "fr_drug_brand_name": "PMS-GALANTAMINE ER",
    "fr_drug_common_name": "GALANTAMINE",
    "en_ingredients": "GALANTAMINE",
    "fr_ingredients": "GALANTAMINE",
    "drug_strength": "8MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147335,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25948,
      "drug_code": 88332,
      "updated_date": "2025-12-03T01:30:52-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352498,
          "ingredient": {
            "id": 3218,
            "ingredient_code": 12329,
            "en_name": "GALANTAMINE",
            "fr_name": "Galantamine (Bromhydrate de galantamine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02398370",
      "brand_name": "PMS-GALANTAMINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144660002"
    },
    "created_date": "2021-10-15T13:12:40-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02398370",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2021-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-15T13:12:53-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-GALANTAMINE ER",
    "en_drug_common_name": "GALANTAMINE",
    "fr_drug_brand_name": "PMS-GALANTAMINE ER",
    "fr_drug_common_name": "GALANTAMINE",
    "en_ingredients": "GALANTAMINE",
    "fr_ingredients": "GALANTAMINE",
    "drug_strength": "8MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147338,
    "drug": {
      "current_status": "MARKETED",
      "id": 28808,
      "drug_code": 90922,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260456,
          "ingredient": {
            "id": 2680,
            "ingredient_code": 11865,
            "en_name": "CELECOXIB",
            "fr_name": "Célécoxib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02424533",
      "brand_name": "JAMP-CELECOXIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137043001"
    },
    "created_date": "2021-10-15T13:13:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02424533",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "M01AH",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2021-10-15T00:00:00-04:00",
    "actual_start_date": "2021-09-15T00:00:00-04:00",
    "actual_end_date": "2021-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-24T16:03:52-05:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-CELECOXIB",
    "en_drug_common_name": "Celecoxib Capsules",
    "fr_drug_brand_name": "JAMP-Celecoxib",
    "fr_drug_common_name": "Capsules de célécoxib",
    "en_ingredients": "CELECOXIB",
    "fr_ingredients": "Célécoxib",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147340,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25950,
      "drug_code": 88333,
      "updated_date": "2025-12-03T01:30:52-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352499,
          "ingredient": {
            "id": 3218,
            "ingredient_code": 12329,
            "en_name": "GALANTAMINE",
            "fr_name": "Galantamine (Bromhydrate de galantamine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02398389",
      "brand_name": "PMS-GALANTAMINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144660004"
    },
    "created_date": "2021-10-15T13:13:55-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02398389",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2021-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-15T13:14:16-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-GALANTAMINE ER",
    "en_drug_common_name": "GALANTAMINE",
    "fr_drug_brand_name": "PMS-GALANTAMINE ER",
    "fr_drug_common_name": "GALANTAMINE",
    "en_ingredients": "GALANTAMINE",
    "fr_ingredients": "GALANTAMINE",
    "drug_strength": "16MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147344,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25950,
      "drug_code": 88333,
      "updated_date": "2025-12-03T01:30:52-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352499,
          "ingredient": {
            "id": 3218,
            "ingredient_code": 12329,
            "en_name": "GALANTAMINE",
            "fr_name": "Galantamine (Bromhydrate de galantamine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02398389",
      "brand_name": "PMS-GALANTAMINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144660004"
    },
    "created_date": "2021-10-15T13:14:44-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02398389",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2021-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-15T13:14:58-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-GALANTAMINE ER",
    "en_drug_common_name": "GALANTAMINE",
    "fr_drug_brand_name": "PMS-GALANTAMINE ER",
    "fr_drug_common_name": "GALANTAMINE",
    "en_ingredients": "GALANTAMINE",
    "fr_ingredients": "GALANTAMINE",
    "drug_strength": "16MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147347,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25952,
      "drug_code": 88334,
      "updated_date": "2025-12-03T01:30:52-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352500,
          "ingredient": {
            "id": 3218,
            "ingredient_code": 12329,
            "en_name": "GALANTAMINE",
            "fr_name": "Galantamine (Bromhydrate de galantamine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "24",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02398397",
      "brand_name": "PMS-GALANTAMINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144660005"
    },
    "created_date": "2021-10-15T13:15:32-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02398397",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2021-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-15T13:15:46-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-GALANTAMINE ER",
    "en_drug_common_name": "GALANTAMINE",
    "fr_drug_brand_name": "PMS-GALANTAMINE",
    "fr_drug_common_name": "GALANTAMINE",
    "en_ingredients": "GALANTAMINE",
    "fr_ingredients": "GALANTAMINE",
    "drug_strength": "24MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147352,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25952,
      "drug_code": 88334,
      "updated_date": "2025-12-03T01:30:52-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352500,
          "ingredient": {
            "id": 3218,
            "ingredient_code": 12329,
            "en_name": "GALANTAMINE",
            "fr_name": "Galantamine (Bromhydrate de galantamine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "24",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02398397",
      "brand_name": "PMS-GALANTAMINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144660005"
    },
    "created_date": "2021-10-15T13:16:24-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02398397",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2021-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-15T13:16:35-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-GALANTAMINE ER",
    "en_drug_common_name": "GALANTAMINE",
    "fr_drug_brand_name": "PMS-GALANTAMINE ER",
    "fr_drug_common_name": "GALANTAMINE",
    "en_ingredients": "GALANTAMINE",
    "fr_ingredients": "GALANTAMINE",
    "drug_strength": "24MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147357,
    "drug": {
      "current_status": "MARKETED",
      "id": 22082,
      "drug_code": 84459,
      "updated_date": "2025-05-15T02:32:51-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257910,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359588",
      "brand_name": "JAMP-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332005"
    },
    "created_date": "2021-10-15T13:17:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359588",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-05-31T00:00:00-04:00",
    "actual_start_date": "2021-09-15T00:00:00-04:00",
    "actual_end_date": "2022-05-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T21:21:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-RISPERIDONE",
    "en_drug_common_name": "Risperidone Tablets1",
    "fr_drug_brand_name": "JAMP-Risperidone",
    "fr_drug_common_name": "Comprimés de rispéridone",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "4.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147369,
    "drug": {
      "current_status": "MARKETED",
      "id": 5882,
      "drug_code": 4092,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250592,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037842",
      "brand_name": "SODIUM CHLORIDE INJECTION USP",
      "brand_name_fr": "CHLORURE DE SODIUM INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "56634",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2021-10-15T13:56:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037842",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2021-11-15T00:00:00-05:00",
    "estimated_end_date": "2022-04-11T00:00:00-04:00",
    "actual_end_date": "2022-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-12T02:07:34-04:00",
    "status": "resolved",
    "en_comments": "Issue has been resolved.",
    "en_drug_brand_name": "SODIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "SODIUM CHLORIDE INJECTION USP",
    "fr_drug_brand_name": "CHLORURE DE SODIUM INJECTABLE USP",
    "fr_drug_common_name": "CHLORURE DE SODIUM INJECTABLE USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "250 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147388,
    "drug": {
      "current_status": "DORMANT",
      "id": 28180,
      "drug_code": 90319,
      "updated_date": "2025-12-03T02:32:35-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369056,
          "ingredient": {
            "id": 1522,
            "ingredient_code": 1966,
            "en_name": "NIFEDIPINE",
            "fr_name": "Nifédipine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02418630",
      "brand_name": "PMS-NIFEDIPINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115253004"
    },
    "created_date": "2021-10-15T14:38:57-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02418630",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C08CA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "discontinuation_date": "2021-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-15T14:39:14-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-NIFEDIPINE ER",
    "en_drug_common_name": "NIFEDIPINE",
    "fr_drug_brand_name": "PMS-NIFEDIPINE ER",
    "fr_drug_common_name": "NIFEDIPINE",
    "en_ingredients": "NIFEDIPINE",
    "fr_ingredients": "Nifédipine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147393,
    "drug": {
      "current_status": "MARKETED",
      "id": 27888,
      "drug_code": 90087,
      "updated_date": "2025-05-15T02:34:07-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260131,
          "ingredient": {
            "id": 1522,
            "ingredient_code": 1966,
            "en_name": "NIFEDIPINE",
            "fr_name": "Nifédipine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02416301",
      "brand_name": "PMS-NIFEDIPINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115253005"
    },
    "created_date": "2021-10-15T14:40:16-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02416301",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C08CA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "discontinuation_date": "2021-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "format 100 is available",
    "fr_discontinuation_comments": "format 100 is available",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-15T14:40:36-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-NIFEDIPINE ER",
    "en_drug_common_name": "NIFEDIPINE",
    "fr_drug_brand_name": "PMS-NIFEDIPINE ER",
    "fr_drug_common_name": "NIFEDIPINE",
    "en_ingredients": "NIFEDIPINE",
    "fr_ingredients": "Nifédipine",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147417,
    "drug": {
      "current_status": "DORMANT",
      "id": 4576,
      "drug_code": 229,
      "updated_date": "2025-12-03T02:32:11-05:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8365773,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00038229",
      "brand_name": "STERILE WATER FOR IRRIGATION USP",
      "brand_name_fr": "EAU STÉRILE POUR IRRIGATION USP",
      "descriptor": "SINGLE-USE",
      "pediatric_flag": false,
      "accession_number": "08242",
      "number_of_ais": "1",
      "ai_group_no": "0105143002"
    },
    "created_date": "2021-10-15T15:33:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00038229",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2021-12-01T00:00:00-05:00",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_end_date": "2022-03-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-04T14:34:15-05:00",
    "status": "resolved",
    "en_comments": "This issue has been resolved.",
    "en_drug_brand_name": "STERILE WATER FOR IRRIGATION USP",
    "en_drug_common_name": "Sterile Water for Irrigation USP",
    "fr_drug_brand_name": "Eau Stérile pour Irrigation USP",
    "fr_drug_common_name": "Eau Stérile pour Irrigation USP",
    "en_ingredients": "WATER",
    "fr_ingredients": "Eau",
    "drug_strength": "100%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "TOPICAL\r\nIRRIGATION\r\nINTRAPERITONEAL\r\nTOPICAL\r\nIRRIGATION\r\nINTRAPERITONEAL",
    "drug_route_fr": "Topique\r\nIrrigation\r\nIntrapéritonéale\r\nTopique\r\nIrrigation\r\nIntrapéritonéale",
    "drug_package_quantity": "500 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147420,
    "drug": {
      "current_status": "DORMANT",
      "id": 3016,
      "drug_code": 1746,
      "updated_date": "2025-12-03T02:32:11-05:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8365881,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037974",
      "brand_name": "DEXTROSE INJECTION USP",
      "brand_name_fr": "DEXTROSE INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "43678",
      "number_of_ais": "1",
      "ai_group_no": "0102181001"
    },
    "created_date": "2021-10-15T15:37:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037974",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2022-02-02T00:00:00-05:00",
    "estimated_end_date": "2022-02-28T00:00:00-05:00",
    "actual_end_date": "2021-11-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-02T13:49:58-04:00",
    "status": "avoided_shortage",
    "en_comments": "Shortage avoided.",
    "en_drug_brand_name": "DEXTROSE INJECTION USP",
    "en_drug_common_name": "Dextrose Injection USP",
    "fr_drug_brand_name": "Dextrose injectable USP",
    "fr_drug_common_name": "Dextrose injectable USP",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "500MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "500 mL in 1000 mL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147427,
    "drug": {
      "current_status": "MARKETED",
      "id": 24938,
      "drug_code": 87449,
      "updated_date": "2025-12-03T00:32:03-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259021,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259020,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388960",
      "brand_name": "LOSARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168001"
    },
    "created_date": "2021-10-15T17:25:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388960",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2021-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-10-15T17:27:08-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "LOSARTAN HCT",
    "en_drug_common_name": "Losartan HCT",
    "fr_drug_brand_name": "LOSARTAN HCT",
    "fr_drug_common_name": "Losartan HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147430,
    "drug": {
      "current_status": "MARKETED",
      "id": 24938,
      "drug_code": 87449,
      "updated_date": "2025-12-03T00:32:03-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259021,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259020,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388960",
      "brand_name": "LOSARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168001"
    },
    "created_date": "2021-10-15T17:26:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388960",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2021-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-10-15T17:26:53-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "LOSARTAN HCT",
    "en_drug_common_name": "Losartan HCT",
    "fr_drug_brand_name": "LOSARTAN HCT",
    "fr_drug_common_name": "Losartan HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147435,
    "drug": {
      "current_status": "MARKETED",
      "id": 24940,
      "drug_code": 87450,
      "updated_date": "2025-12-03T00:32:03-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259023,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259022,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388979",
      "brand_name": "LOSARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168003"
    },
    "created_date": "2021-10-15T17:29:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388979",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2021-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-10-15T17:30:12-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "LOSARTAN HCT",
    "en_drug_common_name": "Losartan HCT",
    "fr_drug_brand_name": "LOSARTAN HCT",
    "fr_drug_common_name": "Losartan HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147438,
    "drug": {
      "current_status": "MARKETED",
      "id": 24940,
      "drug_code": 87450,
      "updated_date": "2025-12-03T00:32:03-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259023,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259022,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388979",
      "brand_name": "LOSARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168003"
    },
    "created_date": "2021-10-15T17:30:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388979",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2021-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-10-15T17:30:59-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "LOSARTAN HCT",
    "en_drug_common_name": "Losartan HCT",
    "fr_drug_brand_name": "LOSARTAN HCT",
    "fr_drug_common_name": "Losartan HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147441,
    "drug": {
      "current_status": "MARKETED",
      "id": 11006,
      "drug_code": 67033,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8254138,
          "ingredient": {
            "id": 500,
            "ingredient_code": 6850,
            "en_name": "BENZOYL PEROXIDE",
            "fr_name": "Peroxyde de benzoyle"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8254137,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02243158",
      "brand_name": "CLINDOXYL GEL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0242561001"
    },
    "created_date": "2021-10-15T17:31:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243158",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "D10AF",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2022-01-04T00:00:00-05:00",
    "actual_start_date": "2021-10-12T00:00:00-04:00",
    "actual_end_date": "2022-01-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-05T19:57:34-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CLINDOXYL GEL",
    "en_drug_common_name": "clindamycin and benzoyl peroxide gel",
    "fr_drug_brand_name": "gel CLINDOXYL",
    "fr_drug_common_name": "gel de clindamycine et de peroxyde de benzoyle",
    "en_ingredients": "CLINDAMYCIN\r\nBENZOYL PEROXIDE",
    "fr_ingredients": "Peroxyde de benzoyle",
    "drug_strength": "1%\r\n5%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "45G",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147444,
    "drug": {
      "current_status": "MARKETED",
      "id": 24942,
      "drug_code": 87451,
      "updated_date": "2025-12-03T00:32:03-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259025,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259024,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388987",
      "brand_name": "LOSARTAN HCT DS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168002"
    },
    "created_date": "2021-10-15T17:37:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388987",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2021-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-10-15T17:37:24-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "LOSARTAN HCT",
    "en_drug_common_name": "Losartan HCT",
    "fr_drug_brand_name": "LOSARTAN HCT",
    "fr_drug_common_name": "Losartan HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "25MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147447,
    "drug": {
      "current_status": "MARKETED",
      "id": 24942,
      "drug_code": 87451,
      "updated_date": "2025-12-03T00:32:03-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259025,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259024,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388987",
      "brand_name": "LOSARTAN HCT DS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168002"
    },
    "created_date": "2021-10-15T17:37:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388987",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2021-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-10-15T17:38:03-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "LOSARTAN HCT",
    "en_drug_common_name": "Losartan HCT",
    "fr_drug_brand_name": "LOSARTAN HCT",
    "fr_drug_common_name": "Losartan HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "25MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147450,
    "drug": {
      "current_status": "MARKETED",
      "id": 24594,
      "drug_code": 87188,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258882,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386305",
      "brand_name": "SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415004"
    },
    "created_date": "2021-10-15T17:40:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386305",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-07-15T00:00:00-04:00",
    "actual_start_date": "2021-10-04T00:00:00-04:00",
    "actual_end_date": "2022-07-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-19T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SIMVASTATIN",
    "en_drug_common_name": "Simvastatin",
    "fr_drug_brand_name": "SIMVASTATIN",
    "fr_drug_common_name": "Simvastatin",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147453,
    "drug": {
      "current_status": "MARKETED",
      "id": 28388,
      "drug_code": 90516,
      "updated_date": "2025-12-03T00:32:28-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260285,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420597",
      "brand_name": "DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548001"
    },
    "created_date": "2021-10-15T17:42:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420597",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2022-04-01T00:00:00-04:00",
    "estimated_end_date": "2022-06-15T00:00:00-04:00",
    "actual_start_date": "2022-05-01T00:00:00-04:00",
    "actual_end_date": "2022-06-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-06-20T12:38:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DONEPEZIL",
    "en_drug_common_name": "Donepezil",
    "fr_drug_brand_name": "DONEPEZIL",
    "fr_drug_common_name": "Donepezil",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147456,
    "drug": {
      "current_status": "MARKETED",
      "id": 28390,
      "drug_code": 90517,
      "updated_date": "2025-12-03T00:32:28-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260286,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420600",
      "brand_name": "DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548002"
    },
    "created_date": "2021-10-15T17:43:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420600",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2022-04-01T00:00:00-04:00",
    "estimated_end_date": "2022-06-15T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-06-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-06-20T12:39:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DONEPEZIL",
    "en_drug_common_name": "Donepezil",
    "fr_drug_brand_name": "DONEPEZIL",
    "fr_drug_common_name": "Donepezil",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147459,
    "drug": {
      "current_status": "MARKETED",
      "id": 24592,
      "drug_code": 87187,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258881,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386291",
      "brand_name": "SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415001"
    },
    "created_date": "2021-10-15T17:46:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386291",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2021-11-01T00:00:00-04:00",
    "estimated_end_date": "2022-07-15T00:00:00-04:00",
    "actual_start_date": "2021-11-01T00:00:00-04:00",
    "actual_end_date": "2022-06-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-07-18T20:22:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SIMVASTATIN",
    "en_drug_common_name": "Simvastatin",
    "fr_drug_brand_name": "SIMVASTATIN",
    "fr_drug_common_name": "Simvastatin",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147462,
    "drug": {
      "current_status": "MARKETED",
      "id": 24594,
      "drug_code": 87188,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258882,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386305",
      "brand_name": "SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415004"
    },
    "created_date": "2021-10-15T17:55:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386305",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2021-11-21T00:00:00-05:00",
    "estimated_end_date": "2022-07-15T00:00:00-04:00",
    "actual_start_date": "2021-11-22T00:00:00-05:00",
    "actual_end_date": "2022-07-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-07-18T20:23:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SIMVASTATIN",
    "en_drug_common_name": "Simvastatin",
    "fr_drug_brand_name": "SIMVASTATIN",
    "fr_drug_common_name": "Simvastatin",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147481,
    "drug": {
      "current_status": "MARKETED",
      "id": 6770,
      "drug_code": 44255,
      "updated_date": "2025-12-03T00:30:37-05:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8253174,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02182882",
      "brand_name": "COZAAR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9979",
      "number_of_ais": "1",
      "ai_group_no": "0127971002"
    },
    "created_date": "2021-10-15T20:17:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02182882",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2022-01-17T00:00:00-05:00",
    "actual_start_date": "2021-10-15T00:00:00-04:00",
    "actual_end_date": "2022-01-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-08T06:00:07-05:00",
    "status": "resolved",
    "en_comments": "Orders partially released Oct 27 and Dec 17,2021",
    "fr_comments": "Les commandes en souffrance ont été partiellement libérées le 27 Octobre 2021 et  le 17 Decembre 2021",
    "en_drug_brand_name": "COZAAR",
    "en_drug_common_name": "losartan potassium tablets",
    "fr_drug_brand_name": "COZAAR",
    "fr_drug_common_name": "comprimés de losartan potassique",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147497,
    "drug": {
      "current_status": "MARKETED",
      "id": 58660,
      "drug_code": 81334,
      "updated_date": "2025-05-15T02:32:26-04:00",
      "company": {
        "id": 918,
        "created_date": "2017-03-09T13:23:27-05:00",
        "updated_date": "2025-05-15T02:30:19-04:00",
        "company_code": 13433,
        "mfr_code": "",
        "name": "LANTHEUS MI CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1111 DR. FREDERIK-PHILIPS BLVD., SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2X6",
        "post_office_box": "",
        "contact_information": "lmicanada@lantheus.com\r\n1-800-811-5500"
      },
      "drug_ingredients": [
        {
          "id": 8257039,
          "ingredient": {
            "id": 14563,
            "ingredient_code": 20480,
            "en_name": "BICISATE DIHYDROCHLORIDE",
            "fr_name": "Dichlorhydrate de bicisate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02327848",
      "brand_name": "NEUROLITE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152594001"
    },
    "created_date": "2021-10-16T19:35:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327848",
    "company_name": "LANTHEUS MI CANADA INC",
    "atc_number": "V09A",
    "anticipated_start_date": "2021-11-05T00:00:00-04:00",
    "estimated_end_date": "2022-02-14T00:00:00-05:00",
    "actual_start_date": "2021-11-01T00:00:00-04:00",
    "actual_end_date": "2022-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2022-01-19T16:13:31-05:00",
    "status": "resolved",
    "en_drug_brand_name": "NEUROLITE",
    "en_drug_common_name": "Kit for the Preparation of Technetium Tc99m Bicisate for injection",
    "fr_drug_brand_name": "NEUROLITE",
    "fr_drug_common_name": "Trousse pour la préparation du bicisate de technétium [Tc99m] injectable",
    "en_ingredients": "BICISATE DIHYDROCHLORIDE",
    "fr_ingredients": "Dichlorhydrate de bicisate",
    "drug_strength": "0.9MG",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "Kits of 2 and kits of 5 vials",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147501,
    "drug": {
      "current_status": "MARKETED",
      "id": 18262,
      "drug_code": 79542,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256405,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02309750",
      "brand_name": "PMS-LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971001"
    },
    "created_date": "2021-10-18T11:55:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02309750",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2022-02-18T00:00:00-05:00",
    "actual_start_date": "2021-10-15T00:00:00-04:00",
    "actual_end_date": "2022-02-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-11T14:55:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "PMS-LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147504,
    "drug": {
      "current_status": "MARKETED",
      "id": 18266,
      "drug_code": 79544,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256407,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02309777",
      "brand_name": "PMS-LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971002"
    },
    "created_date": "2021-10-18T11:56:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02309777",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2022-03-02T00:00:00-05:00",
    "actual_start_date": "2021-10-15T00:00:00-04:00",
    "actual_end_date": "2022-02-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-28T16:30:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "PMS-LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147507,
    "drug": {
      "current_status": "MARKETED",
      "id": 18264,
      "drug_code": 79543,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256406,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02309769",
      "brand_name": "PMS-LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971003"
    },
    "created_date": "2021-10-18T11:57:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02309769",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2022-02-18T00:00:00-05:00",
    "actual_start_date": "2021-10-15T00:00:00-04:00",
    "actual_end_date": "2022-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-10T18:18:32-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "PMS-LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147555,
    "drug": {
      "current_status": "MARKETED",
      "id": 6084,
      "drug_code": 4258,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 510,
        "created_date": "2017-03-09T13:22:50-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16647,
        "mfr_code": "",
        "name": "SEARCHLIGHT PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1600 RUE NOTRE DAME OUEST, SUITE 312",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3J 1M1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250617,
          "ingredient": {
            "id": 2062,
            "ingredient_code": 10278,
            "en_name": "OXTRIPHYLLINE",
            "fr_name": "Oxtriphylline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250616,
          "ingredient": {
            "id": 300,
            "ingredient_code": 9615,
            "en_name": "GUAIFENESIN",
            "fr_name": "Guaïfénésine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00476374",
      "brand_name": "CHOLEDYL EXPECTORANT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57130",
      "number_of_ais": "2",
      "ai_group_no": "0200552001"
    },
    "created_date": "2021-10-19T14:19:43-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00476374",
    "company_name": "ERFA CANADA 2012 INC",
    "atc_number": "R03DA",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "discontinuation_date": "2021-10-19T00:00:00-04:00",
    "anticipated_discontinuation_date": "2021-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2021-10-20T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "CHOLEDYL EXPECTORANT ELIXIR",
    "en_drug_common_name": "CHOLEDYL ELIXIR EXPECTORANT",
    "fr_drug_brand_name": "CHOLEDYL EXPECTORANT ELIXIR",
    "fr_drug_common_name": "CHOLEDYL ELIXIR EXPECTORANT",
    "en_ingredients": "GUAIFENESIN\r\nOXTRIPHYLLINE",
    "fr_ingredients": "Guaïfénésine\r\nOxtriphylline",
    "drug_strength": "50MG\r\n100MG",
    "drug_dosage_form": "ELIXIR",
    "drug_dosage_form_fr": "Élixir",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500ML",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147570,
    "drug": {
      "current_status": "MARKETED",
      "id": 20570,
      "drug_code": 82303,
      "updated_date": "2025-12-03T00:31:30-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257278,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257277,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337444",
      "brand_name": "SANDOZ IRBESARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086003"
    },
    "created_date": "2021-10-19T14:38:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02337444",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2021-10-29T00:00:00-04:00",
    "actual_start_date": "2021-10-19T00:00:00-04:00",
    "actual_end_date": "2021-10-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-26T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "en_drug_common_name": "IRBESARTAN HCT",
    "fr_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "fr_drug_common_name": "IRBESARTAN HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "25MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147573,
    "drug": {
      "current_status": "MARKETED",
      "id": 18048,
      "drug_code": 79242,
      "updated_date": "2025-05-15T02:32:07-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256348,
          "ingredient": {
            "id": 2294,
            "ingredient_code": 11086,
            "en_name": "PANTOPRAZOLE",
            "fr_name": "Pantoprazole (Pantoprazole sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02306727",
      "brand_name": "PANTOPRAZOLE SODIUM FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133229001"
    },
    "created_date": "2021-10-19T14:40:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02306727",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2021-11-12T00:00:00-05:00",
    "actual_start_date": "2021-10-19T00:00:00-04:00",
    "actual_end_date": "2021-11-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-11-16T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PANTOPRAZOLE SODIUM FOR INJECTION",
    "en_drug_common_name": "PANTOPRAZOLE SODIUM INJ",
    "fr_drug_brand_name": "PANTOPRAZOLE SODIUM FOR INJECTION",
    "fr_drug_common_name": "PANTOPRAZOLE SODIUM INJ",
    "en_ingredients": "PANTOPRAZOLE",
    "fr_ingredients": "PANTOPRAZOLE",
    "drug_strength": "40MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10LYVI",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147577,
    "drug": {
      "current_status": "MARKETED",
      "id": 19264,
      "drug_code": 80536,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256738,
          "ingredient": {
            "id": 3490,
            "ingredient_code": 1739,
            "en_name": "CLADRIBINE",
            "fr_name": "Cladribine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02319918",
      "brand_name": "CLADRIBINE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124270001"
    },
    "created_date": "2021-10-19T19:21:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02319918",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "L01BB",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2021-11-17T00:00:00-05:00",
    "estimated_end_date": "2022-02-22T00:00:00-05:00",
    "actual_start_date": "2021-11-17T00:00:00-05:00",
    "actual_end_date": "2022-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-28T13:56:50-05:00",
    "status": "resolved",
    "en_comments": "Generic Medical Partners is an alternate supplier of Cladribine Injection and have been informed of our impending supply interruption.",
    "fr_comments": "Partenaires Médicaux Génériques étant un autre fournisseur de Cladribine injectable, nous l’avons informé de notre situation imminente d’interruption d’approvisionnement.",
    "en_drug_brand_name": "CLADRIBINE INJECTION",
    "en_drug_common_name": "Cladribine Injection 1 mg/mL SD Vial 10 mL",
    "fr_drug_brand_name": "Cladribine injectable, 1 mg/mL",
    "fr_drug_common_name": "Cladribine injectable, 1 mg/mL, fioles DU, 10 mL",
    "en_ingredients": "CLADRIBINE",
    "fr_ingredients": "Cladribine",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147580,
    "drug": {
      "current_status": "MARKETED",
      "id": 3700,
      "drug_code": 19168,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8252455,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02182874",
      "brand_name": "COZAAR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81459",
      "number_of_ais": "1",
      "ai_group_no": "0127971003"
    },
    "created_date": "2021-10-19T19:34:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02182874",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2021-10-29T00:00:00-04:00",
    "actual_start_date": "2021-10-19T00:00:00-04:00",
    "actual_end_date": "2021-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-10-28T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Back orders were partially released on Oct 21st.",
    "fr_comments": "Les commandes en souffrance ont été partiellement libérées le 21 octobre.",
    "en_drug_brand_name": "COZAAR",
    "en_drug_common_name": "losartan potassium tablets",
    "fr_drug_brand_name": "COZAAR",
    "fr_drug_common_name": "comprimés de losartan potassique",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147619,
    "drug": {
      "current_status": "MARKETED",
      "id": 5132,
      "drug_code": 31361,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252790,
          "ingredient": {
            "id": 420,
            "ingredient_code": 7375,
            "en_name": "OXYTOCIN",
            "fr_name": "Oxytocine/Ocytocine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139561",
      "brand_name": "OXYTOCIN INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "F8601",
      "number_of_ais": "1",
      "ai_group_no": "0106478002"
    },
    "created_date": "2021-10-20T19:12:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139561",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "H01BB",
    "atc_description": "POSTERIOR PITUITARY LOBE HORMONES",
    "anticipated_start_date": "2021-11-01T00:00:00-04:00",
    "estimated_end_date": "2022-01-01T00:00:00-05:00",
    "actual_start_date": "2021-11-01T00:00:00-04:00",
    "actual_end_date": "2022-01-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-06T21:27:07-05:00",
    "status": "resolved",
    "en_comments": "Allocation strategy implemented to stretch inventory and ensure equitable distribution. Please see customer communication.",
    "fr_comments": "Stratégie d'allocation mise en œuvre pour étendre l'inventaire et assurer une distribution équitable. Veuillez consulter la communication client.",
    "en_drug_brand_name": "OXYTOCIN INJECTION, USP",
    "en_drug_common_name": "Oxytocin Injection, USP Synthetic 10 USP units/mL SD Vial 1 mL",
    "fr_drug_brand_name": "Oxytocine injectable, USP",
    "fr_drug_common_name": "Oxytocine injectable, USP synthétique, 10 unités USP/mL, fioles DU de 1 mL",
    "en_ingredients": "OXYTOCIN",
    "fr_ingredients": "Oxytocine/Ocytocine",
    "drug_strength": "10UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "1 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147622,
    "drug": {
      "current_status": "MARKETED",
      "id": 3560,
      "drug_code": 18936,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252401,
          "ingredient": {
            "id": 1044,
            "ingredient_code": 4808,
            "en_name": "CALCIUM GLUCONATE",
            "fr_name": "Gluconate de calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02141019",
      "brand_name": "CALCIUM GLUCONATE INJECTION, USP 10%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81222",
      "number_of_ais": "1",
      "ai_group_no": "0108566002"
    },
    "created_date": "2021-10-20T19:15:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02141019",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05BB",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2021-11-01T00:00:00-04:00",
    "estimated_end_date": "2022-03-07T00:00:00-05:00",
    "actual_start_date": "2021-02-01T00:00:00-05:00",
    "actual_end_date": "2022-03-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-21T16:05:50-04:00",
    "status": "resolved",
    "en_comments": "Effective Mar. 7, 2022, 100mL will be used to cover 100% of 100mL demand plus 100% of 50mL demand on a mL per mL basis for contract customers.\t\t\r\nPlease see customer communication.",
    "fr_comments": "À compter du 7 mars 2022, le 100 mL sera utilisé pour couvrir 100 % de la demande du 100 mL plus 100 % de la demande du 50 mL sur une base de mL par mL pour les clients contractuels.\r\nVeuillez consulter la communication client.",
    "en_drug_brand_name": "CALCIUM GLUCONATE INJECTION, USP 10%",
    "en_drug_common_name": "Calcium Gluconate Injection, USP 10% 100 mg/mL SD Vial (Plastic) 100 mL",
    "fr_drug_brand_name": "Gluconate de calcium injectable, USP à 10 %",
    "fr_drug_common_name": "Gluconate de calcium injectable, USP à 10 %, 100 mg/mL, fioles DU (plastique) de 100 mL",
    "en_ingredients": "CALCIUM GLUCONATE",
    "fr_ingredients": "Gluconate de calcium",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "100 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147629,
    "drug": {
      "current_status": "MARKETED",
      "id": 3560,
      "drug_code": 18936,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252401,
          "ingredient": {
            "id": 1044,
            "ingredient_code": 4808,
            "en_name": "CALCIUM GLUCONATE",
            "fr_name": "Gluconate de calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02141019",
      "brand_name": "CALCIUM GLUCONATE INJECTION, USP 10%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81222",
      "number_of_ais": "1",
      "ai_group_no": "0108566002"
    },
    "created_date": "2021-10-20T19:18:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02141019",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05BB",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2022-01-01T00:00:00-05:00",
    "estimated_end_date": "2022-12-31T00:00:00-05:00",
    "actual_start_date": "2022-03-01T00:00:00-05:00",
    "actual_end_date": "2022-12-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-01-03T03:50:45-05:00",
    "status": "resolved",
    "en_comments": "Effective May. 2, 2022, will be placed on allocation. Contract customers will be allocated 150% historical monthly demand.",
    "fr_comments": "À compter de 2 mai, 2022, sera mis en attribution. Les clients sous contrat se verront attribuer 150 % de la demande mensuelle historique",
    "en_drug_brand_name": "CALCIUM GLUCONATE INJECTION, USP 10%",
    "en_drug_common_name": "Calcium Gluconate Injection, USP 10% 100 mg/mL SD Vial (Plastic) 50 mL",
    "fr_drug_brand_name": "Gluconate de calcium injectable, USP à 10 %",
    "fr_drug_common_name": "Gluconate de calcium injectable, USP à 10 %, 100 mg/mL, fioles DU (plastique) de 50 mL",
    "en_ingredients": "CALCIUM GLUCONATE",
    "fr_ingredients": "Gluconate de calcium",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147647,
    "drug": {
      "current_status": "MARKETED",
      "id": 6616,
      "drug_code": 43843,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253114,
          "ingredient": {
            "id": 1580,
            "ingredient_code": 2953,
            "en_name": "CYTARABINE",
            "fr_name": "Cytarabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02126656",
      "brand_name": "CYTARABINE INJECTION",
      "brand_name_fr": "CYTARABINE INJECTABLE",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "S9913",
      "number_of_ais": "1",
      "ai_group_no": "0108854005"
    },
    "created_date": "2021-10-20T20:20:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02126656",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "actual_start_date": "2021-10-20T00:00:00-04:00",
    "actual_end_date": "2021-12-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-12-09T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CYTARABINE INJECTION",
    "en_drug_common_name": "CYTARABINE INJECTION",
    "fr_drug_brand_name": "CYTARABINE pour injection",
    "fr_drug_common_name": "CYTARABINE pour injection",
    "en_ingredients": "CYTARABINE",
    "fr_ingredients": "Cytarabine",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRATHECAL\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRATHECAL",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntrathécale\r\nSous-cutanée\r\nIntraveineuse\r\nIntrathécale",
    "drug_package_quantity": "1 x 20mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147650,
    "drug": {
      "current_status": "MARKETED",
      "id": 18786,
      "drug_code": 80046,
      "updated_date": "2025-05-15T02:32:14-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8256566,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02314932",
      "brand_name": "LEVOFLOXACIN IN 5% DEXTROSE INJECTION",
      "brand_name_fr": "LÉVOFLOXACINE DANS DU DEXTROSE À 5% INJECTABLE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663001"
    },
    "created_date": "2021-10-20T20:26:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314932",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "actual_start_date": "2021-10-25T00:00:00-04:00",
    "actual_end_date": "2023-03-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-15T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LEVOFLOXACIN IN 5% DEXTROSE INJECTION",
    "en_drug_common_name": "LEVOFLOXACIN IN 5% DEXTROSE INJECTION",
    "fr_drug_brand_name": "Lévofloxacine dans dextrose à 5 % injectable",
    "fr_drug_common_name": "Lévofloxacine dans dextrose à 5 % injectable",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "24 x 100mL bag",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147653,
    "drug": {
      "current_status": "MARKETED",
      "id": 18786,
      "drug_code": 80046,
      "updated_date": "2025-05-15T02:32:14-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8256566,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02314932",
      "brand_name": "LEVOFLOXACIN IN 5% DEXTROSE INJECTION",
      "brand_name_fr": "LÉVOFLOXACINE DANS DU DEXTROSE À 5% INJECTABLE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663001"
    },
    "created_date": "2021-10-20T20:31:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314932",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2022-07-29T00:00:00-04:00",
    "actual_start_date": "2021-10-25T00:00:00-04:00",
    "actual_end_date": "2022-07-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-03T14:47:33-05:00",
    "status": "resolved",
    "en_comments": "Inventory is on preventative allocation.",
    "fr_comments": "L'inventaire est sous allocation préventive.",
    "en_drug_brand_name": "LEVOFLOXACIN IN 5% DEXTROSE INJECTION",
    "en_drug_common_name": "LEVOFLOXACIN IN 5% DEXTROSE INJECTION",
    "fr_drug_brand_name": "Lévofloxacine dans dextrose à 5 % injectable",
    "fr_drug_common_name": "Lévofloxacine dans dextrose à 5 % injectable",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "24 x 150mL bag",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147696,
    "drug": {
      "current_status": "MARKETED",
      "id": 1598,
      "drug_code": 13439,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251767,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01910280",
      "brand_name": "TEVA-CLOBETASOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74826",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2021-10-21T16:00:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01910280",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2021-11-30T00:00:00-05:00",
    "actual_start_date": "2021-10-20T00:00:00-04:00",
    "actual_end_date": "2021-11-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-18T18:56:49-05:00",
    "status": "resolved",
    "en_comments": "Allocating to 100% of market until end of November.",
    "en_drug_brand_name": "TEVA-CLOBETASOL",
    "en_drug_common_name": "CLOBETASOL 0.05% OINT",
    "fr_drug_brand_name": "CLOBETASOL 0.05% OINT",
    "fr_drug_common_name": "TEVA-CLOBETASOL 0.05% OINT",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15G",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147699,
    "drug": {
      "current_status": "MARKETED",
      "id": 27928,
      "drug_code": 90124,
      "updated_date": "2025-05-15T02:34:07-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260142,
          "ingredient": {
            "id": 2704,
            "ingredient_code": 11893,
            "en_name": "ABACAVIR",
            "fr_name": "Abacavir (Sulfate d'abacavir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8260141,
          "ingredient": {
            "id": 1582,
            "ingredient_code": 122,
            "en_name": "LAMIVUDINE",
            "fr_name": "Lamivudine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02416662",
      "brand_name": "TEVA-ABACAVIR/LAMIVUDINE",
      "brand_name_fr": "TEVA-ABACAVIR/LAMIVUDINE",
      "descriptor": "FIXED-DOSE COMBINATION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251241001"
    },
    "created_date": "2021-10-21T16:02:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02416662",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J05AR",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2021-12-31T00:00:00-05:00",
    "actual_start_date": "2021-10-20T00:00:00-04:00",
    "actual_end_date": "2021-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-12-17T13:52:15-05:00",
    "status": "resolved",
    "en_comments": "Short dated lots",
    "fr_comments": "Shortdateed Lots",
    "en_drug_brand_name": "TEVA-ABACAVIR/LAMIVUDINE",
    "en_drug_common_name": "ABACAVIR/LAMIVUDINE 600/300MG TAB",
    "fr_drug_brand_name": "TEVA-ABACAVIR/LAMIVUDINE 600/300MG TAB",
    "fr_drug_common_name": "ABACAVIR/LAMIVUDINE 600/300MG TAB",
    "en_ingredients": "LAMIVUDINE\r\nABACAVIR",
    "fr_ingredients": "Lamivudine",
    "drug_strength": "300MG\r\n600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147702,
    "drug": {
      "current_status": "MARKETED",
      "id": 25662,
      "drug_code": 88063,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259273,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259272,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395541",
      "brand_name": "TEVA-CANDESARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0244181001"
    },
    "created_date": "2021-10-21T16:04:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395541",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2021-10-20T00:00:00-04:00",
    "actual_end_date": "2022-01-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-01-07T19:05:30-05:00",
    "status": "resolved",
    "en_comments": "Prev Lots were shortdated",
    "fr_comments": "Shortdated Lots",
    "en_drug_brand_name": "TEVA-CANDESARTAN/HCTZ",
    "en_drug_common_name": "CANDESARTAN/HCTZ 16/12.5MG TB",
    "fr_drug_brand_name": "TEVA-CANDESARTAN/HCTZ 16/12.5MG TB",
    "fr_drug_common_name": "CANDESARTAN/HCTZ 16/12.5MG TB",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nCANDESARTAN CILEXETIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nCandésartan cilexétil",
    "drug_strength": "12.5MG\r\n16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "P/P 30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147705,
    "drug": {
      "current_status": "MARKETED",
      "id": 18384,
      "drug_code": 79653,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256441,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310910",
      "brand_name": "TEVA-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055003"
    },
    "created_date": "2021-10-21T16:06:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310910",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2021-11-30T00:00:00-05:00",
    "actual_start_date": "2021-10-20T00:00:00-04:00",
    "actual_end_date": "2021-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-08T21:08:21-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN 40MG FC TAB",
    "fr_drug_brand_name": "TEVA-ATORVASTATIN 40MG FC TAB",
    "fr_drug_common_name": "ATORVASTATIN 40MG FC TAB",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147708,
    "drug": {
      "current_status": "MARKETED",
      "id": 30360,
      "drug_code": 9241,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251136,
          "ingredient": {
            "id": 40,
            "ingredient_code": 2037,
            "en_name": "NAPROXEN SODIUM",
            "fr_name": "Naproxène sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "275",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00778389",
      "brand_name": "TEVA-NAPROXEN SODIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68168",
      "number_of_ais": "1",
      "ai_group_no": "0113934001"
    },
    "created_date": "2021-10-21T16:08:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00778389",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2021-11-30T00:00:00-05:00",
    "actual_start_date": "2021-10-20T00:00:00-04:00",
    "actual_end_date": "2021-11-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-05T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-NAPROXEN SODIUM",
    "en_drug_common_name": "NAPROXEN SODIUM 275MG TAB",
    "fr_drug_brand_name": "TEVA-NAPROXEN SODIUM 275MG TAB",
    "fr_drug_common_name": "NAPROXEN SODIUM 275MG TAB",
    "en_ingredients": "NAPROXEN SODIUM",
    "fr_ingredients": "Naproxène sodique",
    "drug_strength": "275MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147711,
    "drug": {
      "current_status": "MARKETED",
      "id": 17050,
      "drug_code": 78072,
      "updated_date": "2025-05-15T02:31:56-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256015,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295415",
      "brand_name": "TEVA-OMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2021-10-21T16:12:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295415",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2021-11-30T00:00:00-05:00",
    "actual_start_date": "2021-10-20T00:00:00-04:00",
    "actual_end_date": "2021-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-11T19:27:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OMEPRAZOLE",
    "en_drug_common_name": "OMEPRAZOLE 20MG TAB",
    "fr_drug_brand_name": "TEVA-OMEPRAZOLE 20MG TAB",
    "fr_drug_common_name": "OMEPRAZOLE 20MG TAB",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147714,
    "drug": {
      "current_status": "MARKETED",
      "id": 17320,
      "drug_code": 78368,
      "updated_date": "2025-05-15T02:31:58-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256099,
          "ingredient": {
            "id": 2640,
            "ingredient_code": 11819,
            "en_name": "RISEDRONATE SODIUM",
            "fr_name": "Risédronate sodique (Hémipentahydrate de risédronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02298384",
      "brand_name": "TEVA-RISEDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135301001"
    },
    "created_date": "2021-10-21T16:14:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02298384",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2021-10-20T00:00:00-04:00",
    "actual_end_date": "2021-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-12-17T13:54:20-05:00",
    "status": "resolved",
    "en_comments": "Shortdated Lots",
    "fr_comments": "Shortdated Lots",
    "en_drug_brand_name": "TEVA-RISEDRONATE",
    "en_drug_common_name": "RISEDRONATE 30MG TAB",
    "fr_drug_brand_name": "TEVA-RISEDRONATE 30MG TAB",
    "fr_drug_common_name": "RISEDRONATE 30MG TAB",
    "en_ingredients": "RISEDRONATE SODIUM",
    "fr_ingredients": "Risédronate sodique",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147717,
    "drug": {
      "current_status": "MARKETED",
      "id": 3620,
      "drug_code": 19058,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252415,
          "ingredient": {
            "id": 124,
            "ingredient_code": 2585,
            "en_name": "SALBUTAMOL",
            "fr_name": "Salbutamol (Sulfate de salbutamol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02173360",
      "brand_name": "TEVA-SALBUTAMOL STERINEBS P.F.",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81347",
      "number_of_ais": "1",
      "ai_group_no": "0108887001"
    },
    "created_date": "2021-10-21T16:15:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02173360",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "R03AC",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2022-10-20T00:00:00-04:00",
    "actual_start_date": "2021-10-20T00:00:00-04:00",
    "actual_end_date": "2022-10-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-18T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SALBUTAMOL STERINEBS P.F.",
    "en_drug_common_name": "SALBUTAMOL 2MG/ML NEBS",
    "fr_drug_brand_name": "TEVA-SALBUTAMOL 2MG/ML NEBS",
    "fr_drug_common_name": "SALBUTAMOL 2MG/ML NEBS",
    "en_ingredients": "SALBUTAMOL",
    "fr_ingredients": "Salbutamol",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "2.5ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147731,
    "drug": {
      "current_status": "MARKETED",
      "id": 62314,
      "drug_code": 92377,
      "updated_date": "2025-12-03T00:32:47-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261084,
          "ingredient": {
            "id": 2292,
            "ingredient_code": 11081,
            "en_name": "ROPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de ropivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02439409",
      "brand_name": "ROPIVACAINE HYDROCHLORIDE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133273005"
    },
    "created_date": "2021-10-21T19:44:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439409",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2021-10-26T00:00:00-04:00",
    "estimated_end_date": "2021-12-20T00:00:00-05:00",
    "actual_start_date": "2021-10-26T00:00:00-04:00",
    "actual_end_date": "2021-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-31T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Our Ropivacaine Hydrochloride Injection, USP 10 mg/mL Ampoule 10 mL is available for substitution.",
    "fr_comments": "En guise de substitut, nous vous proposons notre préparation de Chlorhydrate de ropivacaïne injectable, USP 10 mg/mL Ampoule 10 mL.",
    "en_drug_brand_name": "ROPIVACAINE HYDROCHLORIDE INJECTION, USP",
    "en_drug_common_name": "Ropivacaine Hydrochloride Injection,  USP 10 mg/mL Ampoule 20 mL",
    "fr_drug_brand_name": "Chlorhydrate de ropivacaïne injectable, USP",
    "fr_drug_common_name": "Chlorhydrate de ropivacaïne injectable, USP 10 mg/mL Ampoule 20 mL",
    "en_ingredients": "ROPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de ropivacaïne",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nEPIDURAL",
    "drug_route_fr": "Épidurale\r\nÉpidurale",
    "drug_package_quantity": "20mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147737,
    "drug": {
      "current_status": "MARKETED",
      "id": 15650,
      "drug_code": 76364,
      "updated_date": "2025-05-15T02:31:44-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255614,
          "ingredient": {
            "id": 3278,
            "ingredient_code": 12794,
            "en_name": "HYDROXYETHYL STARCH 130/0.4",
            "fr_name": "Amidon hydroxyéthylé 130/0,4"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02278057",
      "brand_name": "VOLUVEN",
      "brand_name_fr": "",
      "descriptor": "6% HYDROXYETHYL STARCH 130/0.4 IN 0.9% SODIUM CHLORIDE INJECTION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0147581001"
    },
    "created_date": "2021-10-21T19:47:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02278057",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05AA",
    "atc_description": "BLOOD AND RELATED PRODUCTS",
    "anticipated_start_date": "2021-10-27T00:00:00-04:00",
    "estimated_end_date": "2021-12-14T00:00:00-05:00",
    "actual_start_date": "2021-10-27T00:00:00-04:00",
    "actual_end_date": "2021-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-16T19:42:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VOLUVEN",
    "en_drug_common_name": "Voluven®  (6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection) 500 mL",
    "fr_drug_brand_name": "Voluven 500mL",
    "fr_drug_common_name": "Voluven (hydroxyéthylamidon 130/0,4 à 6 % dans une solution de chlorure de sodium injectable à 0,9 %), 500 mL",
    "en_ingredients": "HYDROXYETHYL STARCH 130/0.4",
    "fr_ingredients": "Amidon hydroxyéthylé 130/0,4",
    "drug_strength": "6%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "500mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147748,
    "drug": {
      "current_status": "MARKETED",
      "id": 18692,
      "drug_code": 79958,
      "updated_date": "2025-12-03T00:31:20-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256538,
          "ingredient": {
            "id": 2442,
            "ingredient_code": 11516,
            "en_name": "ROPINIROLE",
            "fr_name": "Ropinirole (Chlorhydrate de ropinirole)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02314061",
      "brand_name": "SPC-ROPINIROLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132618004"
    },
    "created_date": "2021-10-21T20:55:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314061",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2021-10-22T00:00:00-04:00",
    "actual_start_date": "2021-10-12T00:00:00-04:00",
    "actual_end_date": "2021-11-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-26T18:18:09-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-ROPINIROLE",
    "en_drug_common_name": "RAN-ROPINIROLE",
    "fr_drug_brand_name": "RAN-ROPINIROLE",
    "fr_drug_common_name": "RAN-ROPINIROLE",
    "en_ingredients": "ROPINIROLE",
    "fr_ingredients": "ROPINIROLE",
    "drug_strength": "2.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147781,
    "drug": {
      "current_status": "MARKETED",
      "id": 3698,
      "drug_code": 19167,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8252454,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02182815",
      "brand_name": "COZAAR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81458",
      "number_of_ais": "1",
      "ai_group_no": "0127971001"
    },
    "created_date": "2021-10-21T21:58:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02182815",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2022-02-18T00:00:00-05:00",
    "actual_start_date": "2021-10-21T00:00:00-04:00",
    "actual_end_date": "2022-02-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-02-19T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "COZAAR",
    "en_drug_common_name": "losartan potassium tablets",
    "fr_drug_brand_name": "COZAAR",
    "fr_drug_common_name": "comprimés de losartan potassique",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147784,
    "drug": {
      "current_status": "MARKETED",
      "id": 25002,
      "drug_code": 87515,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259042,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259041,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389657",
      "brand_name": "MINT-LOSARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168001"
    },
    "created_date": "2021-10-22T02:25:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389657",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2023-03-31T00:00:00-04:00",
    "actual_start_date": "2021-10-21T00:00:00-04:00",
    "actual_end_date": "2024-06-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-05T19:28:34-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-LOSARTAN/HCTZ",
    "en_drug_common_name": "Losartan Hydrochlorothiazide",
    "fr_drug_brand_name": "Mint-Losartan/HCTZ",
    "fr_drug_common_name": "Losartan/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147787,
    "drug": {
      "current_status": "MARKETED",
      "id": 25004,
      "drug_code": 87516,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259044,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259043,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389665",
      "brand_name": "MINT-LOSARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168003"
    },
    "created_date": "2021-10-22T02:29:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389665",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2021-10-21T00:00:00-04:00",
    "actual_end_date": "2023-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-01T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-LOSARTAN/HCTZ",
    "en_drug_common_name": "losartan Hydrochlorothiazide",
    "fr_drug_brand_name": "Mint-Losartan/HCTZ",
    "fr_drug_common_name": "Losartan/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147790,
    "drug": {
      "current_status": "MARKETED",
      "id": 25006,
      "drug_code": 87517,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259046,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259045,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389673",
      "brand_name": "MINT-LOSARTAN/HCTZ DS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168002"
    },
    "created_date": "2021-10-22T02:30:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389673",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2023-03-31T00:00:00-04:00",
    "actual_start_date": "2021-10-21T00:00:00-04:00",
    "actual_end_date": "2024-06-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-05T19:29:18-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-LOSARTAN/HCTZ DS",
    "en_drug_common_name": "losartan Hydrochlorothiazide",
    "fr_drug_brand_name": "Mint-Losartan/HCTZ",
    "fr_drug_common_name": "Losartan/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "25.0MG\r\n100.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147806,
    "drug": {
      "current_status": "MARKETED",
      "id": 31718,
      "drug_code": 94104,
      "updated_date": "2025-05-15T02:35:23-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261914,
          "ingredient": {
            "id": 590,
            "ingredient_code": 4922,
            "en_name": "VITAMIN D3",
            "fr_name": "Vitamine D3"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2800",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261913,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02454467",
      "brand_name": "APO-ALENDRONATE/VITAMIN D3",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251575001"
    },
    "created_date": "2021-10-22T12:54:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02454467",
    "company_name": "APOTEX INC",
    "atc_number": "M05BB",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2021-10-28T00:00:00-04:00",
    "actual_start_date": "2021-10-18T00:00:00-04:00",
    "actual_end_date": "2021-10-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-29T13:29:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ALENDRONATE/VITAMIN D3",
    "en_drug_common_name": "ALENDRONATE",
    "fr_drug_brand_name": "APO-ALENDRONATE/D3",
    "fr_drug_common_name": "ALENDRONATE",
    "en_ingredients": "VITAMIN D3\r\nALENDRONIC ACID",
    "fr_ingredients": "Vitamine D3",
    "drug_strength": "2800UNIT\r\n70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147809,
    "drug": {
      "current_status": "DORMANT",
      "id": 26476,
      "drug_code": 88796,
      "updated_date": "2025-05-15T06:55:49-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368932,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02403137",
      "brand_name": "APO-AMITRIPTYLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101524001"
    },
    "created_date": "2021-10-22T12:56:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403137",
    "company_name": "APOTEX INC",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2021-10-18T00:00:00-04:00",
    "actual_end_date": "2022-05-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-13T21:07:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMITRIPTYLINE",
    "en_drug_common_name": "AMITRIPTYLINE",
    "fr_drug_brand_name": "APO AMITRIPTYLINE",
    "fr_drug_common_name": "AMITRIPTYLINE",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147812,
    "drug": {
      "current_status": "MARKETED",
      "id": 26482,
      "drug_code": 88799,
      "updated_date": "2025-05-15T02:33:51-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259549,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02403161",
      "brand_name": "APO-AMITRIPTYLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101524004"
    },
    "created_date": "2021-10-22T12:59:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403161",
    "company_name": "APOTEX INC",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2021-10-18T00:00:00-04:00",
    "actual_end_date": "2022-06-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-17T13:29:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMITRIPTYLINE",
    "en_drug_common_name": "AMITRIPTYLINE",
    "fr_drug_brand_name": "APO AMITRIPTYLINE",
    "fr_drug_common_name": "AMITRIPTYLINE",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147815,
    "drug": {
      "current_status": "DORMANT",
      "id": 26016,
      "drug_code": 88401,
      "updated_date": "2025-12-03T02:32:33-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368887,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02399105",
      "brand_name": "APO-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220004"
    },
    "created_date": "2021-10-22T13:02:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02399105",
    "company_name": "APOTEX INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2021-10-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-22T13:03:18-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "APO-CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "32MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147818,
    "drug": {
      "current_status": "MARKETED",
      "id": 13600,
      "drug_code": 73416,
      "updated_date": "2025-05-15T02:31:34-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254914,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02249324",
      "brand_name": "APO-METHYLPHENIDATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548001"
    },
    "created_date": "2021-10-22T13:05:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02249324",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "actual_start_date": "2021-10-18T00:00:00-04:00",
    "actual_end_date": "2021-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-09T14:38:23-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METHYLPHENIDATE",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "APO-METHYLPHENIDATE",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147821,
    "drug": {
      "current_status": "MARKETED",
      "id": 10032,
      "drug_code": 64500,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253821,
          "ingredient": {
            "id": 1004,
            "ingredient_code": 11340,
            "en_name": "PAROXETINE",
            "fr_name": "Paroxétine (Chlorhydrate de paroxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240909",
      "brand_name": "APO-PAROXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123131001"
    },
    "created_date": "2021-10-22T13:07:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240909",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2021-10-29T00:00:00-04:00",
    "actual_start_date": "2021-10-18T00:00:00-04:00",
    "actual_end_date": "2021-10-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-29T13:35:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PAROXETINE",
    "en_drug_common_name": "PAROXETINE",
    "fr_drug_brand_name": "APO-PAROXETINE",
    "fr_drug_common_name": "PAROXETINE",
    "en_ingredients": "PAROXETINE",
    "fr_ingredients": "PAROXETINE",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147826,
    "drug": {
      "current_status": "MARKETED",
      "id": 3152,
      "drug_code": 18040,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252242,
          "ingredient": {
            "id": 946,
            "ingredient_code": 1939,
            "en_name": "TRAZODONE HYDROCHLORIDE",
            "fr_name": "Chlohydrate de trazodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02147653",
      "brand_name": "APO-TRAZODONE D TABLETS 150MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80254",
      "number_of_ais": "1",
      "ai_group_no": "0115713003"
    },
    "created_date": "2021-10-22T13:12:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02147653",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2021-11-26T00:00:00-05:00",
    "actual_start_date": "2021-10-18T00:00:00-04:00",
    "actual_end_date": "2021-11-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-22T14:24:38-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TRAZODONE D TABLETS 150MG",
    "en_drug_common_name": "TRAZODONE",
    "fr_drug_brand_name": "APO-TRAZODONE",
    "fr_drug_common_name": "TRAZODONE",
    "en_ingredients": "TRAZODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlohydrate de trazodone",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147831,
    "drug": {
      "current_status": "MARKETED",
      "id": 3914,
      "drug_code": 1954,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 500,
        "created_date": "2017-03-09T13:22:49-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11482,
        "mfr_code": "",
        "name": "AMPHASTAR PHARMACEUTICALS, INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11570 SIXTH STREET",
        "province": "CALIFORNIA",
        "country": "UNITED STATES",
        "city": "RANCHO CUCAMONGA",
        "postal_code": "91730",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250340,
          "ingredient": {
            "id": 1572,
            "ingredient_code": 7516,
            "en_name": "TETRACOSACTIDE",
            "fr_name": "Tétracosactide (Complexe tétracosactide-hydroxyde de zinc)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "00022381",
      "brand_name": "CORTROSYN INJ 0.25MG",
      "brand_name_fr": "CORTROSYN INJ 0.25MG",
      "descriptor": "ALSO KNOWN AS COSYNTROPIN",
      "pediatric_flag": false,
      "accession_number": "45903",
      "number_of_ais": "1",
      "ai_group_no": "0106365002"
    },
    "created_date": "2021-10-22T14:00:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00022381",
    "company_name": "AMPHASTAR PHARMACEUTICALS, INC.",
    "atc_number": "H01AA",
    "atc_description": "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",
    "anticipated_start_date": "2021-10-25T00:00:00-04:00",
    "estimated_end_date": "2022-01-24T00:00:00-05:00",
    "actual_start_date": "2021-10-25T00:00:00-04:00",
    "actual_end_date": "2022-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-19T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CORTROSYN INJ 0.25MG",
    "en_drug_common_name": "Cosyntropin",
    "fr_drug_brand_name": "Cortrosyn  Injection 0.25 mg/vial",
    "fr_drug_common_name": "Cosyntropin",
    "en_ingredients": "TETRACOSACTIDE",
    "fr_ingredients": "Tétracosactide",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "0.25 mg/vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147837,
    "drug": {
      "current_status": "DORMANT",
      "id": 4528,
      "drug_code": 2213,
      "updated_date": "2025-05-15T06:55:19-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366036,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00335053",
      "brand_name": "ELAVIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "48166",
      "number_of_ais": "1",
      "ai_group_no": "0101524001"
    },
    "created_date": "2021-10-22T14:36:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00335053",
    "company_name": "AA PHARMA INC",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2021-10-22T00:00:00-04:00",
    "actual_end_date": "2022-06-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-17T19:50:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ELAVIL",
    "en_drug_common_name": "Elavil",
    "fr_drug_brand_name": "ELAVIL",
    "fr_drug_common_name": "ELAVIL",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147840,
    "drug": {
      "current_status": "DORMANT",
      "id": 4528,
      "drug_code": 2213,
      "updated_date": "2025-05-15T06:55:19-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366036,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00335053",
      "brand_name": "ELAVIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "48166",
      "number_of_ais": "1",
      "ai_group_no": "0101524001"
    },
    "created_date": "2021-10-22T14:37:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00335053",
    "company_name": "AA PHARMA INC",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2021-10-22T00:00:00-04:00",
    "actual_end_date": "2022-06-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-17T19:50:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ELAVIL",
    "en_drug_common_name": "Elavil",
    "fr_drug_brand_name": "ELAVIL",
    "fr_drug_common_name": "ELAVIL",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147843,
    "drug": {
      "current_status": "DORMANT",
      "id": 4530,
      "drug_code": 2214,
      "updated_date": "2025-12-03T02:32:11-05:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366037,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00335061",
      "brand_name": "ELAVIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "48167",
      "number_of_ais": "1",
      "ai_group_no": "0101524002"
    },
    "created_date": "2021-10-22T14:39:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00335061",
    "company_name": "AA PHARMA INC",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2021-10-22T00:00:00-04:00",
    "actual_end_date": "2022-05-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-07T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ELAVIL",
    "en_drug_common_name": "Elavil",
    "fr_drug_brand_name": "ELAVIL",
    "fr_drug_common_name": "ELAVIL",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147846,
    "drug": {
      "current_status": "DORMANT",
      "id": 4530,
      "drug_code": 2214,
      "updated_date": "2025-12-03T02:32:11-05:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366037,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00335061",
      "brand_name": "ELAVIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "48167",
      "number_of_ais": "1",
      "ai_group_no": "0101524002"
    },
    "created_date": "2021-10-22T14:40:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00335061",
    "company_name": "AA PHARMA INC",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2021-10-22T00:00:00-04:00",
    "actual_end_date": "2022-06-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-23T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ELAVIL",
    "en_drug_common_name": "Elavil",
    "fr_drug_brand_name": "ELAVIL",
    "fr_drug_common_name": "ELAVIL",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147849,
    "drug": {
      "current_status": "MARKETED",
      "id": 4534,
      "drug_code": 2215,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250390,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00335088",
      "brand_name": "ELAVIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "48168",
      "number_of_ais": "1",
      "ai_group_no": "0101524003"
    },
    "created_date": "2021-10-22T14:41:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00335088",
    "company_name": "AA PHARMA INC",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2021-10-22T00:00:00-04:00",
    "actual_end_date": "2022-05-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-07T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ELAVIL",
    "en_drug_common_name": "Elavil",
    "fr_drug_brand_name": "ELAVIL",
    "fr_drug_common_name": "ELAVIL",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147852,
    "drug": {
      "current_status": "MARKETED",
      "id": 4534,
      "drug_code": 2215,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250390,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00335088",
      "brand_name": "ELAVIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "48168",
      "number_of_ais": "1",
      "ai_group_no": "0101524003"
    },
    "created_date": "2021-10-22T14:42:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00335088",
    "company_name": "AA PHARMA INC",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2021-10-22T00:00:00-04:00",
    "actual_end_date": "2022-06-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-23T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ELAVIL",
    "en_drug_common_name": "Elavil",
    "fr_drug_brand_name": "ELAVIL",
    "fr_drug_common_name": "ELAVIL",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147855,
    "drug": {
      "current_status": "MARKETED",
      "id": 20418,
      "drug_code": 8199,
      "updated_date": "2025-05-15T02:30:41-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251074,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00754129",
      "brand_name": "ELAVIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "66506",
      "number_of_ais": "1",
      "ai_group_no": "0101524004"
    },
    "created_date": "2021-10-22T14:43:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00754129",
    "company_name": "AA PHARMA INC",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2021-10-22T00:00:00-04:00",
    "actual_end_date": "2022-06-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-18T05:00:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ELAVIL",
    "en_drug_common_name": "Elavil",
    "fr_drug_brand_name": "ELAVIL",
    "fr_drug_common_name": "ELAVIL",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147858,
    "drug": {
      "current_status": "MARKETED",
      "id": 98819,
      "drug_code": 93938,
      "updated_date": "2020-04-03T06:53:05-04:00",
      "company": {
        "id": 1020,
        "created_date": "2017-03-09T13:23:37-05:00",
        "updated_date": "2025-05-15T02:30:19-04:00",
        "company_code": 13175,
        "mfr_code": "",
        "name": "UCB CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "602",
        "street_name": "2201 BRISTOL CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0J8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261842,
          "ingredient": {
            "id": 4154,
            "ingredient_code": 22702,
            "en_name": "BRIVARACETAM",
            "fr_name": "BRIVARACÉTAM"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02452987",
      "brand_name": "BRIVLERA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0157931001"
    },
    "created_date": "2021-10-22T19:12:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452987",
    "company_name": "UCB CANADA INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2021-10-22T00:00:00-04:00",
    "estimated_end_date": "2021-11-02T00:00:00-04:00",
    "actual_start_date": "2021-10-22T00:00:00-04:00",
    "actual_end_date": "2021-11-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-11-06T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BRIVLERA",
    "en_drug_common_name": "BRIVLERA",
    "fr_drug_brand_name": "BRIVLERA",
    "fr_drug_common_name": "BRIVLERA",
    "en_ingredients": "BRIVARACETAM",
    "fr_ingredients": "BRIVARACÉTAM",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "300mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147863,
    "drug": {
      "current_status": "MARKETED",
      "id": 57196,
      "drug_code": 95569,
      "updated_date": "2025-12-03T00:33:30-05:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262677,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02467305",
      "brand_name": "M-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121002"
    },
    "created_date": "2021-10-22T21:09:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02467305",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2021-11-10T00:00:00-05:00",
    "actual_start_date": "2021-10-18T00:00:00-04:00",
    "actual_end_date": "2021-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-29T20:03:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "M-PREGABALIN",
    "en_drug_common_name": "Pregabalin",
    "fr_drug_brand_name": "M-Pregabalin",
    "fr_drug_common_name": "Pregabalin",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147866,
    "drug": {
      "current_status": "MARKETED",
      "id": 57198,
      "drug_code": 95571,
      "updated_date": "2025-12-03T00:33:30-05:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262679,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02467321",
      "brand_name": "M-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121005"
    },
    "created_date": "2021-10-22T21:13:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02467321",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2021-11-10T00:00:00-05:00",
    "actual_start_date": "2021-10-12T00:00:00-04:00",
    "actual_end_date": "2021-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-10-29T20:01:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "M-PREGABALIN",
    "en_drug_common_name": "Pregabalin",
    "fr_drug_brand_name": "M-Pregabalin",
    "fr_drug_common_name": "Pregabalin",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147907,
    "drug": {
      "current_status": "MARKETED",
      "id": 20678,
      "drug_code": 82439,
      "updated_date": "2025-12-03T00:31:31-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257316,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02338742",
      "brand_name": "SANDOZ ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963002"
    },
    "created_date": "2021-10-25T13:51:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02338742",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2021-12-03T00:00:00-05:00",
    "actual_start_date": "2021-10-25T00:00:00-04:00",
    "actual_end_date": "2021-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-07T01:39:22-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "SANDOZ ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147911,
    "drug": {
      "current_status": "MARKETED",
      "id": 11662,
      "drug_code": 68780,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254336,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244790",
      "brand_name": "SANDOZ MORPHINE SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545009"
    },
    "created_date": "2021-10-25T13:54:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244790",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2021-11-19T00:00:00-05:00",
    "actual_start_date": "2021-10-25T00:00:00-04:00",
    "actual_end_date": "2021-11-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-11-16T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ MORPHINE SR",
    "en_drug_common_name": "MORPHINE SR",
    "fr_drug_brand_name": "SANDOZ MORPHINE SR",
    "fr_drug_common_name": "MORPHINE SR",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100PRT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147914,
    "drug": {
      "current_status": "MARKETED",
      "id": 12752,
      "drug_code": 71630,
      "updated_date": "2025-05-15T02:31:25-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254658,
          "ingredient": {
            "id": 186,
            "ingredient_code": 9152,
            "en_name": "DOCUSATE SODIUM",
            "fr_name": "Docusate sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247385",
      "brand_name": "SANDOZ DOCUSATE SODIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104351002"
    },
    "created_date": "2021-10-25T13:56:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247385",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A06AA",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "estimated_end_date": "2022-07-15T00:00:00-04:00",
    "actual_start_date": "2021-10-25T00:00:00-04:00",
    "actual_end_date": "2022-07-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-07-14T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ DOCUSATE SODIUM",
    "en_drug_common_name": "DOCUSATE SOD",
    "fr_drug_brand_name": "SANDOZ DOCUSATE SODIUM",
    "fr_drug_common_name": "DOCUSATE SOD",
    "en_ingredients": "DOCUSATE SODIUM",
    "fr_ingredients": "Docusate sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000SGC BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147917,
    "drug": {
      "current_status": "MARKETED",
      "id": 7348,
      "drug_code": 49612,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253283,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02230540",
      "brand_name": "CLINDAMYCIN INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105830002"
    },
    "created_date": "2021-10-25T13:58:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230540",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01FF",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2021-11-26T00:00:00-05:00",
    "actual_start_date": "2021-10-25T00:00:00-04:00",
    "actual_end_date": "2021-11-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-11-25T02:59:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CLINDAMYCIN INJECTION USP",
    "en_drug_common_name": "CLINDAMYCIN INJ",
    "fr_drug_brand_name": "CLINDAMYCIN INJECTION USP",
    "fr_drug_common_name": "CLINDAMYCIN INJ",
    "en_ingredients": "CLINDAMYCIN",
    "fr_ingredients": "CLINDAMYCIN",
    "drug_strength": "150MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "2ML 10LIVI",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147920,
    "drug": {
      "current_status": "MARKETED",
      "id": 10890,
      "drug_code": 66810,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254105,
          "ingredient": {
            "id": 2240,
            "ingredient_code": 11178,
            "en_name": "AMIKACIN",
            "fr_name": "Amikacine (Sulfate d'amikacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02242971",
      "brand_name": "AMIKACIN SULFATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111922001"
    },
    "created_date": "2021-10-25T14:00:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242971",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01GB",
    "atc_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
    "estimated_end_date": "2021-12-10T00:00:00-05:00",
    "actual_start_date": "2021-10-25T00:00:00-04:00",
    "actual_end_date": "2021-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-12-07T01:35:50-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AMIKACIN SULFATE INJECTION USP",
    "en_drug_common_name": "AMIKACIN SO4",
    "fr_drug_brand_name": "AMIKACIN SULFATE INJECTION USP",
    "fr_drug_common_name": "AMIKACIN SO4",
    "en_ingredients": "AMIKACIN",
    "fr_ingredients": "AMIKACIN",
    "drug_strength": "250MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "2ML 10LIVI",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147924,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2610,
      "drug_code": 16227,
      "updated_date": "2025-05-15T03:42:26-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8296670,
          "ingredient": {
            "id": 904,
            "ingredient_code": 2001,
            "en_name": "CHROMIUM",
            "fr_name": "Chrome (Chélate de chrome et d'acide aminé)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8296669,
          "ingredient": {
            "id": 618,
            "ingredient_code": 7218,
            "en_name": "IODINE",
            "fr_name": "Iode"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8296668,
          "ingredient": {
            "id": 788,
            "ingredient_code": 2295,
            "en_name": "SELENIUM",
            "fr_name": "Sélénium (Sélénite de sodium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8296667,
          "ingredient": {
            "id": 880,
            "ingredient_code": 331,
            "en_name": "ZINC",
            "fr_name": "Zinc (Oxyde de zinc, Sulfate de zinc)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8296666,
          "ingredient": {
            "id": 898,
            "ingredient_code": 10194,
            "en_name": "MANGANESE",
            "fr_name": "Manganèse (Sulfate de manganèse)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8296665,
          "ingredient": {
            "id": 912,
            "ingredient_code": 582,
            "en_name": "COPPER",
            "fr_name": "Cuivre ((FR) COPPER OXIDE)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02091127",
      "brand_name": "MICRO PLUS 6  (CONCENTRATE)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78078",
      "number_of_ais": "6",
      "ai_group_no": "0631329002"
    },
    "created_date": "2021-10-25T14:09:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02091127",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "actual_start_date": "2021-10-25T00:00:00-04:00",
    "actual_end_date": "2021-10-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-26T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "This product will be discontinued effective Dec 2021 and has been replaced with Baxter Product Code 2166 / 44091451 MICRO+6 CONCENTRATE (DIN 02507587) UPC 057513221668.\r\nBaxter Product Code 2166 / 44091451 MICRO + 6 CONCENTRATE 10ML 10LIVI V1 CA, is available for customers to order.",
    "fr_comments": "Ce produit sera discontinué en Dec. 2021 et sera remplacé par le produit Baxter Product Code 2166 / 44091451 MICRO+6 CONCENTRATE (DIN 02507587) CUP 057513221668.\r\nBaxter Product Code 2166 / 44091451 MICRO + 6 CONCENTRATE 10ML 10LIVI V1 CA, est disponible auprès des clients.",
    "en_drug_brand_name": "MICRO PLUS 6    (CONCENTRATE)",
    "en_drug_common_name": "MICRO + 6 CONCENTRATE",
    "fr_drug_brand_name": "MICRO PLUS 6 (CONCENTRATE)",
    "fr_drug_common_name": "MICRO + 6 CONCENTRATE",
    "en_ingredients": "IODINE\r\nSELENIUM\r\nCHROMIUM\r\nMANGANESE\r\nCOPPER\r\nZINC",
    "fr_ingredients": "Iode\r\nSélénium\r\nChrome\r\nManganèse\r\nCuivre\r\nZinc",
    "drug_strength": "75MCG\r\n60MCG\r\n10MCG\r\n0.5MG\r\n1MG\r\n5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10ML 10LIVI",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147927,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2610,
      "drug_code": 16227,
      "updated_date": "2025-05-15T03:42:26-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8296670,
          "ingredient": {
            "id": 904,
            "ingredient_code": 2001,
            "en_name": "CHROMIUM",
            "fr_name": "Chrome (Chélate de chrome et d'acide aminé)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8296669,
          "ingredient": {
            "id": 618,
            "ingredient_code": 7218,
            "en_name": "IODINE",
            "fr_name": "Iode"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8296668,
          "ingredient": {
            "id": 788,
            "ingredient_code": 2295,
            "en_name": "SELENIUM",
            "fr_name": "Sélénium (Sélénite de sodium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8296667,
          "ingredient": {
            "id": 880,
            "ingredient_code": 331,
            "en_name": "ZINC",
            "fr_name": "Zinc (Oxyde de zinc, Sulfate de zinc)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8296666,
          "ingredient": {
            "id": 898,
            "ingredient_code": 10194,
            "en_name": "MANGANESE",
            "fr_name": "Manganèse (Sulfate de manganèse)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8296665,
          "ingredient": {
            "id": 912,
            "ingredient_code": 582,
            "en_name": "COPPER",
            "fr_name": "Cuivre ((FR) COPPER OXIDE)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02091127",
      "brand_name": "MICRO PLUS 6  (CONCENTRATE)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78078",
      "number_of_ais": "6",
      "ai_group_no": "0631329002"
    },
    "created_date": "2021-10-25T14:14:05-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02091127",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "discontinuation_date": "2021-10-25T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "This product will be discontinued effective Dec 2021 and has been replaced with Baxter Product Code 2166 / 44091451 MICRO+6 CONCENTRATE (DIN 02507587) UPC 057513221668.\r\nBaxter Product Code 2166 / 44091451 MICRO + 6 CONCENTRATE 10ML 10LIVI V1 CA, is available for customers to order.",
    "fr_discontinuation_comments": "Ce produit sera discontinué en Dec.2021 et a été remplacé par le produit Baxter Product Code 2166 / 44091451 MICRO+6 CONCENTRATE (DIN 02507587) CUP 057513221668.\r\nBaxter Product Code 2166 / 44091451 MICRO + 6 CONCENTRATE 10ML 10LIVI V1 CA, est maintenant disponible pour les clients.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T05:00:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MICRO PLUS 6    (CONCENTRATE)",
    "en_drug_common_name": "MICRO + 6 CONCENTRATE",
    "fr_drug_brand_name": "MICRO PLUS 6    (CONCENTRATE)",
    "fr_drug_common_name": "MICRO + 6    CONCENTRATE",
    "en_ingredients": "IODINE\r\nSELENIUM\r\nCHROMIUM\r\nMANGANESE\r\nCOPPER\r\nZINC",
    "fr_ingredients": "Iode\r\nSélénium\r\nChrome\r\nManganèse\r\nCuivre\r\nZinc",
    "drug_strength": "75MCG\r\n60MCG\r\n10MCG\r\n0.5MG\r\n1MG\r\n5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10ML 10LIVI",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147948,
    "drug": {
      "current_status": "MARKETED",
      "id": 100115,
      "drug_code": 98367,
      "updated_date": "2020-04-03T06:54:24-04:00",
      "company": {
        "id": 7815,
        "created_date": "2018-05-03T02:30:12-04:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 17067,
        "mfr_code": "",
        "name": "AVIR PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264551,
          "ingredient": {
            "id": 198,
            "ingredient_code": 7581,
            "en_name": "BUDESONIDE",
            "fr_name": "Budésonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02493675",
      "brand_name": "JORVEZA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116807013"
    },
    "created_date": "2021-10-25T20:04:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02493675",
    "company_name": "AVIR PHARMA INC.",
    "atc_number": "A07EA",
    "atc_description": "INTESTINALANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2021-11-01T00:00:00-04:00",
    "estimated_end_date": "2022-01-21T00:00:00-05:00",
    "actual_start_date": "2022-01-21T00:00:00-05:00",
    "actual_end_date": "2022-01-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-01-22T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "JORVEZA",
    "en_drug_common_name": "Jorveza 1mg",
    "fr_drug_brand_name": "Jorveza",
    "fr_drug_common_name": "Jorveza 1mg",
    "en_ingredients": "BUDESONIDE",
    "fr_ingredients": "Budésonide",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147957,
    "drug": {
      "current_status": "MARKETED",
      "id": 30224,
      "drug_code": 92274,
      "updated_date": "2025-05-15T02:34:41-04:00",
      "company": {
        "id": 94,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 9307,
        "mfr_code": "AZC08",
        "name": "ASTRAZENECA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1004 MIDDLEGATE ROAD, SUITE 5000",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4Y 1M4",
        "post_office_box": "",
        "contact_information": "Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com."
      },
      "drug_ingredients": [
        {
          "id": 8261039,
          "ingredient": {
            "id": 2980,
            "ingredient_code": 12770,
            "en_name": "PALIVIZUMAB",
            "fr_name": "Palivizumab"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02438364",
      "brand_name": "SYNAGIS",
      "brand_name_fr": "",
      "descriptor": "1ML SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0147401002"
    },
    "created_date": "2021-10-26T03:04:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02438364",
    "company_name": "ASTRAZENECA CANADA INC",
    "atc_number": "J06BB",
    "atc_description": "IMMUNOGLOBULINS",
    "anticipated_start_date": "2021-11-28T00:00:00-05:00",
    "estimated_end_date": "2021-12-02T00:00:00-05:00",
    "actual_start_date": "2021-11-28T00:00:00-05:00",
    "actual_end_date": "2021-12-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-12-04T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SYNAGIS",
    "en_drug_common_name": "palivizumab injection",
    "fr_drug_brand_name": "SYNAGIS",
    "fr_drug_common_name": "palivizumab injectable",
    "en_ingredients": "PALIVIZUMAB",
    "fr_ingredients": "Palivizumab",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "1 vial containing 1 mL of solution",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 147980,
    "drug": {
      "current_status": "MARKETED",
      "id": 5910,
      "drug_code": 415,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8250151,
          "ingredient": {
            "id": 2076,
            "ingredient_code": 3359,
            "en_name": "DIHYDROERGOTAMINE MESYLATE",
            "fr_name": "Mésylate de dihydroergotamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00027243",
      "brand_name": "DIHYDROERGOTAMINE (DHE), 1MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "15434",
      "number_of_ais": "1",
      "ai_group_no": "0108813001"
    },
    "created_date": "2021-10-26T14:54:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00027243",
    "company_name": "STERIMAX INC",
    "atc_number": "N02CA",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "anticipated_start_date": "2021-11-01T00:00:00-04:00",
    "estimated_end_date": "2022-01-17T00:00:00-05:00",
    "actual_end_date": "2022-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-01-20T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "One-time allocation of remaining stock will be available at McKesson on November 1st.",
    "fr_comments": "Allocation de l'inventaire restant sera disponible à travers McKesson le 1ier novembre.",
    "en_drug_brand_name": "DIHYDROERGOTAMINE (DHE), 1MG/ML",
    "en_drug_common_name": "DIHYDROERGOTAMINE MESYLATE INJECTION USP (DHE)",
    "fr_drug_brand_name": "MÉSYLATE DE DIHYDROERGOTAMINE INJECTABLE USP (DHE)",
    "fr_drug_common_name": "MÉSYLATE DE DIHYDROERGOTAMINE INJECTABLE USP (DHE)",
    "en_ingredients": "DIHYDROERGOTAMINE MESYLATE",
    "fr_ingredients": "Mésylate de dihydroergotamine",
    "drug_strength": "1MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "5 AMPOULES",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148000,
    "drug": {
      "current_status": "MARKETED",
      "id": 26062,
      "drug_code": 88431,
      "updated_date": "2025-05-15T02:33:46-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259399,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02399423",
      "brand_name": "MAR-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417001"
    },
    "created_date": "2021-10-26T17:47:05-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02399423",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "discontinuation_date": "2018-01-24T00:00:00-05:00",
    "anticipated_discontinuation_date": "2018-01-24T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued SKU",
    "fr_discontinuation_comments": "Discontinued SKU",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T17:55:30-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "MAR-SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE HYDROCHLORIDE",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "250 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148007,
    "drug": {
      "current_status": "MARKETED",
      "id": 26064,
      "drug_code": 88432,
      "updated_date": "2025-05-15T02:33:46-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259400,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02399431",
      "brand_name": "MAR-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417002"
    },
    "created_date": "2021-10-26T17:54:12-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02399431",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "discontinuation_date": "2018-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued",
    "fr_discontinuation_comments": "Discontinued SKU",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T17:54:44-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "MAR-SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE HYDROCHLORIDE",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "250 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148014,
    "drug": {
      "current_status": "MARKETED",
      "id": 26342,
      "drug_code": 88696,
      "updated_date": "2025-05-15T02:33:49-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259505,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402092",
      "brand_name": "MAR-DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548001"
    },
    "created_date": "2021-10-26T18:02:40-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02402092",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2017-03-13T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-03-13T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued SKU",
    "fr_discontinuation_comments": "Discontinued SKU",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T18:03:15-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-DONEPEZIL",
    "en_drug_common_name": "DONEPEZIL",
    "fr_drug_brand_name": "MAR-DONEPEZIL",
    "fr_drug_common_name": "DONEPEZIL",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148021,
    "drug": {
      "current_status": "MARKETED",
      "id": 26344,
      "drug_code": 88697,
      "updated_date": "2025-05-15T02:33:49-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259506,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402106",
      "brand_name": "MAR-DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548002"
    },
    "created_date": "2021-10-26T18:10:42-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02402106",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2017-03-13T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-03-13T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued SKU",
    "fr_discontinuation_comments": "Discontinued SKU",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T18:11:09-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-DONEPEZIL",
    "en_drug_common_name": "DONEPEZIL",
    "fr_drug_brand_name": "MAR-DONEPEZIL",
    "fr_drug_common_name": "DONEPEZIL",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148028,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11178,
      "drug_code": 67506,
      "updated_date": "2025-05-15T04:03:09-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8333934,
          "ingredient": {
            "id": 62,
            "ingredient_code": 9412,
            "en_name": "NITROGLYCERIN",
            "fr_name": "Nitroglycérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02243588",
      "brand_name": "MYLAN-NITRO SUBLINGUAL SPRAY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103615009"
    },
    "created_date": "2021-10-26T18:13:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243588",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C01DA",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "estimated_end_date": "2021-11-09T00:00:00-05:00",
    "actual_start_date": "2021-10-25T00:00:00-04:00",
    "actual_end_date": "2021-11-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-17T12:09:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-NITRO SUBLINGUAL SPRAY",
    "en_drug_common_name": "NITRO SUBLINGUAL SPRAY",
    "fr_drug_brand_name": "MYLAN-NITRO SUBLINGUAL SPRAY",
    "fr_drug_common_name": "NITRO SUBLINGUAL SPRAY",
    "en_ingredients": "NITROGLYCERIN",
    "fr_ingredients": "Nitroglycérine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "SUBLINGUAL\r\nSUBLINGUAL",
    "drug_route_fr": "Sublinguale\r\nSublinguale",
    "drug_package_quantity": "1BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148031,
    "drug": {
      "current_status": "MARKETED",
      "id": 31002,
      "drug_code": 93136,
      "updated_date": "2025-05-15T02:35:06-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261456,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02446081",
      "brand_name": "MAR-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350001"
    },
    "created_date": "2021-10-26T18:14:50-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02446081",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "discontinuation_date": "2017-09-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued SKU",
    "fr_discontinuation_comments": "Discontinued SKU",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T18:15:37-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-DULOXETINE",
    "en_drug_common_name": "DULOXETNE",
    "fr_drug_brand_name": "MAR-DULOXETINE",
    "fr_drug_common_name": "DULOXETINE",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "DULOXETINE HYDROCHLORIDE",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148076,
    "drug": {
      "current_status": "MARKETED",
      "id": 25342,
      "drug_code": 87817,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259186,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392909",
      "brand_name": "MAR-FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116847003"
    },
    "created_date": "2021-10-26T20:37:15-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02392909",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "discontinuation_date": "2017-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T20:37:41-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-FLUOXETINE",
    "en_drug_common_name": "Fluoxetine",
    "fr_drug_brand_name": "MAR-Fluoxetine",
    "fr_drug_common_name": "Fluoxetine",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "Fluoxetine",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148079,
    "drug": {
      "current_status": "MARKETED",
      "id": 25344,
      "drug_code": 87818,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259187,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392917",
      "brand_name": "MAR-FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116847001"
    },
    "created_date": "2021-10-26T20:38:41-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02392917",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "discontinuation_date": "2017-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T20:39:01-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-FLUOXETINE",
    "en_drug_common_name": "Fluoxetine",
    "fr_drug_brand_name": "MAR-Fluoxetine",
    "fr_drug_common_name": "Fluoxetine",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "Fluoxetine",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148082,
    "drug": {
      "current_status": "MARKETED",
      "id": 25344,
      "drug_code": 87818,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259187,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392917",
      "brand_name": "MAR-FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116847001"
    },
    "created_date": "2021-10-26T20:39:46-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02392917",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "discontinuation_date": "2017-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T20:40:10-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-FLUOXETINE",
    "en_drug_common_name": "Fluoxetine",
    "fr_drug_brand_name": "MAR-Fluoxetine",
    "fr_drug_common_name": "Fluoxetine",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "Fluoxetine",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148085,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24962,
      "drug_code": 87462,
      "updated_date": "2025-05-15T04:20:21-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351807,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389118",
      "brand_name": "MAR-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783005"
    },
    "created_date": "2021-10-26T20:41:28-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02389118",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2019-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T20:41:50-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-OLANZAPINE ODT",
    "en_drug_common_name": "Olanzapine",
    "fr_drug_brand_name": "MAR-Olanzapine ODT",
    "fr_drug_common_name": "Olanzapine",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148088,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24958,
      "drug_code": 87460,
      "updated_date": "2025-05-15T04:20:21-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351805,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389088",
      "brand_name": "MAR-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783003"
    },
    "created_date": "2021-10-26T20:42:43-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02389088",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2019-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T20:43:08-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-OLANZAPINE ODT",
    "en_drug_common_name": "Olanzapine",
    "fr_drug_brand_name": "MAT-Olanzapine ODT",
    "fr_drug_common_name": "Olanzapine",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148091,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24964,
      "drug_code": 87463,
      "updated_date": "2025-05-15T04:20:21-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351808,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389126",
      "brand_name": "MAR-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783006"
    },
    "created_date": "2021-10-26T20:43:56-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02389126",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2019-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T20:44:16-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-OLANZAPINE ODT",
    "en_drug_common_name": "Olanzapine",
    "fr_drug_brand_name": "MAR-Olanzapine ODT",
    "fr_drug_common_name": "Olanzapine",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148094,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24960,
      "drug_code": 87461,
      "updated_date": "2025-05-15T04:20:21-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351806,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389096",
      "brand_name": "MAR-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2021-10-26T20:45:07-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02389096",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2019-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T20:45:25-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-OLANZAPINE ODT",
    "en_drug_common_name": "Olanzapine",
    "fr_drug_brand_name": "MAR-Olanzapine ODT",
    "fr_drug_common_name": "Olanzapine",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148097,
    "drug": {
      "current_status": "MARKETED",
      "id": 31552,
      "drug_code": 93870,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261797,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452324",
      "brand_name": "MAR-AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072001"
    },
    "created_date": "2021-10-26T20:46:49-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02452324",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "discontinuation_date": "2018-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T20:47:13-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-AZITHROMYCIN",
    "en_drug_common_name": "Azithromycin",
    "fr_drug_brand_name": "MAR-Azithromycin",
    "fr_drug_common_name": "Azithromycin",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148100,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28412,
      "drug_code": 90542,
      "updated_date": "2025-05-15T04:22:07-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8354392,
          "ingredient": {
            "id": 3218,
            "ingredient_code": 12329,
            "en_name": "GALANTAMINE",
            "fr_name": "Galantamine (Bromhydrate de galantamine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420821",
      "brand_name": "MAR-GALANTAMINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144660002"
    },
    "created_date": "2021-10-26T20:48:29-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02420821",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2017-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T20:48:55-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-GALANTAMINE ER",
    "en_drug_common_name": "Galantamine",
    "fr_drug_brand_name": "MAR-Galantamine ER",
    "fr_drug_common_name": "Galantamine",
    "en_ingredients": "GALANTAMINE",
    "fr_ingredients": "Galantamine",
    "drug_strength": "8MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148103,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28414,
      "drug_code": 90543,
      "updated_date": "2025-05-15T04:22:07-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8354393,
          "ingredient": {
            "id": 3218,
            "ingredient_code": 12329,
            "en_name": "GALANTAMINE",
            "fr_name": "Galantamine (Bromhydrate de galantamine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420848",
      "brand_name": "MAR-GALANTAMINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144660004"
    },
    "created_date": "2021-10-26T20:49:57-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02420848",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2017-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T20:50:20-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-GALANTAMINE ER",
    "en_drug_common_name": "Galantamine",
    "fr_drug_brand_name": "MAR-Galantamine ER",
    "fr_drug_common_name": "Galantamine",
    "en_ingredients": "GALANTAMINE",
    "fr_ingredients": "Galantamine",
    "drug_strength": "16MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148106,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28416,
      "drug_code": 90544,
      "updated_date": "2025-05-15T04:22:07-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8354394,
          "ingredient": {
            "id": 3218,
            "ingredient_code": 12329,
            "en_name": "GALANTAMINE",
            "fr_name": "Galantamine (Bromhydrate de galantamine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "24",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420856",
      "brand_name": "MAR-GALANTAMINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144660005"
    },
    "created_date": "2021-10-26T20:51:07-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02420856",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2017-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T20:51:39-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-GALANTAMINE ER",
    "en_drug_common_name": "Galantamine",
    "fr_drug_brand_name": "MAR-Galantamine ER",
    "fr_drug_common_name": "Galantamine",
    "en_ingredients": "GALANTAMINE",
    "fr_ingredients": "Galantamine",
    "drug_strength": "24MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148109,
    "drug": {
      "current_status": "MARKETED",
      "id": 23790,
      "drug_code": 86441,
      "updated_date": "2025-05-15T02:33:11-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258574,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378620",
      "brand_name": "MAR-METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2021-10-26T20:52:51-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02378620",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2017-03-13T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T20:53:07-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-METFORMIN",
    "en_drug_common_name": "Metformin",
    "fr_drug_brand_name": "MAR-Metformin",
    "fr_drug_common_name": "Metformin",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148112,
    "drug": {
      "current_status": "MARKETED",
      "id": 23792,
      "drug_code": 86442,
      "updated_date": "2025-05-15T02:33:11-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258575,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "850",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378639",
      "brand_name": "MAR-METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773002"
    },
    "created_date": "2021-10-26T20:54:19-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02378639",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2017-03-13T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T20:54:39-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-METFORMIN",
    "en_drug_common_name": "Metformin",
    "fr_drug_brand_name": "MAR-Metformin",
    "fr_drug_common_name": "Metformin",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "850MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148115,
    "drug": {
      "current_status": "MARKETED",
      "id": 23790,
      "drug_code": 86441,
      "updated_date": "2025-05-15T02:33:11-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258574,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378620",
      "brand_name": "MAR-METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2021-10-26T20:55:35-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02378620",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2017-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T20:55:55-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-METFORMIN",
    "en_drug_common_name": "Metformin",
    "fr_drug_brand_name": "MAR-Metformin",
    "fr_drug_common_name": "Metformin",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148118,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30554,
      "drug_code": 92596,
      "updated_date": "2025-05-15T04:23:55-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8355907,
          "ingredient": {
            "id": 1648,
            "ingredient_code": 11114,
            "en_name": "VALACYCLOVIR",
            "fr_name": "Valaciclovir (Chlorhydrate de valacyclovir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02441586",
      "brand_name": "MAR-VALACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128626001"
    },
    "created_date": "2021-10-26T20:57:20-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02441586",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2018-05-02T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-26T20:57:41-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MAR-VALACYCLOVIR",
    "en_drug_common_name": "Valacyclovir",
    "fr_drug_brand_name": "MAR-Valacyclovir",
    "fr_drug_common_name": "Valacyclovir",
    "en_ingredients": "VALACYCLOVIR",
    "fr_ingredients": "Valacyclovir",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148301,
    "drug": {
      "current_status": "MARKETED",
      "id": 11612,
      "drug_code": 68609,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254325,
          "ingredient": {
            "id": 2934,
            "ingredient_code": 1216,
            "en_name": "MILRINONE",
            "fr_name": "Milrinone (Lactate de milrinone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02244622",
      "brand_name": "MILRINONE LACTATE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131285001"
    },
    "created_date": "2021-10-27T17:18:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244622",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "C01CE",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "anticipated_start_date": "2021-11-01T00:00:00-04:00",
    "estimated_end_date": "2021-11-10T00:00:00-05:00",
    "actual_end_date": "2021-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-11T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MILRINONE LACTATE INJECTION, USP",
    "en_drug_common_name": "Milrinone Lactate Injection  1 mg/mL SD Vial 10 mL",
    "fr_drug_brand_name": "Lactate de milrinone injectable",
    "fr_drug_common_name": "Lactate de milrinone injectable  1 mg/mL, fioles DU de 10 mL",
    "en_ingredients": "MILRINONE",
    "fr_ingredients": "Lactate de milrinone injectable",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148306,
    "drug": {
      "current_status": "MARKETED",
      "id": 100236,
      "drug_code": 98587,
      "updated_date": "2020-04-03T06:54:32-04:00",
      "company": {
        "id": 140,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 4835,
        "mfr_code": "ODN07",
        "name": "ODAN LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "325 STILLVIEW AVENUE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "POINTE-CLAIRE",
        "postal_code": "H9R 2Y6",
        "post_office_box": "",
        "contact_information": "info@odanlab.com\r\nTel.: 1-800-387-9342\r\nFax: 1-800-329-6326"
      },
      "drug_ingredients": [
        {
          "id": 8264799,
          "ingredient": {
            "id": 1082,
            "ingredient_code": 901,
            "en_name": "ITRACONAZOLE",
            "fr_name": "Itraconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02495988",
      "brand_name": "ODAN ITRACONAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123311001"
    },
    "created_date": "2021-10-27T17:22:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02495988",
    "company_name": "ODAN LABORATORIES LTD",
    "atc_number": "J02AC",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "estimated_end_date": "2021-12-10T00:00:00-05:00",
    "actual_start_date": "2021-10-27T00:00:00-04:00",
    "actual_end_date": "2021-12-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-05T13:29:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ODAN ITRACONAZOLE",
    "en_drug_common_name": "Itraconazole Oral Solution",
    "fr_drug_brand_name": "Odan Itraconazole",
    "fr_drug_common_name": "Solution orale d'itraconazole",
    "en_ingredients": "ITRACONAZOLE",
    "fr_ingredients": "Itraconazole",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "150 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148315,
    "drug": {
      "current_status": "MARKETED",
      "id": 14684,
      "drug_code": 74976,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255280,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02264315",
      "brand_name": "HEPARIN SODIUM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104596004"
    },
    "created_date": "2021-10-27T18:39:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02264315",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2021-11-15T00:00:00-05:00",
    "estimated_end_date": "2021-12-10T00:00:00-05:00",
    "actual_start_date": "2021-11-15T00:00:00-05:00",
    "actual_end_date": "2021-12-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-09T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Available without restriction.",
    "en_drug_brand_name": "HEPARIN SODIUM INJECTION, USP",
    "en_drug_common_name": "Heparin Sodium Injection, USP  1 000 USP units/mL MD Vial 10 mL",
    "fr_drug_brand_name": "Héparine sodique injectable, USP",
    "fr_drug_common_name": "Héparine sodique injectable, USP  1 000 unités USP/mL, fioles DM de 10 mL",
    "en_ingredients": "HEPARIN SODIUM",
    "fr_ingredients": "Héparine sodique",
    "drug_strength": "1000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "10 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148318,
    "drug": {
      "current_status": "MARKETED",
      "id": 66450,
      "drug_code": 97315,
      "updated_date": "2025-05-15T02:37:04-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263719,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02482746",
      "brand_name": "MORPHINE SULFATE INJECTION, USP",
      "brand_name_fr": "SULFATE DE MORPHINE INJECTABLE, USP",
      "descriptor": "SINGLE USE VIAL, PRESERVATIVE FREE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545001"
    },
    "created_date": "2021-10-27T18:40:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02482746",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2021-11-15T00:00:00-05:00",
    "estimated_end_date": "2021-12-16T00:00:00-05:00",
    "actual_start_date": "2021-11-15T00:00:00-05:00",
    "actual_end_date": "2021-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-17T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MORPHINE SULFATE INJECTION, USP",
    "en_drug_common_name": "Morphine Sulfate Injection, USP  10 mg / mL Vial 1 mL",
    "fr_drug_brand_name": "Sulfate de morphine injectable, USP",
    "fr_drug_common_name": "Sulfate de morphine injectable, USP  10 mg/mL, fioles de 1 mL",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "1 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148369,
    "drug": {
      "current_status": "MARKETED",
      "id": 2630,
      "drug_code": 16264,
      "updated_date": "2025-12-03T00:30:32-05:00",
      "company": {
        "id": 392,
        "created_date": "2017-03-09T13:22:44-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 17099,
        "mfr_code": "",
        "name": "TILLOTTS PHARMA GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "WARMBACHER STRASSE 80",
        "province": "BADEN-WUERTTEMBERG",
        "country": "GERMANY",
        "city": "RHEINFELDEN",
        "postal_code": "79618",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252108,
          "ingredient": {
            "id": 198,
            "ingredient_code": 7581,
            "en_name": "BUDESONIDE",
            "fr_name": "Budésonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02052431",
      "brand_name": "ENTOCORT ENEMA",
      "brand_name_fr": "ENTOCORT EN LAVEMENT",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78144",
      "number_of_ais": "1",
      "ai_group_no": "0116807015"
    },
    "created_date": "2021-10-28T13:01:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02052431",
    "company_name": "TILLOTTS PHARMA GMBH",
    "atc_number": "A07EA",
    "atc_description": "INTESTINALANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2021-11-22T00:00:00-05:00",
    "actual_start_date": "2021-10-28T00:00:00-04:00",
    "actual_end_date": "2021-11-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-11-24T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "issue with datalogger during freight",
    "fr_comments": "issue with datalogger during freight",
    "en_drug_brand_name": "ENTOCORT ENEMA",
    "en_drug_common_name": "Entocort Enema",
    "fr_drug_brand_name": "ENTOCORT ENEMA",
    "fr_drug_common_name": "Entocort Enema",
    "en_ingredients": "SODIUM CHLORIDE\r\nBUDESONIDE",
    "fr_ingredients": "Chlorure de sodium\r\nBudésonide",
    "drug_strength": "115ML\r\n2.3MG",
    "drug_dosage_form": "ENEMA\r\nTABLET\r\nKIT",
    "drug_dosage_form_fr": "Lavement\r\nComprimé\r\nTrousse",
    "drug_route": "RECTAL\r\nRECTAL",
    "drug_route_fr": "Rectale\r\nRectale",
    "drug_package_quantity": "7 solutions",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148398,
    "drug": {
      "current_status": "MARKETED",
      "id": 11588,
      "drug_code": 68534,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8254319,
          "ingredient": {
            "id": 2928,
            "ingredient_code": 896,
            "en_name": "PAMIDRONATE DISODIUM",
            "fr_name": "Pamidronate disodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02244551",
      "brand_name": "PAMIDRONATE DISODIUM FOR INJECTION",
      "brand_name_fr": "PAMIDRONATE DISODIQUE POUR INJECTION",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123608005"
    },
    "created_date": "2021-10-28T14:30:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244551",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2021-12-13T00:00:00-05:00",
    "actual_start_date": "2021-11-23T00:00:00-05:00",
    "actual_end_date": "2021-12-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-14T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PAMIDRONATE DISODIUM FOR INJECTION",
    "en_drug_common_name": "PAMIDRONATE DISODIUM FOR INJECTION",
    "fr_drug_brand_name": "Pamidronate Disodium",
    "fr_drug_common_name": "Pamidronate Disodium",
    "en_ingredients": "PAMIDRONATE DISODIUM",
    "fr_ingredients": "Pamidronate disodique",
    "drug_strength": "6MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1 x 10mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148421,
    "drug": {
      "current_status": "MARKETED",
      "id": 970,
      "drug_code": 12261,
      "updated_date": "2025-05-15T02:30:52-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251605,
          "ingredient": {
            "id": 356,
            "ingredient_code": 8450,
            "en_name": "AMPICILLIN",
            "fr_name": "Ampicilline (Ampicilline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "00872644",
      "brand_name": "AMPICILLIN SODIUM FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73331",
      "number_of_ais": "1",
      "ai_group_no": "0105872002"
    },
    "created_date": "2021-10-28T15:51:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00872644",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01CA",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2021-11-30T00:00:00-05:00",
    "actual_start_date": "2021-10-26T00:00:00-04:00",
    "actual_end_date": "2021-11-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-11-25T19:44:23-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AMPICILLIN SODIUM FOR INJECTION, USP",
    "en_drug_common_name": "AMPICILLIN SODIUM INJ 250MG",
    "fr_drug_brand_name": "AMPICILLIN SODIUM INJ 250MG",
    "fr_drug_common_name": "AMPICILLIN SODIUM INJ 250MG",
    "en_ingredients": "AMPICILLIN",
    "fr_ingredients": "Ampicilline",
    "drug_strength": "250MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10pk",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148424,
    "drug": {
      "current_status": "MARKETED",
      "id": 4550,
      "drug_code": 2233,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250395,
          "ingredient": {
            "id": 1724,
            "ingredient_code": 8375,
            "en_name": "CLOXACILLIN",
            "fr_name": "Cloxacilline (Cloxacilline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00337765",
      "brand_name": "TEVA-CLOXACILLIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "48251",
      "number_of_ais": "1",
      "ai_group_no": "0131306002"
    },
    "created_date": "2021-10-28T15:53:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00337765",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01CF",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2021-12-31T00:00:00-05:00",
    "actual_start_date": "2021-10-26T00:00:00-04:00",
    "actual_end_date": "2021-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-02T20:26:12-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CLOXACILLIN",
    "en_drug_common_name": "CLOXACILLIN 250MG CAPS",
    "fr_drug_brand_name": "TEVA-CLOXACILLIN 250MG CAPS",
    "fr_drug_common_name": "CLOXACILLIN 250MG CAPS",
    "en_ingredients": "CLOXACILLIN",
    "fr_ingredients": "CLOXACILLIN",
    "drug_strength": "250MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148427,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8900,
      "drug_code": 61179,
      "updated_date": "2025-05-15T03:56:43-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8325595,
          "ingredient": {
            "id": 2564,
            "ingredient_code": 11770,
            "en_name": "NARATRIPTAN",
            "fr_name": "Naratriptan (Chlorhydrate de naratriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02237820",
      "brand_name": "AMERGE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131121001"
    },
    "created_date": "2021-10-28T15:58:44-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02237820",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "discontinuation_date": "2022-08-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-08-09T17:51:07-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "AMERGE",
    "en_drug_common_name": "Naratriptan Tablets",
    "fr_drug_brand_name": "AMERGE",
    "fr_drug_common_name": "Comprimés de naratriptan",
    "en_ingredients": "NARATRIPTAN",
    "fr_ingredients": "Naratriptan (Chlorhydrate de naratriptan)",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "All pack sizes/  Tous les formats",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148430,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8902,
      "drug_code": 61180,
      "updated_date": "2025-05-15T03:56:43-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8325596,
          "ingredient": {
            "id": 2564,
            "ingredient_code": 11770,
            "en_name": "NARATRIPTAN",
            "fr_name": "Naratriptan (Chlorhydrate de naratriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02237821",
      "brand_name": "AMERGE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131121002"
    },
    "created_date": "2021-10-28T16:03:29-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02237821",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "discontinuation_date": "2022-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-12-02T16:47:08-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "AMERGE",
    "en_drug_common_name": "Naratriptan Tablets",
    "fr_drug_brand_name": "AMERGE",
    "fr_drug_common_name": "Comprimés de naratriptan",
    "en_ingredients": "NARATRIPTAN",
    "fr_ingredients": "Naratriptan (Chlorhydrate de naratriptan)",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "All pack sizes / Tous les formats",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148433,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10130,
      "drug_code": 64893,
      "updated_date": "2025-05-15T04:00:45-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8331122,
          "ingredient": {
            "id": 2746,
            "ingredient_code": 11933,
            "en_name": "INACTIVATED POLIOVIRUS TYPE I",
            "fr_name": "Poliovirus de type I inactivé"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8331121,
          "ingredient": {
            "id": 2750,
            "ingredient_code": 11935,
            "en_name": "INACTIVATED POLIOVIRUS TYPE III",
            "fr_name": "Poliovirus de type III inactivé"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8331120,
          "ingredient": {
            "id": 2398,
            "ingredient_code": 7935,
            "en_name": "TETANUS TOXOID",
            "fr_name": "Anatoxine tétanique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8331119,
          "ingredient": {
            "id": 2748,
            "ingredient_code": 11934,
            "en_name": "INACTIVATED POLIOVIRUS TYPE II",
            "fr_name": "Poliovirus de type II inactivé"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8331118,
          "ingredient": {
            "id": 2400,
            "ingredient_code": 7941,
            "en_name": "DIPHTHERIA TOXOID",
            "fr_name": "Anatoxine diphtérique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8331117,
          "ingredient": {
            "id": 2396,
            "ingredient_code": 20,
            "en_name": "PERTUSSIS TOXOID",
            "fr_name": "Anatoxine coquelucheuse"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8331116,
          "ingredient": {
            "id": 2394,
            "ingredient_code": 19,
            "en_name": "FILAMENTOUS HAEMAGGLUTININ",
            "fr_name": "Hémagglutinine filamenteuse"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8331115,
          "ingredient": {
            "id": 2390,
            "ingredient_code": 17,
            "en_name": "PERTACTIN",
            "fr_name": "Pertactine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02241284",
      "brand_name": "INFANRIX-IPV",
      "brand_name_fr": "",
      "descriptor": "PRE-FILLED SYRINGES",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "8",
      "ai_group_no": "0839081001"
    },
    "created_date": "2021-10-28T17:03:53-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02241284",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07CA",
    "atc_description": "BACTERIAL AND VIRAL VACCINES, COMBINED",
    "discontinuation_date": "2021-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-28T17:06:39-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "INFANRIX-IPV",
    "en_drug_common_name": "Combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine",
    "fr_drug_brand_name": "INFANRIX-IPV",
    "fr_drug_common_name": "Vaccin associé antidiphtérique, antitétanique, anticoquelucheux acellulaire et antipoliomyélitique inactivé",
    "en_ingredients": "INACTIVATED POLIOVIRUS TYPE III\r\nINACTIVATED POLIOVIRUS TYPE II\r\nINACTIVATED POLIOVIRUS TYPE I\r\nTETANUS TOXOID\r\nDIPHTHERIA TOXOID\r\nPERTACTIN\r\nFILAMENTOUS HAEMAGGLUTININ\r\nPERTUSSIS TOXOID",
    "fr_ingredients": "Poliovirus de type III inactivé\r\nPoliovirus de type II inactivé\r\nPoliovirus de type I inactivé\r\nAnatoxine tétanique\r\nAnatoxine diphtérique\r\nPertactine\r\nHémagglutinine filamenteuse\r\nAnatoxine coquelucheuse",
    "drug_strength": "32UNIT\r\n8UNIT\r\n40UNIT\r\n40UNIT\r\n30UNIT\r\n8MCG\r\n25MCG\r\n25MCG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "All pack sizes / Tous les formats",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148460,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2978,
      "drug_code": 17276,
      "updated_date": "2025-05-15T03:43:51-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8298798,
          "ingredient": {
            "id": 1148,
            "ingredient_code": 2104,
            "en_name": "BACLOFEN",
            "fr_name": "Baclofène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02131064",
      "brand_name": "LIORESAL INTRATHECAL 2MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79429",
      "number_of_ais": "1",
      "ai_group_no": "0113246003"
    },
    "created_date": "2021-10-28T21:19:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02131064",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "M03BX",
    "atc_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
    "anticipated_start_date": "2021-11-01T00:00:00-04:00",
    "actual_end_date": "2021-11-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-01-17T19:42:50-05:00",
    "status": "resolved",
    "en_comments": "Delay in product release.",
    "fr_comments": "Retard dans la disponibilite du produit",
    "en_drug_brand_name": "LIORESAL INTRATHECAL 2MG/ML",
    "en_drug_common_name": "LIORESAL INTRA 10MG/5ML 1 X 5 AMPS",
    "fr_drug_brand_name": "LIORESAL INTRATHECALE 2MG/ML",
    "fr_drug_common_name": "LIORESAL INTRA 10MG/5ML 1 X 5 AMPS",
    "en_ingredients": "BACLOFEN",
    "fr_ingredients": "Baclofène",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRATHECAL\r\nINTRATHECAL",
    "drug_route_fr": "Intrathécale\r\nIntrathécale",
    "drug_package_quantity": "1X5 AMPS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148466,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3112,
      "drug_code": 17954,
      "updated_date": "2025-05-15T03:44:05-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8299837,
          "ingredient": {
            "id": 1148,
            "ingredient_code": 2104,
            "en_name": "BACLOFEN",
            "fr_name": "Baclofène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02131056",
      "brand_name": "LIORESAL INTRATHECAL 0.5MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80165",
      "number_of_ais": "1",
      "ai_group_no": "0113246005"
    },
    "created_date": "2021-10-28T21:30:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02131056",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "M03BX",
    "atc_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
    "anticipated_start_date": "2021-11-05T00:00:00-04:00",
    "actual_end_date": "2021-11-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-01-17T19:34:33-05:00",
    "status": "resolved",
    "en_comments": "Delay in product release",
    "fr_comments": "Retard dans la disponibilite du produit.\r\nDisponibilite limitee des produits.",
    "en_drug_brand_name": "LIORESAL INTRATHECAL 0.5MG/ML",
    "en_drug_common_name": "LIORESAL 10MG/20ML 1X1 AMPS",
    "fr_drug_brand_name": "LIORESAL INTRATHECALE 0.5MG/ML",
    "fr_drug_common_name": "LIORESAL 10MG/20ML 1X1 AMPS",
    "en_ingredients": "BACLOFEN",
    "fr_ingredients": "Baclofène",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRATHECAL\r\nINTRATHECAL",
    "drug_route_fr": "Intrathécale\r\nIntrathécale",
    "drug_package_quantity": "1 X 1 AMPS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148469,
    "drug": {
      "current_status": "MARKETED",
      "id": 3700,
      "drug_code": 19168,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8252455,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02182874",
      "brand_name": "COZAAR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81459",
      "number_of_ais": "1",
      "ai_group_no": "0127971003"
    },
    "created_date": "2021-10-29T02:07:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02182874",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2022-01-05T00:00:00-05:00",
    "actual_start_date": "2021-10-28T00:00:00-04:00",
    "actual_end_date": "2022-01-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-06T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "COZAAR",
    "en_drug_common_name": "losartan potassium tablets",
    "fr_drug_brand_name": "COZAAR",
    "fr_drug_common_name": "comprimés de losartan potassique",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148491,
    "drug": {
      "current_status": "MARKETED",
      "id": 27340,
      "drug_code": 89591,
      "updated_date": "2025-12-03T00:32:21-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259887,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259886,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02411296",
      "brand_name": "APO-AMLODIPINE-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251555004"
    },
    "created_date": "2021-10-29T13:48:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02411296",
    "company_name": "APOTEX INC",
    "atc_number": "C10BX",
    "atc_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
    "estimated_end_date": "2021-11-19T00:00:00-05:00",
    "actual_start_date": "2021-10-26T00:00:00-04:00",
    "actual_end_date": "2021-11-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-08T12:55:13-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMLODIPINE-ATORVASTATIN",
    "en_drug_common_name": "AMLODIPINE-ATORVASTATIN",
    "fr_drug_brand_name": "APO-AMLODIPINE-ATORVASTATIN",
    "fr_drug_common_name": "AMLODIPINE-ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN\r\nAMLODIPINE",
    "fr_ingredients": "AMLODIPINE-ATORVASTATIN",
    "drug_strength": "80MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148496,
    "drug": {
      "current_status": "MARKETED",
      "id": 31650,
      "drug_code": 93991,
      "updated_date": "2025-12-03T00:33:04-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261861,
          "ingredient": {
            "id": 2176,
            "ingredient_code": 7942,
            "en_name": "CETIRIZINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de cétirizine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02453363",
      "brand_name": "APO-CETIRIZINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122686003"
    },
    "created_date": "2021-10-29T13:59:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453363",
    "company_name": "APOTEX INC",
    "atc_number": "R06AE",
    "atc_description": "ANTIHISTAMINES FOR SYSTEMIC USE",
    "estimated_end_date": "2021-12-10T00:00:00-05:00",
    "actual_start_date": "2021-10-26T00:00:00-04:00",
    "actual_end_date": "2021-12-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-06T15:42:49-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CETIRIZINE",
    "en_drug_common_name": "CETIRIZINE",
    "fr_drug_brand_name": "APO-CETIRIZINE",
    "fr_drug_common_name": "CETIRIZINE",
    "en_ingredients": "CETIRIZINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de cétirizine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148503,
    "drug": {
      "current_status": "MARKETED",
      "id": 22186,
      "drug_code": 84561,
      "updated_date": "2025-12-03T00:31:42-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257943,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02360640",
      "brand_name": "APO-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783006"
    },
    "created_date": "2021-10-29T14:01:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02360640",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2021-12-17T00:00:00-05:00",
    "actual_start_date": "2021-10-25T00:00:00-04:00",
    "actual_end_date": "2021-11-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-26T18:01:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148506,
    "drug": {
      "current_status": "MARKETED",
      "id": 22180,
      "drug_code": 84558,
      "updated_date": "2025-12-03T00:31:42-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257940,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02360616",
      "brand_name": "APO-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783003"
    },
    "created_date": "2021-10-29T14:02:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02360616",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2021-12-17T00:00:00-05:00",
    "actual_start_date": "2021-10-25T00:00:00-04:00",
    "actual_end_date": "2021-12-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-06T15:46:45-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148509,
    "drug": {
      "current_status": "MARKETED",
      "id": 16534,
      "drug_code": 77362,
      "updated_date": "2025-05-15T02:31:51-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255878,
          "ingredient": {
            "id": 2138,
            "ingredient_code": 11104,
            "en_name": "ONDANSETRON",
            "fr_name": "Ondansétron"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02288184",
      "brand_name": "APO-ONDANSETRON",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131120003"
    },
    "created_date": "2021-10-29T14:04:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02288184",
    "company_name": "APOTEX INC",
    "atc_number": "A04AA",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "estimated_end_date": "2022-03-04T00:00:00-05:00",
    "actual_start_date": "2021-10-26T00:00:00-04:00",
    "actual_end_date": "2022-02-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-28T13:27:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ONDANSETRON",
    "en_drug_common_name": "ONDANSETRON",
    "fr_drug_brand_name": "APO-ONDANSETRON",
    "fr_drug_common_name": "ONDANSETRON",
    "en_ingredients": "ONDANSETRON",
    "fr_ingredients": "Ondansétron",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "10 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148529,
    "drug": {
      "current_status": "MARKETED",
      "id": 2290,
      "drug_code": 15163,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8252009,
          "ingredient": {
            "id": 1108,
            "ingredient_code": 2282,
            "en_name": "DANAZOL",
            "fr_name": "Danazol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02018152",
      "brand_name": "CYCLOMEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76844",
      "number_of_ais": "1",
      "ai_group_no": "0110952002"
    },
    "created_date": "2021-10-29T15:48:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02018152",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "G03XA",
    "atc_description": "OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM",
    "anticipated_start_date": "2021-11-06T00:00:00-04:00",
    "estimated_end_date": "2022-01-07T00:00:00-05:00",
    "actual_end_date": "2021-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-01-06T21:07:54-05:00",
    "status": "resolved",
    "en_comments": "Disruption of the manufacturing of the product. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Perturbation de la fabrication du produit. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "CYCLOMEN",
    "en_drug_common_name": "Cyclomen 100mg",
    "fr_drug_brand_name": "CYCLOMEN",
    "fr_drug_common_name": "Cyclomen 100mg",
    "en_ingredients": "DANAZOL",
    "fr_ingredients": "Danazol",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148536,
    "drug": {
      "current_status": "MARKETED",
      "id": 31682,
      "drug_code": 94035,
      "updated_date": "2025-12-03T00:33:05-05:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8261875,
          "ingredient": {
            "id": 4160,
            "ingredient_code": 22706,
            "en_name": "ALIROCUMAB",
            "fr_name": "Alirocumab"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02453819",
      "brand_name": "PRALUENT",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE PREFILLED PEN",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0158030001"
    },
    "created_date": "2021-10-29T15:54:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453819",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "C10AX",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2021-11-08T00:00:00-05:00",
    "actual_start_date": "2021-10-29T00:00:00-04:00",
    "actual_end_date": "2021-11-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-11-09T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "PRALUENT",
    "en_drug_common_name": "Praluent 75mg",
    "fr_drug_brand_name": "PRALUENT",
    "fr_drug_common_name": "Praluent 75mg",
    "en_ingredients": "ALIROCUMAB",
    "fr_ingredients": "Alirocumab",
    "drug_strength": "75MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "2",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148539,
    "drug": {
      "current_status": "MARKETED",
      "id": 55786,
      "drug_code": 77467,
      "updated_date": "2025-05-15T02:31:51-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255890,
          "ingredient": {
            "id": 1286,
            "ingredient_code": 232,
            "en_name": "PERINDOPRIL ERBUMINE",
            "fr_name": "Périndopril erbumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02289296",
      "brand_name": "APO-PERINDOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127178003"
    },
    "created_date": "2021-10-29T18:37:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02289296",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2021-11-26T00:00:00-05:00",
    "actual_start_date": "2021-10-25T00:00:00-04:00",
    "actual_end_date": "2021-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-15T19:26:54-05:00",
    "status": "resolved",
    "en_comments": "100 bottles are available",
    "fr_comments": "100 bottles are available",
    "en_drug_brand_name": "APO-PERINDOPRIL",
    "en_drug_common_name": "PERINDOPRIL",
    "fr_drug_brand_name": "APO-PERINDOPRIL",
    "fr_drug_common_name": "PERINDOPRIL",
    "en_ingredients": "PERINDOPRIL ERBUMINE",
    "fr_ingredients": "Périndopril erbumine",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148545,
    "drug": {
      "current_status": "MARKETED",
      "id": 101851,
      "drug_code": 98324,
      "updated_date": "2023-10-26T00:04:16-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264523,
          "ingredient": {
            "id": 2640,
            "ingredient_code": 11819,
            "en_name": "RISEDRONATE SODIUM",
            "fr_name": "Risédronate sodique (Hémipentahydrate de risédronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "35",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02493268",
      "brand_name": "AA-RISEDRONATE DR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135301003"
    },
    "created_date": "2021-10-29T18:39:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02493268",
    "company_name": "APOTEX INC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2021-11-19T00:00:00-05:00",
    "actual_start_date": "2021-10-26T00:00:00-04:00",
    "actual_end_date": "2021-11-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-19T16:21:20-05:00",
    "status": "resolved",
    "en_comments": "30 bottles are available",
    "fr_comments": "30 bottles are available",
    "en_drug_brand_name": "APO-RISEDRONATE DR",
    "en_drug_common_name": "RISEDRONATE DR",
    "fr_drug_brand_name": "APO-RISEDRONATE DR",
    "fr_drug_common_name": "RISEDRONATE DR",
    "en_ingredients": "RISEDRONATE SODIUM",
    "fr_ingredients": "Risédronate sodique",
    "drug_strength": "35MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 148550,
    "drug": {
      "current_status": "MARKETED",
      "id": 6774,
      "drug_code": 44257,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8253176,
          "ingredient": {
            "id": 202,
            "ingredient_code": 7358,
            "en_name": "CHORIONIC GONADOTROPIN",
            "fr_name": "Ganodotrophine chorionique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02182904",
      "brand_name": "PREGNYL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9981",
      "number_of_ais": "1",
      "ai_group_no": "0106481003"
    },
    "created_date": "2021-10-29T19:59:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02182904",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "G03GA",
    "atc_description": "GONADOTROPHINS AND OTHER OVULATION STIMULANTS",
    "anticipated_start_date": "2021-10-29T00:00:00-04:00",
    "estimated_end_date": "2022-04-22T00:00:00-04:00",
    "actual_start_date": "2021-10-29T00:00:00-04:00",
    "actual_end_date": "2022-04-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-04-12T12:32:00-04:00",
    "status": "resolved",
    "en_comments": "Back orders released on April 7th - Limited quantities available",
    "fr_comments": "Les commandes en souffrance ont été libérées le 7 avril - Quantités limitées disponibles.",
    "en_drug_brand_name": "PREGNYL",
    "en_drug_common_name": "chorionic gonadotropin for injection",
    "fr_drug_brand_name": "PREGNYL",
    "fr_drug_common_name": "gonadotrophine chorionique pour injection",
    "en_ingredients": "CHORIONIC GONADOTROPIN",
    "fr_ingredients": "Ganodotrophine chorionique",
    "drug_strength": "10000UNIT",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nLIQUID\r\nKIT",
    "drug_dosage_form_fr": "Poudre pour solution\r\nLiquide\r\nTrousse",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "10000U VIAL & 10ML SOLVENT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  }
]